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&One&of&the&major&burdens&in&the&global&pig9rearing&industry&is&the&disease&called&post9weaning& diarrhoea& (PWD),& caused& predominantly& by& enterotoxigenic&Escherichia& coli& bearing&F4& fimbriae& (F4+ETEC)& (Fairbrother& et& al.,& 2005).&This&disease&causes&reduction&in&weight&gain&and&in&extreme&cases&(~2%&reported&in&Belgium)&it&leads&to&death&of&piglets.&Consequently,&both&of&these&conditions&lead&to& unavoidable& economic& losses& for& the& farmers& (Amezcua& et& al.,& 2002).& In&Belgium&itself,&ETEC&related&PWD&leads&to&losses&of&about&EUR&15&million&every&year,&which& is& roughly& about& 1%& of& the& annual& returns& of& porcine&meat,& and& a&significant& reduction& of& already& low& profit& margin1.& Globally,& there& are& no&solutions&towards&post9weaning&diarrhoea&caused&by&F4+ETEC.&Antibiotics&were&used&prophylactically&until& recently,&but&because&of&an& increasing&occurrence&of&antibiotic& resistance,& a&ban&on& the&prophylactic&use&of&antibiotics&was& installed.&However&use&of&antibiotics&is&still&prevalent,&but&now&as&therapeutic&against&PWD.&The&serious&risk&of&introducing&antibiotic&resistant&strains&has&led&to&a&worldwide&increasing& demand& for& alternative& strategies& to& prevent& PWD.& Some& of& these&antibiotic&alternatives&include&probiotic,&prebiotic&feed&additives&or&even&organic&acids;& but& none& of& these& products& sufficiently& reduce& or& prevent& incidence& of&ETEC&related&PWD&(Fairbrother&et&al.,&2005;&Roselli&et&al.,&2005;&Vondruskova&et&al.,&2010).&&Of&several&experimented&techniques&to&prevent&PWD,&better&results&are&obtained&with& passive& immunisation& strategies.& Piglets& are& protected& when& fed& feed&containing& plasma& protein& obtained& from& porcine& slaughterhouses& which& is&anticipated&to&contain&anti9ETEC&antibodies&or&when&fed&with&specific&anti9ETEC&antibodies&obtained&from&immunized&hen&eggs&(Niewold!et!al.,&2007;&Yokoyama!
et!al.,&1992).&However&it&is&difficult&to&regulate&the&proportion&of&antibodies&from&batch& to& batch& from& both& these& sources.& Moreover& the& anti9ETEC& antibodies&produced&in&eggs&are&expensive,&while&the&use&of&slaughterhouse&derived&animal&products& in& animal& feed& is& discouraged& due& to& important& health& and& safety&concerns.&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&1&The&archive&of&Dierengezondheidszorg&Vlaanderen&(Animal&Health&Care,&Flanders)&&&http://www.dierengezondheidszorg.be/ondersteuning/praktijk_advies_publikaties_varkens/autopsie%20varkens%202007.pdf&
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The&crucial&initial&step&in&colonization&of&the&host&tissue&occurs&by&attachment&of&the& F4+ETEC& bacteria& to& the& microvilli& via& the& F4& fimbriae.& The& adhesive&characteristic&of&F4&fimbriae&has&been&shown&to&be&exhibited&by&the&polymerizing&subunits9&FaeG&(Bakker!et!al.,&1992a;&Bakker!et!al.,&1992b).&We&therefore&opted&to&obstruct& this& initial& infection&step&of&F4+ETEC&colonizing& the&host& tissue&by&oral&administration&of&adhesion9blocking&anti9FaeG&antibodies&to&just9weaned&piglets.&For&convenience&of&oral&administration,&and&cost&effective&production&we&aimed&at& producing& these& anti9FaeG& antibodies& in& seeds,& so& that& they&may& directly& be&incorporated&in&the&starter&feed&of&weaned&piglets.&Thus,& our& main& objective& was& to& develop& a& general& approach& to& protect& just9weaned& piglets& by& oral& feed& based& passive& immunization& during& the& critical&period& of& three& weeks& after& weaning& when& piglets& are& most& susceptible& to&infection&by&ETEC.&We&chalked&out&a&49part&strategy&with&the&aim&to&achieve&this&objective.&In& the& first& step& we& intended& to& develop& a& robust& antibody& with& high& binding&affinity,&which&can&also&be&easily&expressed&and&bulk&produced.&Hence&rather&than&conventional& monoclonal& antibodies,& or& single& chain9Fc& fusion& antibodies& we&decided&to&opt&for&variable&domains&of&heavy&chain&antibodies&(VHH)&of&camelids&(Hamers9Casterman! et! al.,& 1993).& Specific& VHHs& were& to& be& isolated& by&immunizing&a&lama&with&the&purified&FaeG&adhesin.&On&selection&of&best&anti9FaeG&monomeric&VHHs&they&would&be&cloned&and&characterised.&&In&the&second&step&we&planned&to&graft&the&anti9FaeG&VHH&on&the&Fc&domains&of&IgG3& (Butler! et! al.,& 2009)& and& IgAb& (Brown! et! al.,& 1995)& to& generate& bi9& or&tetravalent&antibodies.&The&porcine&IgG3&and&the&IgAb&are&both&suggested&of&being&fairly& resistant& to&proteases& and& this& attribute&makes& them&an& ideal& Fc& for& oral&immunization&(Brown!et!al.,&1995;&Butler!et!al.,&2009).&Also&the&fusion&with&the&Fc&domains&should&lead&to&dimerization&and&thus&increase&the&avidity.&Additionally&by&co9expression&of&porcine&joining&chain&and&porcine&secretory&component&with&VHH9IgA& fusion&molecule&we& sought& to& investigate& the& production& of& secretory&IgA&(SIgA).&SIgA&are&tetravalent,&robust&and&have&high&retention&time&at&mucosal&surfaces.&
Scope&and&Objectives&
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Passive immunisation and 
the role of plant expression systems
A cost effective shortcut to attain protection against infection
Vikram Virdi, Sylvie De Buck, Henri De Greve and Ann Depicker
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&&V.V.&wrote&the&chapter&and&S.D.B,&H.D.G&and&A.D&edited&it.&& & & &&&&&&&&&&&&&&&&&&The&above&artwork&depicts&various&biological&functions&of&an&antibody&in&evading&pathogens,&which&can&be&achieved&by&direct&administration&of&specific&antibodies.&Adapted&from&Casadevall&et&al.,&2004&
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antimicrobial armamentarium is inadequate. At the
same time, the development of PCR and other rapid
diagnostic techniques has provided new options that
could support antibody-based therapies. Importantly,
the efficacy of anti-infective antibody-based therapies
can be assessed relatively easily, as there are well-defined
clinical end points that can be used to determine
whether therapy has been successful.
A peculiar characteristic of antibody-based therapies
is that their efficacy diminishes rapidly as the duration
of infection increases.Antibody reagents with therapeutic
potential are often evaluated by administration to naive
hosts before infection. Although this approach to select
antibody preparations was well established during the
development of serum therapy, it is noteworthy that
serum was effective in humans even when adminis-
tered several days after the onset of symptoms, despite
having little or no therapeutic efficacy in mouse mod-
els2. However, even in humans, the efficacy of thera-
peutic antibodies diminished rapidly after the onset of
symptoms2,5. The mechanism responsible for this is
not well understood, but might reflect a rapid increase
in the microbial burden in the animal models used,
which are usually selected on the basis of their marked
susceptibility to the agent in question28. A loss of effi-
cacy with increased duration of infection or disease
could limit the application of antibody-based strate-
gies to prophylaxis and/or conditions where an early
diagnosis is possible.
infectious agents such as prions or viruses. Although
tight regulation and regulatory vigilance and surveillance
can reduce this concern, the need for ongoing monitor-
ing and testing for contamination contributes to the
high cost of developing and administering antibody
therapies. In addition, antibody-based therapies require
considerable logistical support. As antibodies are pro-
teins, they cannot be given orally, except for those used
to treat certain types of mucosal infectious diseases,
such as Cryptosporidium parvum-associated diarrhoea,
and therefore, systemic administration is required.
Owing to their high specificity, antibodies have
activity against the microorganism to which they bind.
Antibody therapy therefore requires knowledge of the
causative microbial agent, which in turn requires rapid
microbiological diagnosis. Additionally, because anti-
body efficacy is highest when given early in the course
of infection, rapid diagnosis is essential for the success
of antibody therapy. For example, the efficacy of serum
therapy for pneumococcal pneumonia is markedly
reduced after the first three days of symptoms2,5. In the
first decades of the antibiotic era, the lack of innova-
tion in microbiological diagnosis was tolerated owing
to the availability of broad-spectrum antimicrobial
agents. However, the need for rapid diagnostic tech-
niques has assumed greater urgency with the emer-
gence of fungi in immunocompromised hosts and
nosocomial infections, resistant bacteria and previ-
ously unknown viral diseases for which the available
Activation of
complement
















Figure 1 | The different biological effects of antibodies. Toxin and virus neutralization, complement activation and direct
antimicrobial functions such as the generation of oxidants are independent of other components of the host immune system,
whereas antibody-dependent cellular cytotoxicity and opsonization depend o  other host cells and mediators.
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Abstract:!!On&encountering&a&pathogen,&the&immune&system&can&develop&specific&resistance&to& control& the& spread& of& infection& and& prevent& any& subsequent& infection& of& the&same&pathogen.&The&molecules&called&antibodies&are&a&key&factor&in&establishing&this& immunity.& Vaccines& are& aimed& at& priming& of& the& immune& system& and&development& of& protective& antibodies& usually& prior& (weeks& to& months)& to& the&contingency&of&encountering&a&pathogen.&However&there&are&many&circumstances&in& which& vaccines& might& be& less& suitable,& particularly& in& situations& where&immediate& immunity& is& needed.& To& achieve& immediate& immunity& pathogen9specific&antibodies&can&be&administered;&this&medical&procedure&is&called&passive&immunisation.&&&Passive&immunisation&has&proven&to&be&life&saving&in&many&acute&infections,&e.g.&human& respiratory& syncytial& viral& infections& in& neonates,& hepatitis& B& virus&infection,&etc.&Apart& from& infectious&diseases,&passive& immunisation& is&now&also&used& within& the& cancer& treatment.& Such& passive& immunisation& therapies& are&extremely& expensive& since& it& requires& large& amounts& of& specific& antibodies& that&are& produced& in& recombinant& systems.& Today&most& therapeutic& antibodies& are&produced& in& mammalian& cells,& and& attempts& are& being& made& to& produce&antibodies& in& cost& effective& alternative& expression& systems.& Antibodies& can& be&produced& in& plants,& and& since& plant& production& systems& require& relatively& less&capital& investments,& the& final& cost& of& plant&made& antibody& is& estimated& to& be& a&fraction&of&the&current&cost.&In&addition,&plant&production&systems&are&not&prone&to&mammalian&pathogens&and&hence&provide&a&safe&expression&system.&This&eases&the& downstream& processing& and& helps& in& maintaining& the& benefit& of& low&production& cost.& The& current& molecular& techniques& in& the& field& of& in! planta&expression&have&enabled&high9level&expression&of&a&variety&of&antibodies.&These&antibodies& can& be& specifically& produced& in& different& plant& organs& like&roots/tubers,&leaves,&seeds&etc.&of&a&variety&of&plants&like&potato,&tobacco,&maize,&rice,&pea&etc.&Providing&for&a&very&wide&range&of&possibilities&to&develop&a&plant9based& passive& immunisation& therapy,& for& instance& production& of& antibodies& in&edible&tissue&allows&for&convenient&needle9less&oral&passive&immunisation&at&the&gastric&mucosal&surface.&&
Chapter&2&
 14 
This& review& intends& to& shed& light& on& the& role& of& plants& as& a& flexible& expression&system& for& passive& immunotherapy.& We& build& the& discussion& by& revealing& the&scope& of& passive& immunisation& (i),& then& the& various& antibody& formats& that& can&help& in& achieving& the& goal& of& immune& prophylaxis& (ii),& followed& by& a& brief&introduction& to& the& current& expression& systems& (iii)& and& then& describe& plant9based& production& system& (iv),& laying& more& emphasis& on& in& leaf& and& in& seed&production&for&therapeutic&application&in&humans&as&well&as&animals.&&
General!introduction!and!scope!of!passive!immunisation!!One&of&the&most&important&arsenals&in&fighting&against&infectious&diseases&is&the&protein& molecule& called& immunoglobulin& (Ig)& or& antibody& (Ab).& On& natural&infection&and&on&vaccination,&the&immune&system&is&primed&to&produce&pathogen9specific&antibodies,&which&in&turn&protect&from&subsequent&infection&by&the&same&pathogen& through& various&mechanisms& (discussed& later)(Durandy! et! al.,& 2009).&Vaccination& has& been& one& of& the& single& most& important& medical& procedures&developed& to& attain& long9term& protection& against& disease9causing& pathogens;& it&has&enabled&eradication&of&dreaded&disease&like&small&pox,&and&pushed&polio&near&verge& of& extinction2.& However,& vaccination& is& predominantly& prophylactic& and&usually& needs& to& be& administered& well& in& advance& to& protect& against& possible&infections.& In& many& instances& vaccines& are& not& suitable,& like& protection& of&neonatal& from&vertical& transmission&of& viruses& from&mother,& protection& against&biological& warfare,& emerging& diseases,& protection& of& neonatal& and& pre9mature&births,& protection& of& elderly& and& immunocompromised& patients;& or& in& case& of&vaccine&non9responders,&or&individuals&at&risk&of&vaccine9induced&side&effects.&In&most&of&these&cases&immediate&protection&is&needed.&In&such&instances&immediate&protection&can&be&achieved&by&direct&administration&of&disease9specific&protective&antibodies.& The& administration& of& disease9specific& antibodies& either&prophylactically&or&post9exposure& is& called&passive& immunisation& (Gonik,&2011;&Naz& and& Rajesh,& 2004;& Raab,& 2011;& Zeitlin! et! al.,& 2000;& Zeitlin! et! al.,& 1999).&(Differences&between&active&and&passive&immunisation:&see&table&2.1)&Passive& immunisation& occurs& in& nature& as& well,& where& it& is& called& maternal&immunity& i.e.& antibodies& are& transferred& from&mother& to& the& offspring.& In&most&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&2&http://www.cdc.gov/vaccines/vac9gen/downloads/pg_why_immz.pdf&
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animals,&the&transfer&occurs&through&the&placenta&before&birth&(Garty!et!al.,&1994;&Zhang!et!al.,&2012)&and&in&mammals&also&later&through&maternal&milk&in&early&life&(Hasselquist&and&Nilsson,&2009).&In&farm&animals&like&pigs,&horse,&sheep&and&cow&the& transfer& of& maternal& immunity& occurs& exclusively& through& colostrum& and&milk,& as& the& placentation& in& these& animals& does& not& allow& transfer& of&immunoglobulins& (Hurley& and& Theil,& 2011).& In& these& economically& important&farm& animals,& the& neonatal& and& newly& weaned& vulnerable& young& ones& can& be&protected& against&many& common& diseases& via& artificial& prolongation& of& passive&immunity&post&weaning.&&
Table!2.1:!Passive!immunisation!versus!active!immunisation!!Points&of&distinction&& Passive&immunisation&& Active&immunisation&&Provides&immediate&protection&& Yes& No&Duration&of&protection&& Days&to&months& Years&&Systemic&immunity&& Yes& Yes&Capacity& to& restriction& exclusively& to&mucosal&surface&if&intended& Yes& No&Controlled&duration&of&activity&& Yes& No&Requirement& of& antigen& specific& host&response& No& Yes&Diverse&response&with&multi9specificities& Not&with& a& single&monoclonal&antibody&but&possible&with&an&oligoclonal& mixture& of&different& monoclonal&antibodies& or& polyclonal&antibodies!
Yes&
Prophylactic&or&post&exposure&& Both& possible,& ideally&prophylactic& or& immediately&on& exposure& (longer& the&duration& of& time& after&exposure,& weaker& is& the&protection)&
Mostly&prophylactic&use&(Except& in& case& of& few&exceptions&like&rabies)&
Table&adapted&from&Zeitlin!et!al.,&2000&and&Casadevall!et!al.,&2004.&&The&use&of&passive& immunisation& for&prevention&of& infectious&disease& in&human&subjects& can& be& traced& back& to& the& 1800s,& when& antibodies& were& sought& from&animal& sera& like& rabbit& and& horse& (Eibl,& 2008).& However,& infusion& of& animal&serum&was&not&tolerated&leading&to&immune&complication&called&‘serum&sickness’&particularly&on&repeated&use.&Later&human&antibodies&(from&human&convalescent&
Chapter&2&
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sera)& were& available& and& passive& immunisation& was& largely& used& during& the&World&War& I,& to& treat& tetanus,& diphtheria& and&pneumococcal& disease.& By&1930s&and&1940s,& the&advancement&of& fractionation&techniques&meant&that&the&plasma&proteins& could& be& separated& and& a& stable& biological& fraction& could& be&administered.&Such& fractionated&serum&was&used&to& treat&poliomyelitis,&mumps,&measles,& pertussis& and& even&hepatitis&A& (Raab,& 2011).& Later,& the&use& of& passive&immunisation& declined& with& the& emergence& of& antibiotics& and& vaccines&(Berghman!et!al.,&2005;&Hsu&and&Safdar,&2011)&but&passive&immunisation&is&still&in&use& (Holliger&and&Hudson,&2005;&Naz&and&Rajesh,&2004).&Moreover& in& recent&years,&due&to&increasing&ban&on&antibiotics&given&the&risk&of&introducing&resistant&bacterial& strains,&a& suitable&alternative& is&urgently&needed.& It& is&anticipated& that&passive&immunisation&will&regain&popularity&and&might&reduce&the&dependency&of&the& traditionally&used&antibiotic& therapy& (Berghman! et!al.,&2005;&Oleksiewicz! et!
al.,&2012;&Zeitlin!et!al.,&2000).&The&technology&for&development&of&antibodies&has&developed&in&leaps&and&bounds,&now&specific&high&quality&antibodies&against&one&specific& epitope9& called& monoclonal& antibodies& (mAb)& can& be& produced&(explained& in& detail& in& subsequent& section).& The& technological& developments,&have& thus& give& a& boost& to& the&passive& immunisation& field& and& aim& to&provide& a&part& of& the& solution& to& the& increased& disease& burden& and& emergence& of& new&pathogens.&&Along&with&infectious&diseases&(Table&2.2&and&2.4),&passive&immunisation&is&also&being& used& to& treat& non9infectious& diseases& like–& cancer& (e.g.& FDA& approved,&Bevacizumab& and& Cetuximab& for& colon& cancer,& Alemtuzumab& for& chronic&lymphocytic&leukaemia),&autoimmune&diseases&(e.g.&FDA&approved,&Adalimumab&for& treatment& of& rheumatoid& arthritis)& and& Alzheimer& (Bapineuzumab& and&Solanezumab&are&among&some&mAb&being&evaluated&in&clinical&trials).&For&some&more& examples& of& various& FDA& approved& clinically& used& antibodies,& and& other&promising&mAbs& in& clinical& and&preclinical& phase&of&development& see&Table&2.2&and&2.4.&(Casadevall!et!al.,&2004;&Holliger&and&Hudson,&2005;&Zeitlin!et!al.,&2000).&Antibody& therapy& is& also& being& used& in& novel& applications& like& regulating& and&controlling& drug& abuse& in& case& of& cocaine& and& nicotine& addiction.& Antibodies&specific& for& these&drugs&prevent& their&access& to& the&brain,&and&thus&regulate& the&drug& induced& effects.& Currently& ongoing& clinical& trials& will& provide& more&
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information& about& this& novel& application& of& antibody& therapy.& For& more& on&passive& immunisation& to& treat& drug& abuse& see& review& by& (Kosten& and& Owens,&2005).&&&Mucosal&surfaces&comprising&the&respiratory&tract,&the&gastrointestinal&tract,&the&reproductive& and& the& genital& tract& are& the& gateways& for& most& pathogenic&infections.& Most& vaccines& fail& to& attain& systemic& as& well& as& mucosal& immune&response,&the&latter&can&prevent&the&pathogenic&invasion&at&the&first&port&of&entry.&Topical& application& of& antibodies& at& mucosal& surface& can& immediately& provide&this&barrier&protection&(Corthésy,&2003;&Corthésy&and&Spertini,&1999).&A&mixture&of& 3& mAb& 2G12,& 2F5,& 4E10& as& a& mAbGel& is& being& evaluated& in& clinical& trial& as&vaginal&microbicide&for&prevention&of&HIV&in&heterosexual&couples.&Development&of& such&microbicides& against& sexually& transmitted&diseases& (STD)&has&profound&importance&in&preventing&unsafe&sex9related&death&and&disability&(Whaley!et!al.,&2011).&&&
Table! 2.2:! Examples! of! some! promissing! antibody! and! antibody! derived!
fragments!!
Indication/pathogen!! Brand! name! (generic!
name)!
Antigen/specific!target! Stage!!
Monoclonal!! & & &RSV& Palivizumab& F&protein& FDA&approved&Anti9angiogenesis& Bevacizumab& VEGF9A& FDA&approved&Rheumatoid&arthritis&& Actemra&(Tocilizumab)& & FDA&approved&HIV& Tanox&(Ibalizumab)& CD4& Phase&IIb&Rabies& Foravirumab& Glycoprotein&G& Phase&II&complete&
Fab!fragment&Cardiovascular&disease& ReoPro& GpIIb/GpIIa& FDA&approved&Rattle&snake&bite& CroFab& Snake&venom& FDA&approved&Macular&degeneration&& Lucentis& VEGF& Phase&III&
ScFv&Coronary&artery&bypass& Pexelizumab& Complement&C5& Phase&II/III&
Tetravalent!ScFv!&Melanoma& SGN917& P97& Preclinical&
ScFv!dimerHFc!(minibody)! & & &Colorectal&cancer& T88.66& CEA& & Preclinical&
Diabody&Ovarian&and&breast&cancer& C6.5K9A& Her2/Neu& Preclinical&
VHH!(camelid)3&RSV& ALX90171&(trivalent)& & Phase&I&Antithrombotic& ALX90081,&ALX90681& Von&Willebrand&factor& Phase&II&Compiled&from&Holliger&and&Hudson,&2005;&Ter&Meulen,&2011,&FDA&website&&Passive& immunisation& or& antibody& therapy& has& great& potential& for& human& and&animal&health.&The&current&cost&of&this&therapy&is&often&very&high&and&a&burden&on&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&3&http://www.ablynx.com/en/research9development/pipeline/&
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health& care& system& (Rietveld! et! al.,& 2010).& Aiming& at& reducing& the& cost& of&production&and&treatment;&different&expression&platforms&are&now&being&refined&and& several& different& antibody& formats& with& engineered& merits& are& being&produced.& In& subsequent& sections& we& introduced& the& various& antibody& and&antibody9derived& formats& that& have& been& developed& and& the& current& platforms&used& by& industry& to& manufacture& them,& and& lastly& we& explore& how& plants& can&provide&a&unique&solution.&&
Antibody!structure,!formats,!function!and!derivatives!The&first&Nobel&Prize&ever&for&Medicine&was&awarded&in&1901&to&Emil&von&Behring&for& the&discovery&of&what&was& then& called& the& ‘serum&antitoxins’.& In&1890,&Emil&Behring& and& Shibasaburo& Kitasato& immunised& rabbits& with& tetanus& and& then&collected& the& serum;& they& noticed& that& when& they& administered& 0.2& ml& of& this&(immune)& serum& to& healthy& mice,& the& mice& were& protected& from& subsequent&challenge& from& the& virulent& strain& of& tetanus;& thus& the& concept& of& passive&immunisation&came& in& to&being.&Later& (1939)&Tiselius&and&Kabat&discovered&on&electrophoreses& of& serum& that& the& protective&molecule&within& the& serum–& now&know& as& ‘antibody’,& belonged& to& the& globulin& fraction& (hence& called&immunoglobulin).&Using&enzymatic&and&chemical&methods&the&basic&structure&of&the&antibodies&was&deciphered.&The&antibodies&are&composed&of&two&(long)&heavy&chains&and&two&(short)&light&chains,&which&are&arranged&in&a&‘Y9shaped’&structure&(Figure&2.1,&a).&&The& two& (upper)& ends& of& the& ‘Y’& shaped& molecule& are& called& the& ‘Fab’& region&(fragment& antigen& binding)& since& they& are& involved& in& antigen& binding.& The&variable& tip& domain& of& the& paired& heavy& and& light& chains& interacts& with& the&antigen&(labelled&VH&and&VL& in&Figure&2.1).&The&tail&end&of& the&two&paired&heavy&chains& forms& the& ‘Fc’& (fragment& crystallisable)& region.& The& Fc& region& in& a& given&class&of&antibody& is&conserved&and&attributes&specific&biological& functions&called&effector&functions.&Depending&upon&the&conserved&domain&of&the&heavy&chain,&the&immunoglobulins& can& be& classified& as& immunoglobulin& G& (IgG,& bearing& the& γ&heavy&chain),&immunoglobulin&A&(IgA,&bearing&α&heavy&chain),&immunoglobulin&D&(IgD,& bearing& the& δ& heavy& chain),& immunoglobulin& E& (IgG,& bearing& the& ε& heavy&chain)&and&immunoglobulin&M&(IgM,&bearing&the&µ&heavy&chain).&The&IgG,&IgD&and&&
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&
Figure!2.1:!The!5!different!antibody!classes!commonly!found!in!mammals.!The&light&chains&are& indicated& in&pink,& each&domain& is& shown&as& a& connected&oval,& note& the&different&number&of&constant&domains&in&heavy&chain.&The&disulphide&bonds&are&indicated&with&a&dark&line.&Here&the&IgA&molecule&is&depicted&as&dimeric&form&joined&by&the&Joining&chain&(blue&–&paper&clip&like),!the&pentameric& IgM&also&bears&a&similar& J&chain.&Reused& from&Goldsby! et!al.,&2003.&For&more&details&see&text.&&&IgE& are& found& in&monomeric& state& in& the& serum& (i.e.& two&heavy& chains& and& two&light&chains&—&H2L2)&(Figure&2.1,&a,&b&and&c)&while&the&IgM&occurs&as&a&pentamer&(H2L2)5& (Figure& 2.1,& e).& The& IgA& occurs& as& polymeric& IgA& (pIgA)& either& as&tetrameric&[(H2L2)4&+&J&chain]&or&dimeric&[(H2L2)2+&J&chain]&form.&A&joining&chain&called& ‘J& chain’& facilitates& the&multimerisation&of& IgM&and& IgA&(Figure&2.1,&d&and&e)(Goldsby! et! al.,& 2003).& IgA& is& the& predominant& antibody& at& most& mucosal&surfaces&where&it&occurs&as&secretory&IgA&(SIgA),&i.e.&a&dimeric&IgA&(dIgA)&with&a&secretory&component&wound&around&the&complex&(Corthésy,&2002;&Strugnell&and&Wijburg,& 2010)(please& see& Figure&5.1& in& Chapter95& for& biogenesis& of& SIgA).& The&basic& 5& antibody& classes& (IgG,& IgA,& IgM,& IgE,& IgD)& can& be& found& in& mammals&(Goldsby! et! al.,& 2003).& While& some& general& differences& are& seen& in& other&vertebrates&e.g.&except&mammals&only&birds&produce&SIgA&(Wieland!et!al.,&2004).&In&classes&Reptilia!and&Aves,&especially&in&the&eggs&of&animals&belonging&to&these&two&classes&a&variant&class&of&Ig–&the&immunoglobulin&Y&(IgY,&yolk&antibodies)&is&
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found&(Chrzastek&and&Piasecki,&2011).&&Besides& these& antibody& formats,& about& two& decades& ago& a& unique& kind& of& antibody&occurring& as& a& homo9dimer& of& heavy& chains& lacking& light& chains& was& discovered& in&camelids& (camels& and& lama)& and& was& named& heavy& chain& antibody& (HCAb)& (Hamers9Casterman! et! al.,& 1993).& Soon& after,& similar& heavy& chain& only& antibodies& were& also&discovered& in& cartilaginous& fishes& (nurse& shark& and&wobbegong),& this& immunoglobulin&was& named& Ig9NAR& where& NAR& stands& for& ‘novel& antigen& receptor’& (Greenberg! et! al.,&1995).&These&two&serendipitous&discoveries&gave&an&impetus&to&the&development&of&the&latest& trend&of& engineered&antibody&with& customised& functions,& for& specific& application&(Muyldermans,& 2001;&Wesolowski! et! al.,& 2009).& The& antigen9binding& tip& ends& of& these&camel& HCAbs& are& called& the& variable& domains& of& heavy& chain& only& antibody& (VHH)& or&nicknamed& Nanobody®& while& the& variable& domains& of& the& shark& Ig9NAR& are& called&variable&domain&of&novel&antigen&receptor&(V9NAR).&Both&these&antigen&binding&variable&domains&are&highly&evolved.&The&VHHs&exhibit&a&long&convex&loop&surface&that&increases&the&repertoire&of&antigen&binding&capacity.&These&VHHs&and&V9NARs&have&the&ability& to&bind&into&deep&enzyme&clefts&and&thus&target&hidden&conformational&antigenic&potentials,&which& are& inaccessible& to& the& conventional& Igs& (de&Marco,& 2011;& Muyldermans,& 2001;&Muyldermans!et!al.,&2001).&&
&
Figure! 2.2:! Schematic! representation! of! fullHlength! antibodies! and! various! antibody!
fragments.! The& constant& domains& are& indicated& in& blue.& The& classical& IgG& structure& is& shown&along&side&the&heavy&chain&only&immunoglobulins&from&camelids&(Camel&Ig)&and&sharks&(IgNAR);&more& explanation& in& text.& The& approximate& molecular& weight& is& indicated& in& brackets.& The&minibody&and&Fab2&are&bound&by&disulphide&bonds&within&the&hinge&region,&while&the&tri9specific&Fab3& is& produced& by& chemically& crosslinking& (sulfhydryl9specific& cross9linker& o9phenylenedimaleimide)&of&3&Fabs&specific&against&different&epitopes.&The&other&variants&based&on&scFv&shown& in& the& figure& involve& fusion& through&different&size& linker.&Reused& from&Holliger&and&Hudson,&2005.&&&The& wide& range& of& these& antibodies& together& with& the& state& of& the& art& chemical& and&genetic&engineering&tools,&together&with&the&choice&of&host&expression&systems&have&now&presented& the& researchers& with& a& myriad& of& possibilities& to& construct& customised&
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antibody& /& antibody9like&molecules.& This& can& be& comparable& to& a& Lego®& kit&where& the&synthesis& of& novel& antibodies& is& constrained& merely& by& human& imagination& (Carter,&2006;&Holliger&and&Hudson,&2005;&Saerens!et!al.,&2008)&(see&Figure&2.2).&&The&construction&of&these&new&antibody&derivatives&are&predominantly&governed&by& the& application&demand,& for& instance&by& joining& the&variable&domains&of& the&heavy& and& light& chain& (VL& +& VH)& a& minimal& sized,& antigen& binding& single& chain&variable&fragment&(ScFv)&(Figure&2.2)&can&be&made.&Further&by&linker&and&fusing&this& assembly& to& the& hinge& and& Fc& leads& to& the& construction& of& single& chain&antibodies&or&ScFv9Fc&(Figure&2.2).&The&ScFv9Fc&is&a&molecule&which&is&lighter&so&has& the& attributes& of& higher& penetration& but& at& the& same& time& is& capable& of&elicitation& all& the& effector& functions& of& the& Fc,& like& cytotoxic& effect,& interaction&through&Fcγ&receptor,&increased&half&life&through&interaction&with&the&neonatal&Fc&receptor&(FcRn)&etc.&(Holliger&and&Hudson,&2005).&The&other&advantage&of&ScFv9Fc& is& the& ease& in& expression& as& just& one& transgene& is& needed& rather& than& co9expression&of&two&transgenes&(encoding&the&light&and&heavy&chains)&as&in&case&of&mAb&(Schirrmann!et!al.,&2008;&Xu!et!al.,&2011a).&&Alternatively,&if&not&needed&for&a&specific&function,&the&Fc&of&a&ScFv9Fc&or&of&a&mAb&can&be&relegated&and&just&the&antigen&binding&domains&can&be&produced&(Fab&or&ScFv),&especially&for&instances&where&even&higher&degree&of&penetration&is&needed&like& in& case& of& delivery& of& carrier& molecule& (for& imaging& or& chemo9toxin)& into&tumour&cells.&In&such&application&the&faster&renal&clearance&of&a&small&molecule&is&also&beneficial& (both& for& imaging& as& it& enables& reduction&of& background,& and& in&target& drug/toxin& delivery)(Holliger& and& Hudson,& 2005)& (Table& 2.2& and& Figure&2.2).&&Antibodies&with&higher& affinity& are&much&desired& for& in! vivo!administration.&By&making&the&antigen&binding&domains&multivalent&an&enhanced&functional&affinity&can&be&achieved,& this& is& termed&as&avidity&(as&naturally&seen& in&pentameric& IgM,&di9&and&tetrameric&IgA).&There&have&been&several&examples&where&using&Fab,&ScFv&or&VHH/V9NAR&bivalent,& trivalent&and& tetravalent&antibody9like&molecules&have&been&produced&and&some&are&being&evaluated&in&clinical&trials&(Figure&2.2,&Table&2.2).& Further& by& fusion& of& antibody& fragments& recognising& different& epitopes&bispecific& and& trispecific& antibodies& have& been& produced&which& present&with& a&
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unique& potential& to& prevent& pathogenic& infections.& For& more& details& on& the&fascinating& plethora& of& antibody& derivatives& see& the& reviews& by& Holliger& and&Hudson,&2005;&Saerens!et!al.,&2008;&Wesolowski!et!al.,&2009.&These&varied&formats&of&antibodies&have&been&expressed&in&several&different&host&systems;&of&these&some&are&making&their&way&to&the&market&while&several&other&perspective& antibody& formats& are& in& clinical& trial.& Table& 2.2& presents& some&examples&of&these&promising&antibody&and&antibody&fragments.&&&&
Table! 2.3:! Different!mechanisms! by!which! antibodies!mediate! protection!
against!specific!pathogens!
Mechanism!! !Examples!!Agglutination&& Crosslinking& of& bacteria& like& Vibrio! cholera& (Corthésy& and&Spertini,&1999)&and&Streptococcus&mutans&causing&dental&carries&(Ma!et!al.,&1990)&is&important&for&protection.&Trapping&in&mucus& Specific& antibodies& help& in& entrapment& of& larvae,& nematodes,&bacteria&which&is&followed&by&rapid&expulsion&(Corthésy,&2002)&Inhibition& of& pathogen& target& cell&interaction&by&preventing&attachment&or&fusion&or&internalisation&
–& Neutralising& activity& of& polyclonal& IgM& in& case& of& influenza&virus& in&predominantly&due& to&preventing&attachment& to& target&cells&&–& Anti9herpes& simplex& virus& monoclonal& antibodies& (mAb)&prevents& fusion& in! vitro,& and& this& mechanism& is& suggested& to&protect&from&vaginal&challenge&&–&Anti9reovirus&mAb&prevents&uncoating& and& internalisation&of&the&virus&&Neutralisation&of&toxin& Toxin9specific&antiserum&protects&against&Staphylococcus!aureus&infection&&Antidote& to& snake& bite& venom& is& a& cocktail& of& animal& derived&anti9venom&immune&sera&(see&WHO&snake&antivenom&website–&http://goo.gl/Js03h)&Complement&activation& Protection& offered& by& anti9RSV& mAb& failed& on& destroying& the&complement&system&with&cobra&venom&factor&(CoVF)&(Corbeil!et!
al.,&1996)&Antibody9Dependant& Cell9mediated&Cytotoxicity&(ADCC)&of&infected&cells& The& action& of&malaria& immune& sera& used& in& human& therapy& is&associated&with&ADCC&activity&and&not&in&inhibition&of&infection&Phagocytosis&via&Fc&receptor& Anti9Pseudomonas! aeruginosa& antibody& enhances& phagocytic&activity&and&increases&survival&of&challenged&guinea&pigs&&Table&adapted&from&Zeitlin!et!al.,&2000,&references&only&to&additional&examples&are&cited.&Also&see&recent&review&by&Durandy!et!al.,&2009.&&
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Antibody!production!platforms!!There& has& been& surging& interest& in& the& manufacturing& of& recombinant&monoclonal& antibodies& and& antibody& fragments.& It& is& estimated& that& antibody&production&business&accounts&for&about&US$30&billion4,&which&is&likely&more&than&30%& of& the& total& capital& earnings& from& biotech& industry& (Holliger& and&Hudson,&2005).&Given&the&large&demand&for&the&antibody&and&antibody&fragments,&several&different&production&systems&have&been&developed&to&meet&this&requirement&and&deliver& high& quality& products& (Schirrmann! et! al.,& 2008).& Production& of&monoclonal&antibodies&has&been&made&possible&with&the&invention&of&hybridoma&technology,&this&involves&fusion&of&spleen&cells&from&an&immunised&mouse&(or&rat)&with& immortalised& myeloma& cells& (Kohler& and& Milstein,& 1975).& Today,& this&platform&contributes&to&some&of&the&major&demand&of&monoclonal&antibodies& in&research&and&diagnostics.&However&for&therapeutic&application,&the&use&of&murine&IgG&is&discouraged&due&to&possible&side&effects&arising&from&immune&response&to&foreign& IgGs.& Hence& for& human& application& humanised& or& at& least& partially&humanised& antibodies& are& needed.& The& production& of& human& hybridomas& has&been& difficult;& instead& B& cells& from& transgenic& mice& with& human& IgG& gene&repertoire&are&used&to&generate&humanised&immunoglobulin&(Bruggemann!et!al.,&1989;& Schirrmann! et! al.,& 2008).&There& are&drawbacks&of& hybridoma& technology&for& passive& immunisation& as& it& is& inefficient& in& producing& antibodies& against&toxins&and&conserved&antigens,&more&over&it&requires&immunisation&and&relies&on&development&of& an& in! vivo& immune& response& (Schirrmann! et! al.,& 2008).& In! vitro&technologies& like& phage& display& have& liberated& from& these& constrains,& and& now&gene&element&of&the&antigen&binding&antibody&domains&can&be&quickly&sequenced&(Smith,& 1985).&Also& in& recent& years,& the& in! vitro! technology& for& development& of&human& monoclonal& directly& from& a& single& B& cell& derived& from& an& ampule& of&peripheral&blood&mononucleocytes&is&well&established&(Tiller!et!al.,&2008).&This&is&done& by& sequestering& the& specific& antibody& coding& genes& using& state& of& the& art&molecular&biology&tools.&Further&these&gene&elements&can&then&be&optimised&for&expression& in& various& systems.& This& technique& has& greatly& contributed& to&discovery& and& development& of& antibodies& particularly& for& HIV& neutralising&antibodies&from&infected&donors&(Andrabi!et!al.,&2012).&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&4&http://www.alderbio.com/5/MARKET%20POTENTIAL/&
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Bacterial&expression&systems&are&very&popular&for&expression&of&various&enzymes&and& proteins& of& commercial& interest.& Both& Gram9negative& and& Gram9positive&strains&have&been&explored&for&production&of&antibodies&and&antibody&fragments&(Schirrmann! et!al.,&2008).&However,&one&of& the&most& important&prerequisite& for&correct& antibody& assembly& is& the& targeting& to& an& oxidising& subcellular&environment& and& precise& glycosylation& (Better! et! al.,& 1988).& Expression& in& the&reducing&environment&of&the&prokaryotic&cytoplasm&usually&results& in&improper&folded& antibodies& usually& forming& aggregates& within& the& inclusion& bodies&(Philibert! et! al.,& 2007;& Schmidt,& 2004).& Targeting& to& the& periplasmic& space&(oxidising& environment)& has& been& successful& for& the& formation& of& disulphide&bonds,& and& thus& facilitating& functionality& of& antibody& and& antibody& fragments&(Sletta!et!al.,&2007).&While&in&case&of&Gram9positive&bacteria&direct&secretion&into&the&medium&has&been&tested&as&well.&The&expression& in& the&periplasm&has&been&commercially&feasible&mostly&for&production&of&antibody&fragments&like&Fabs&and&VHHs,&and&not&so&much&for&production&of&full&length&Ig&(Schirrmann!et!al.,&2008).&Expression&of&full&length&IgG&(aglycosylated)&though&difficult,&can&be&produced&by&fine& tuning& the& regulatory& sequences& and& optimal& periplasmic& secretion&(Simmons!et!al.,&2002).&The&other&demerits&of&the&bacterial&expression&system&are&plasmid&loss,&mutations&in&the&vector,&and&low&yields&in&some&cases&due&to&toxicity&of&the&host.&However&in&optimised&condition,&high&expression&of&antibody&derived&fragments&can&be&achieved,&e.g.&the&anti9hapten&ScFv&was&reported&to&express&up&to&1.2&g/L&in&a&bioreactor&(Sletta!et!al.,&2004).&&&&Eukaryotic&systems&are&preferred&in&many&a&case,&especially&for&the&advantage&of&folding,&assembling&and&precisely&attributing&posttranslational&modifications;&for&instance& the& glycosylation& of& Fc&which& is& required& for& its& effector& functionality&(Chowdhury& and& Wu,& 2005).& Today–& yeast,& filamentous& fungi,& insect& cells,&mammalian&cells,&plant& cells,& and&even& transgenic&animals&and&plants&are&being&used&for&the&production&of&antibody&and&antibody&fragments&for&therapeutic&use.&Each&of&these&systems&has&its&own&merit&and&reasoning&for&development&to&enable&large& scale& production& of& a& specific& Ig& like&molecule& (Schirrmann! et! al.,& 2008).&Yeast&systems&have&the&advantage&of&being&able&to&scale&up&in&large&bioreactors;&it&does&not&produce&endotoxins,&which&is&advantageous&for&downstream&processing&in&therapeutic&use.&More&over&the&antibody/antibody&fragments&can&be&secreted&&
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Table! 2.4! Recent! developments! in! antibacterial! antibodies! for! clinical!
passive!immunisation!!
!Table&has&been&summarised& from&recent& review&by&Oleksiewicz! et!al.,& 2012&and& the& referenced&mentioned& there& in.& (More& details& can& be& found& on& the& company& websites& mentioned& in&parenthesis.&Tip:&see&clinicaltrial.gov&for&updates&of&the&clinical&trial.)&&
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out&of&the&host&cells.&The&secretory&proteome&of&commonly&used&yeast&strains&for&recombinant& protein& production& like& Pichia! pastoris! and! Saccharomyces!
cerevisiae&is&also&very&simple,&which&eases&purification&(Fischer!et!al.,&1999).&&In&P.!pastoris!the&expression&of&ScFv&has&been&reported&as&high&as&1.2&g/L&under&optimised&conditions&(Freyre!et!al.,&2000),&while&S.&cerevisiae!can&yield&over&100&mg/L& of& lama& derived& VHH& (Frenken! et! al.,& 2000).& Fab& and& IgGs& can& also& be&produced&in&yeast&by&co9transformation&of&both&the&antibody&chains&fused&to&the&alpha9factor& prepropeptide& leader& sequence.& Some& of& the& initial& attempts& with&this&co9transformation& technique&yielded&1& to&50&mg/L&assembled&molecules& in&flask&culture&which&when&scaled&up&to&bioreactors&gave&up&to&0.5&g/L&(Horwitz!et!
al.,& 1988).& However& functional& full& length& Igs& were& seldom& produced& in& yeast&cells.& Traditional& difficulties& with& yeast& expression& included& the& lower&transformation&efficiency,&failure&in&expressing&AT&rich&regions,&proteolysis&of&the&secreted&proteins&in&high9density&cultures,&and&hyper9glycosylation&(Schirrmann!
et!al.,&2008;&Sethuraman&and&Stadheim,&2006).&Latest&developments&in&the&field,&including&methods& like& synthetic& gene&optimisation&and& strain&modification&are&providing& impetus& to& the& use& of& yeast& for& full9length& antibody& production.& For&example,&Potgieter&and&co9workers&have&developed&a&glycoengineered&P.!pastoris!strain,& that& is& reported& to& yield& more& than& 1g/L& of& functional& monoclonal&antibodies& that& bear& uniform& N9link& glycans& (Potgieter! et! al.,& 2009).& Such&modified& strains& provide& for& robust,& scalable& platform& that& might& rival&mammalian&production&systems.&Mammalian& cell& cultures& have& been& readily& better& suited& for& obtaining& highly&functional&proteins&with&mammalian&glycosylation.& It& is& due& to& this& reason& that&the&majority& of& therapeutic& antibodies& administered& in& clinics& are& produced& in&mammalian&cells&despite&the&high&cost&of&production.&The&yield&of&the&antibodies&produced& in&mammalian&cells&has& increased&more& than&10& folds& since&1980s& to&more&than&5&g/L&(Wurm,&2004).&This&high&production&level&has&been&possible&by&achieving&high&cell&density,&high&antibody&expression&per&cell&and& improvement&in& chromosomal& integration& of& antibody& producing& genes.& However& stable&transformation& of& mammalian& cells& is& a& lengthy& process.& As& an& alternative,&transient& expression& with& viral& promoters& has& empowered& production& of&
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hundreds&of&milligrams&of&antibodies&(Schirrmann&et!al.,&2008).&Nevertheless&the&mammalian&system&is&still&expensive&and&has&become&the&limiting&factor&for&wide&spread&passive& immunisation.& Expression& in& transgenic& plants& and& animals& is& a&solution&to&effective&scale&up&therapeutic&Ig.&Generation&of&transgenic&animals&like&cows&producing&monoclonal&antibody& in&milk& is&an&exciting&concept&but& is& time&consuming&(Houdebine,&2009;&Houdebine,&2002).&In&comparison,&development&of&transgenic& plants& is& rather& easy.& This& relative& ease& of& transformation& and& the&recent& development& in& technology& for& plant& transformation& tools& has& enabled&effective&production&of&almost&all&kinds&of&antibody&and&antibody&formats&(Paul&and&Ma,&2011;&Xu!et!al.,&2011a),&even&with&engineered&human&like&glycosylation&(Webster& and& Thomas,& 2012).& In& the& next& section& we& describe& the& plant& as&antibody&production&platform&in&detail.&&
Table!2.5:!comparison!of!different!systems!for!antibody!production!!







plants!Production&cost&& &Low& Medium& Medium& High& High& Low&Production&timescale& Short& Medium& Medium& Long& Very&long& Short,&medium,&long*&Propagation& Very&easy& Very&easy& Easy& Medium& Medium& Very&easy&General&Quality& Low& Medium& High& High& High& High&General&Safety& Low& High& High& Low& Low& High&Ease& of&modification&of&glycosylation& Very&difficult& Medium& Difficult&& Difficult&& Very&difficult&& Difficult&Table&reused&from&Ko&and&Koprowski,&2005,&*&depends&on&the&plant&and&the&system,&e.g&transient&
Nicotiana& expression& platforms& is& one& of& the& fastest& production& system,& stable& expression& in&Arabidopsis& is& not& very& lengthy,& however& antibody& production& in& crop& seeds& like& pea& is& time&consuming9&however&scale&up&of&bulk&antibody&is&fast.&&&
Plants!as!antibody!production!platform!The& first&proof&of&expression&of& functional&antibodies& in&plants&was&provided& in&1989&(Hiatt!et!al.,&1989).&In&the&pioneering&paper&two&transgenic&tobacco&plants&each& expressing& light& and& heavy& chain& were& produced& by& Agrobacterium9mediated& transformation& of& tobacco& leaf& discs.& Crossing& these& two& transgenic&tobacco& lines& led& to& the& expression& of& assembled& functional& IgG& antibodies,&accumulating&up&to&1.3%&of&total&soluble&protein&(TSP).&From&then&on,&numerous&antibodies&and&other&proteins&have&been&expressed&in&plants,&demonstrating&that&plants&can&express&components&of&complex&multimeric&proteins,&assemble&these&
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polypeptides&and&produce& functional&proteins& (De&Muynck! et!al.,& 2010;&Hiatt! et!
al.,&1989;&Rybicki,&2010).&Plants&bear&chaperons&like&BiP&(binding&protein)&which&facilitate&the&proper&folding&of&Ig&(Nuttall!et!al.,&2002).&&Since& 1989,& there& has& been& tremendous& development& in& the& expression& of&antibodies&in&plants&(recently&reviewed&in&De&Muynck!et!al.,&2010;&Obembe!et!al.,&2011;&Paul&and&Ma,&2011;&Whaley!et!al.,&2011;&Xu!et!al.,&2011a).&Plant&expression&systems& are& a& very& attractive& platform& for& the& production& of& antibodies,&predominantly&due&to&the&possibility&of&up&scaling&large&quantities&of&antibodies&at& a& fraction& of& the& cost& as& compared& to& conventional& systems.& It& has& been&estimated&that&if&the&antibodies&expresses&up&to&1%&of&TSP&in&plants,&then&the&cost&of&production&would&be&0.1%&of&the&mammalian&cell&culture&system&and&up&to&2910%& of& the& cost& of& production& via& microbial& systems& (Chen! et! al.,& 2005).& The&other&advantage&is&that&plants&do&not&harbour&any&of&the&mammalian&viruses&and&other&mammalian& pathogens,&making& it& comparatively& safer& expression& system&(Pogue! et! al.,& 2010).& This& also& adds& to& the& convenience& of& purification& and&downstream&processing&of&plant&made&antibodies,&which&ensures&the&low&cost&of&the&final&product.&Such&purified&plant&made&antibody&can&be&applied&parenterally&or& a& semi9purified/crude& preparation& can& be& applied& topically.& Expression& in&edible& plant& tissues& like& tuber,& roots,& and& seeds& allows& for& oral& delivery& of&antibodies.& Oral& delivery& of& plant& made& antibodies& can& allow& for& passive&immunisation& against& enteric& diseases,& and& is& more& advantageous& in& passive&immunisation& of& farm& animals.& It& is& anticipated& that& the& in& seed/& in& feed&production&will& open& a& new& avenue& for& passive& immunisation& of& farm& animals,&which& so& far& has& been& impossible& due& to& the& cost& involved& in& passive&immunisation& using& antibodies& produced& in& conventional& systems& (Floss! et! al.,&2007).&Additionally& in& seed&expression,& bears& the&benefit& of& storage& at& ambient&temperature&and&ease&of&transportation,&which&can&enable&decoupling&of&the&scale&up&(fields),&and&downstream&processing&(Khan!et!al.,&2012).&&
Different!plant!based!expression!systems!!There&is&a&huge&diversity&of&green&plants&species&found&on&our&planet,&which&grow&and& flourish& in& different& habitats& right& from& aquatic& unicellular& plants& like&microalgae,&multicellular&aquatic&flowering&plants&like&duckweeds&to&land&plants&
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like&tobacco,&Arabidopsis,&etc.&The&drive&to&achieve&abundant&overall&production&with&lower&capital&investment&have&led&to&exploration&of&all&these&different&plant&systems& for& the& production& of& heterologous& proteins& (Xu! et! al.,& 2011a).& The&common&unifying&element&in&these&varied&species&is&that&all&of&these&autotrophic&plants& have& a& relatively& similar& cellular& machinery,& glycosylation& pattern,& and&most& can& be& transformed& by& Agrobacterium9mediated& transformation& or& by&particle&bombardment&protocols&(Ko&and&Koprowski,&2005;&Xu!et!al.,&2011a).&The&Agrobacterium9mediated& transformation& is& preferred& whenever& possible& over&particle&bombardment,&as&it&tends&to&introduce&low&copy&number&of&the&T9DNA&in&the&plant&genome&(Cheng!et!al.,&2004;&Ko&and&Koprowski,&2005).&Via&both&these&methods,&stable&plants&expressing&antibodies&can&be&produced&and&homozygous&lines& can& be& identified& for& future& bulk& production& of& antibodies.& Stable&expression,&identification&of&primary&transformants,&selection&of&best&plant&lines&does&take&time,&but&once&the&primary&seed&bank&is&selected,&future&scale&up&can&be&done& with& existing& farming& infrastructure.& Alternatively& to& stable& expression&(integration&into&the&genome)&and&development&of&transgenic&plant&lines,&one&can&opt& for& quick& protein& production& by& transient& expression& either& by&
Agrobacterium& infiltration& (Kapila! et! al.,& 1997)& or& by& using& viral& vector&expression& system& like& the& MagnIconTM& system& (Icon& genetics)& (Gleba! et! al.,&2005)&and&Geminiviral& expression& system&(Arizona&State&University)& (Mason! et!




In!leaves!expression!of!antibody!The& most& important& motivation& for& production& of& antibodies& in& leaves& is& the&capacity&to&scale&up&high&amount&of&biomass&in&multiple&harvests&per&annum.&De&Muynck&et! al.& published& a& survey& of& plant&made& full9length& antibodies& in& 2010.&According&to&this&review&more&that&50%&of&plant&made&full&length&antibodies&till&then&were&expressed&in&leaves&(De&Muynck!et!al.,&2010).&Of&the&plant&species&that&have&been&explored& for& in& leaf&production&of& antibody&and&antibody& fragments,&seemingly& tobacco& (mostly& Nicotiana! tabacum& and& Nicotiana! benthamiana&species)& has& emerged& as& one& of& the& leading& platforms& (Paul& and& Ma,& 2011).&Tobacco&can&yield&up&to&300&tons&of&biomass&per&acre,&can&be&conveniently&grown&in&fields&as&well&as&in&greenhouses,&different&species&have&been&well&studied,&and&tobacco&is&not&regarded&as&a&feed/food&plant;&these&merits&make&tobacco&a&very&interesting&plant&for&production&of&antibodies&(and&other&high&value&recombinant&proteins)&(Xu!et!al.,&2011a).&More&importantly,&genetic&manipulations&of&tobacco&are& easy,& and& antibody& genes& can& be& introduced& both& stably& in& the& nucleus& via&Agrobacterium9mediated& transformation& or& can& be& transiently& introduced& by&agro9infiltration,&or&by&viral&vectors&(Whaley&et!al.,&2011;&Xu&et!al.,&2011).&&&One& of& the& most& successful& examples& of& tobacco& made& antibody& for& passive&prophylaxis& is& the& secretory& antibody& CaroRXTM& from& the& company–& Planet&Biotechnology.& This& antibody& is& now& available& within& the& European& Union& for&prevention&of&dental&caries.&SIgA&antibodies&are&ideal&for&immunoprophylaxis&at&the& mucosal& surfaces,& however& recombinant& production& of& these& hetero9decameric& SIgA& antibodies& is& not& commercially& feasible& by& conventional&production& systems;& and& to& date& ‘plants& remain& the& only& viable& platform& for&production&of&SIgA&antibodies’&(Paul&and&Ma,&2011).&All&the&elements&needed&for&the&expression&of&these&SIgA&are&brought&to&one&plant&line&by&successive&crossing&of&tobacco&lines&expressing&light&chain&and&heavy&chain,&then&J&chain&followed&by&SC& expressing& line& (Ma! et! al.,& 1995;& Wycoff,& 2005).& The& ensemble& of& stable&nuclear& transformation& and& classical& breeding& technique& has& proven& to& be& a&robust& system& for&production&of& such&complex&antibodies& (Paul&and&Ma,&2011).&Based&on& the&same&strategy&Planet&Biotechnology& Inc.&has&developed&another&2&
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promising& products5.& One& of& which& is& DoxoRXTM& for& drug& induced& alopecia,& a&common& side& effects& of& cancer& therapy,&while& the& other& is& a& SIgA& antibody& like&adhesion& molecule& RhinoRXTM,& where& the& typical& antigen& binding& domains& of&SIgA&are&replaced&by&the&rhinovirus&binding&cellular&ICAM1&receptor&(patent&no.&EP& 1290027& B1).& This& tetravalent& SIgA9ICAM1& assembly& was& 200& times& more&effective&than&soluble&ICAM1&in&impeding&rhinovirus&in!vitro.&It&is&anticipated&that&the& multivalent& SIgA9ICAM1& would& have& a& longer& life& time& in& nasal& mucosal&application& (Wycoff,& 2005).& The& phase& I& trial& of& both& these& molecules& is&completed&(Obembe!et!al.,&2011).&&Another&successful&example&of&stable&expression&of&antibody&in&tobacco&leaves&is&the&2G12&anti9HIV&antibody.&This&antibody&was&isolated&from&human&sera&and&has&drawn&attention&due&to& its&characteristic&property&to&neutralise&various& isolates&of&HIV&virus&(Paul&and&Ma,&2011;&Trkola!et!al.,&1996).&Within&the&pharma9planta&consortium& this& antibody& was& expressed& under& the& control& of& a& constitutive&promoter& and& tissue9specific& promoters& in& seeds& of& maize& (Rademacher! et! al.,&2008;& Ramessar! et! al.,& 2008)& and& Arabidopsis& (Loos! et! al.,& 2011a),& and& in& the&leaves&of&tobacco.&The&antibody&produced&in&tobacco&plant& lines&was&chosen&for&further& clinical& evaluation,& as& a& topical& vaginal& microbicide& to& prevent& HIV&transmission.& The& Phase& I& clinical& trial& (clinical& trial& no.& NCT01403792)& with&purified& 2G12& produced& in& tobacco& leaves& has& been& completed& recently.& The&2G12& antibody& producing& tobacco& plants& were& grown& in& the& contained&greenhouse& in& compliance& to& cGMP& (current& Good& Manufacturing& Practices)&procedures& at& Fraunhofer& IME,& Aachen,& Germany& (Paul! et! al.,& 2011),& and&immediately&purified&on&site&by&a&customised&downstream&protocol.&Growing&of&plants& in& regulated& greenhouse& condition& is& advantageous& as& it& prevents& the&chances&of&gene&flow&to&the&environment&through&escape&of&pollen&and&dispersal&of& seeds.& The& regulated& environmental& conditions& within& the& greenhouse& like&temperature,&humidity,&etc.&also&enable&maintenance&of&quality&and&quantity&from&one&batch&to&other,&as& it&has&been&noted&that&biotic&and&abiotic& factors&do&affect&yield& of& plant& made& recombinant& protein& (Paul& and& Ma,& 2011).& Production& in&greenhouse& increases& the& cost& of& the& antibody& being& produced& as& compared& to&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&5&www.planetbiotechnology.com&&
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field& grown& therapeutic& antibody,& but& on& the& positive& side& it&will& pave&way& for&establishing&regulatory&procedures&(Paul&and&Ma,&2011;&Paul!et!al.,&2011).&&Exploring& the& advantage& of& contained& growth& condition,& there& are& several&excellent& transient& expression& systems& developed& that& enable& large9scale&production& of& recombinant& protein& including& antibodies.& Using& these& systems&therapeutic& proteins& and& antibodies& can& be& produced& in& about& 8& days& after&cloning&of& the& target&gene&DNA.&Some&of& these& include&systems& like&virus&based&expression&systems&magnICON&(Gleba! et!al.,&2005),&Gemini& (Huang! et!al.,&2010;&Mason!et!al.,&2002&),&Geneware&(Pogue!et!al.,&2010),&and&engineered&vectors&for&agro9infiltration& like& the& pEAQ& system,& in&which& the& T9DNA& also& bears& the& p19&viral&silencing&suppressor&(Sainsbury!et!al.,&2010;&Sainsbury!et!al.,&2009;&Voinnet!
et!al.,&2003).&The&possibility&of&high&scale&antibody&production&in&limited&space&in&greenhouses,&over&a&short&period&of&time&enables&multiple&rounds&of&production.&This&also&eases&the&downstream&processing&and&enables&high&recovery&of&purified&antibody.& Companies& and& institutions& like& Medicago& (Quebec& city,& Quebec,&Canada),& Kentucky& BioProcesses& (Owensboro,& Kentucky,& USA),& Texas& A&M&(college& station,& Texas,& USA),& Fraunhofer& (Newark,& USA)& and& Icon& Genetics&(Bayer,& Halle,& Germany)& have& established& infrastructure& for& large& scale&automated& systems& to& grow& tobacco& plants& in& the& greenhouse,& infiltrate/infect,&and&harvest& the&protein& (Whaley! et!al.,&2011).& In&our&opinion&one&of& the&break9through& possibilities& budding& from& this& technology& platform& would& be& for& the&sector&of&personalised&antibody&therapeutic.&Icon&Genetics,&a&subsidiary&of&Bayer&(Germany),&is&developing&patient9specific&antibodies&as&idiotype&vaccine&to&treat&Non9Hodgkin’s& lymphomas&(NHL).&Cost&effectiveness&of&this&tobacco&production&system&should&make&personalised&cancer&therapy&accessible&to&larger&number&of&patients.&Currently&the&facility&can&produce&antibodies&up&to&0.5&to&4.8&g/Kg&fresh&weight,&while&approximately&225&mg&antibody&per&patient&would&be&required&for&treatment&as&well&as&quality&assurance&tests.&Once&the&antibody&genes&are&isolated&and&cloned,&from&then&onward&in&2&weeks&the&antibody&can&be&administer&to&the&patient&(Paul&and&Ma,&2011;&Whaley!et!al.,&2011).&The&phase&I&clinical& trial&with&tobacco& made& anti9idiotype& vaccine& for& NHL& is& completed& (McCormick! et! al.,&2008)& and& these& transiently& produced& antibodies& are& now& in& clinical& trial.& The&cost&of&bringing&a&product&to&Phase&I&clinical&trial&with&cGMP&mammalian&system&
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is&about&$596&million,&while& in&case&of& transient&plant&systems& is&about&$0.590.8&million&(Whaley!et!al.,&2011).&The& quick& transient& production& platform& is& also& well& suited& for& production& of&antibodies& (or& even& vaccines)& for& pressing& emergency& situations& like& biological&warfare.&A&laboratory&proof&of&concept&for&production&and&efficacy&of&anti9Ebola&monoclonal& antibodies& has& been& provided& in& the& mice& model& (Wilson! et! al.,&2000).&A&primate&study&will&soon&start&with&the&bulk9produced&antibody&in&cGMP&tobacco&manufacturing& facility& (Whaley! et! al.,& 2011).& Similar& projects& aimed& at&immediate&response&with&high&manufacturing&capacity&at&low&cost&for&biological&threats& are& being& developed& for& Marburg& virus,& Lujo& virus,& Staphylococcal&enterotoxin& B,& ricin& etc.& 6(Whaley! et! al.,& 2011).& Along& with& companies,&government&defence& institution& like&DARPA&(Defence&Advance&Research&Project&Agency& of& USA)& have& invested& in& the& contract& cGMP& tobacco& production&platforms.&It&is&aimed&at&producing&three&million&dose&of&about&400&mg&individual&antibody&dose,&in&within&193&months&at&a&cost&of&less&than&US$10&per&dose.&&Some& of& the& interesting& antibodies& for& human& therapeutic& to& watch& out& for& in&near& future&would&be& the&anti9human&respiratory&syncytial&virus& (HRSV)&mAbs.&Currently& passive& immunisation& with& anti9HRSV& antibodies& (like& Synagis®,&Motavizumab®,& Palivizumab®)& is& a& routine& treatment& but& is& limited& to& patients&with& extremely& serious& condition,& as& the& treatment& is& very& expensive& and&unaffordable&for&many&health&systems&in&developing&countries&and&burdens&even&the& developed& health& care& systems& in& many& western& countries& with& high& per&capita&income&(Harkensee!et!al.,&2006;&Rietveld!et!al.,&2010).&Tobacco&production&system& is& also& being& used& for& the& development& of& antibody& therapy& for& non9infections&disease&along&with&cancer,&autoimmune&disease&and&Alzheimer&disease&(for&more&details&see&review&(Whaley!et!al.,&2011)).&&In&all,& the& tobacco& leaf&based&expression&both&stable&as&well& as& transient& seems&very& promising.& On& the& negative& side& though,& agro9infiltration& does& lead& to&abundant& bacterial& cells,& introducing& the& risk& of& bacterial& endotoxin&contamination.& And& the& leaves& have& to& be& processed& immediately& for& optimal&product& recovery& (Paul& and& Ma,& 2011).& However,& innovative,& cost& effective&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&6&http://www.mappbio.com/productdevelopment.html&
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purification&systems&like&the&tobamovirus–protein&A&fusion&are&being&developed&(Werner! et! al.,& 2006);& incorporating& these& inventions& shall& maintain& the& cost&effectiveness&of&plant&expression&systems.&
In!seed!antibody!expression!!Seeds&can&be&regarded&as&natural&protein&production&factory&and&a&storage&house.&As,&in&addition&to&the&merits&of&in!planta&expression,&in&seed&expression&provides&for& long& term& storage,& ease& of& handling& and& transport& without& cold& chain&maintenance&and&it&can&double&up&as&an&oral&delivery&system&as&well&(Floss!et!al.,&2007;& Khan! et! al.,& 2012).& Thus& seed& can& be& used& directly& for& passive& mucosal&immunisation,&which&is&particularly&advantageous&for&animal&disease&(Floss!et!al.,&2007;&Zimmermann! et! al.,& 2009)&and&also& for&human&application.&Alternatively,&for&parenteral&application,&the&high&concentration&of&protein&in&desiccated&seeds&facilitates& the& downstream& processing.& Different& full9length& antibody& and&antibody& formats& like& ScFv,& ScFv9Fc,& VHHs,& VHH9Fc& have& been& expressed&effectively&in&seeds&of&both&monocot&and&dicot&plants&(De&Wilde,&2012;&Khan!et!al.,&2012;&Loos!et!al.,&2011b;&Van&Droogenbroeck!et!al.,&2009)&(Table&2.7).&&
Brief!introductions!to!seeds!Anatomically& seeds&have& three& important&parts,& the&outer&protective& seed& coat,&enclosing& the& endosperm& and& the& embryo.& In& angiosperms& the& characteristic&double&fertilisation&event&leads&to&the&production&of&the&embryo&and&endosperm,&which& is& the& next& plant& generation& and& the& nutritive& tissue& respectively.& The&embryo&in&these&flowering&plants&can&comprise&of&a&single&cotyledon,&their&seeds&are& hence& called& monocotyledonous& (Figure& 2.3,& d)& or& they& might& bear& two&cotyledons& then& the& seeds& are& called& dicotyledonous& (Figure& 2.3,& a,& b& and& c).&Further& in& some& dicotyledonous& plants& the& endosperm& might& be& reabsorbed&during& seed& development,& such& seeds& are& classified& as& non9endospermic&dicotyledonous& seeds& as& oppose& to& endosperm& bearing& endospermic&dicotyledonous& seeds.& Leguminous&plants& like& pea& (Pisum! sativum)& (Figure& 2.3,&b),&garden&bean&(Phaseolus!vulgaris),&soybean&(Glycine!max)&and&most&species&of&the& family&Brassicaceae& like&rape&(Brassica!napus),&wild&mustard&(Sinapis!alba),&wild&radish&(Raphanus!sativus)&are&examples&of&non9endospermic&dicotyledonous&seeds.&The&endospermic&dicotyledonous&seeds&on&the&other&hand&might&have&a&&
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&
Figure!2.3:!Classification!of!
seeds! based! on! basic! seed!
anatomy.!!Angiosperm& seeds& are&basically& classified& as&dicotyledonous&seeds&(a,&b,&c)&with& two& cotyledons& and&monocotyledonous& seeds& (d)&with& one& cotyledon.& The&dicotyledonous& seed& can& be&non9endospermic,& lacking&endosperm& completely& e.g.&peas& (b);& or& they& can& be&endospermic,& having& one&layer& of& endosperm& e.g.&Arabidopsis& (a)& or& the&endosperm& might& extend& to&several&layers&e.g.&tobacco&(c).&Note& the& spatial& distribution&of& the& embryo& (shades& of&green)& and& endosperm& (grey&and&black)&in&the&four&seeds.&&&
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expression!level!!Wheat&&& Ubiquitin91& Human& serum&albumin&& Endoplasmic&reticulum& (ER)&derived& protein&bodies&
0.5%&TSP&
Maize&&& 279kDA&γ9zein&& E.! coli! heat& labile&toxin&(LT9B)& Starch&granules& &Rice& Gt13a,& endosperm&specific&& Human& serum&albumin&& Endosperm& 2.75& g/& kg& of& brown&rice&& Glutein&GluB91& 7Crp& ER& derived& protein&bodies&(PB)& 60&µg/grain&& Glutein&GluB91& Human&interleukin& ER& 4.5&mg/100g&& Glutein&GluB91& Cholera& toxin& B&subunit& PB& 30&µg&per&seed&Soybean&& Soybean& glycinin&promoter& Heat& labile&toxin&(LT9B)& of& enterotoxigenic&
E.!coli!
ER&derived&PB& 2.4%&TSP& &
& Glycinic&G1& Human& basic&fibroblast& growth&factor& Seed& 2.3%&& &α&–&subunit&of&the&&β& –conglycinin&promoter& Human& coagulation&factor&IX&& Protein& storage&vacuole&(PSV)& 0.8&g/kg&seeds&Safflower&& Phaseolin&promoter& Apolipoprotein& al&milano& Apoplast& 7.3&g/kg&seeds&Tobacco&& Soybean& 7S& globulin&promoter& Human&acid&&β9glucosidase&& PSV& 3%&TSP&&Arabidopsis&& Phaseolin&promoter& Human& α9L9iduronidase& ER& 18&µg/mg&TSP&Table&has&been&adapted&from&Khan!et!al.,&2012&&&
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few& layers& of& endosperm& like& in& case& of& tomato& (Lycopersicon! esculentum),&tobacco&(Nicotiana!tabacum)&(Figure&2.3,&c)&or&reduced&to&a&single&cell&layer&like&in&mouse9ear& cress& (Arabidopsis! thaliana)& (Figure&2.3,& a)& (for& a&quick& reference&guide&on&seed&anatomy&see&www.seedbiology.de).&&&The&endosperm&and&the&cotyledons&of&the&embryo&are&the&storage&compartments&and&store&energy&rich&nutrients&for&germination.&Depending&on&the&plant&specie,&the&nature&of&these&stored&energy&sources&vary,&i.e.& in&case&of&oil&seeds,& lipids&as&triacylglycerol& are& stored& in& subcellular& oil& bodies;& the& endosperm& of& cereals&(monocots)& predominantly& bear& carbohydrates& (starch)& followed& by& proteins,&while& soybean& and&pea&have&protein& rich& cotyledons.& For&molecular& farming& of&valued&proteins,&these&storage&compartments&are&predominantly&triggered&using&specific&promoters.&Tables&2.6&and&2.7&summarised&various&such&promoters&used&for&in&seed&expression&of&heterologous&proteins.!!
The! expression! of! antibody! or! antibodyHfragments! in! the! seed& can& be&achieved&by&the&constitutive&viral&promoters&e.g.&35S&promoter&of&the&cauliflower&mosaic& virus& (35S& CaMV).& However& although& this& promoter& can& yield& high&amount&of&antibodies&in&various&plant&tissue,&its&strength&in&driving&expression&in&seeds& is& poor,& and& a& seed9specific& promoter& can& lead& to& high& accumulation& (De&Jaeger!et!al.,&2002;&De&Wilde,&2012;&Petruccelli!et!al.,&2006).&A&murine&full&length&antibody& called& 14D9& when& expressed& under& the& control& of& the& seed9specific&promoter&β9conglycinin&(derived&from&soybean)&lead&to&accumulation&of&about&1&%&of&TSP&in&tobacco&seeds,&while&the&same&heavy&and&light&chains&driven&by&the&35S& CaMV& promoter& expressed& functional& antibody& to& about& 0.4& %& of& TSP& in&seeds&and&up&to&5%&of&TSP&in&leaves&of&tobacco.&&&It&is&reasoned&that&the&seed9specific&promoters&are&usually&active&during&the&seed&filling&stage&(development&and&maturity)&while&the&35S&CaMV&ceases&to&express&after&the&initial&stages,&thus&accounting&for&lower&accumulation&(Chen!et!al.,&1986;&Petruccelli! et! al.,& 2006).& Similar& trend& was& also& observed& for& other& studies&expressing&ScFv9Fc&for&application&other&than&therapeutic&use.&A&ScFv9Fc&against&maltose&binding&protein&(MBP)&when&expressed&in&Arabidopsis&under&the&control&35S&CaMV&promoter&or&the&seed9specific&β9phaseolin&promoter&yielded&only&high&amount&of&functional&anti9MBP&ScFv9FV&with&seed9specific&β9phaseolin&promoter&
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(De&Wilde,&2012).&While&a&ScFv&against&dihydroflavonol949reductase&of&petunia,&which&expressed& to&1%&of&TSP&under& the&control&of&35S&CaMV&expressed&up& to&36%&under&the&control&of&β&phaseolin&promoter&in&Arabidopsis&seeds&(De&Jaeger!
et!al.,&2002).&Besides&the&β9phaseolin&and&β9conglycinin&promoters&mentioned&so&far,& several& different& seed9specific& promoters& like9& USP& (unknown& seed&promoter)(Zimmermann! et! al.,& 2009),& glutelin91& (gt91)& promoter& (Ramessar! et!













Maize&& Full&length&mAb&Anti9HIV&(2G12)&& Human& ER&/&embryo&& 38975&µg/g&& ER&specific&rice&promoter&
(Rademacher!
et!al.,&2008)&
Maize&& Full& length& mAb&Anti9HIV&(2G12)& Human& ER& and&protein&body& 5.7&%&TSP& Glutelin91&(gt91)&promoter& (Ramessar! et!al.,&2008)&Wheat&and&rice& ScFv&(anti9&carcinoembrionic&antigen)&
Human& Endosperm& 30&µg/g&& Ubiquitin91&promoter& (Stoger! et! al.,&2000)&Pea& ScFv&&Anti9F4+ETEC&(BA11)& Piglets& Seeds& 2&g/kg& USP&& (Saalbach! et!al.,&2007)&
Pea&& ScFv& (anti9Eimeria)&& Chickens& Seeds& 1.76&mg/g& USP& (Zimmermann!et!al.,&2009)&Rice&& ScFv(Anti9&K99+ETEC)& Cattle&& Embryo& (Low&expression)& CaMV&& (Sunilkumar!et!al.,&2009)&Abbreviations:& ER9Endoplasmic& reticulum,& CaMV& 35S9& Cauliflower&mosaic& virus& 35S& promoter,&USP9& unidentified& seed& protein& from& Vicia! faba.& The!mAb9& monoclonal& antibody,& ScFv9& single&chain& variable& fragment,& K99+ETEC9& enterotoxigenic& Escherichia! coli& bearing& K99& fimbriae,&F4+ETEC9& enterotoxigenic& E.! coli& bearing& F4& fimbriae.& NB:& Purification& of& antibodies& is& mostly&foreseen& for& the& antibodies& intended& for& human& application& while& for& animal& diseases& its&predominantly&aimed&for&oral&administration&as&semi9processed&crude&seed&flour.&&&Overall& it& has& been& seen& that& promoters& specific& for& endosperm& in& case& of& the&monocot&seeds&and&those&specific&for&cotyledons&(i.e.&the&embryo)&in&case&of&dicot&seeds&generally&lead&to&high&expression&(Khan!et!al.,&2012).&Both&these&respective&compartments&are&the&protein&sinks&of&the&seed.&Compartment&specific&promoter&though& play& a& big& part& in& high& accumulation,& they& are& not& the& sole& factor&
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(Drakakaki! et! al.,& 2006;& Streatfield,& 2007),& since& subcellular& trafficking& and&accumulation& play& an& equally& important& role.& The& endomembrane& system& of&seeds& differs& from& the& other& vegetative& tissues.& The& seed& cells& have& the&specialised& subcellular& structures& called& protein& bodies& (PB),& protein& storage&vacuoles& (PSV),& starch& granules& and& oil& bodies,& which& make& up& the& vaults& of&storage& sink.& Some&of& these& organelles& like& PSV& and&PB& allow& stable& storage& of&antibodies,&influencing&its&stability,&accumulation&and&thus&overall&yield&(Khan!et!
al.,&2012;&Stoger!et!al.,&2000).&However&targeting&of&the&recombinant&proteins&to&a&particular& subcellular& compartment& can& be& tedious.& The& trafficking& of& native&storage&proteins& in& itself& is&highly&convoluted,&and&differs& for& individual&storage&protein&and&the&plant&species&(Khan!et!al.,&2012)&(see&schematic&representation,&Figure& 2.4).& For& instance,& globulins& and& albumins& are& predominant& storage&proteins&of&many&seeds,&which&usually&reach&the&end&destination&of&PSV&from&the&endoplasmic& reticulum& (ER)& en! route& the& Golgi& apparatus& via& dense& vesicles,&however& in& pumpkin& seeds& these& proteins& reach& PSV& by& omitting& the& Golgi&apparatus& but& instead& traffic& through& precursor9accumulating& (PAC)& vesicles&(Hara9Nishimura! et! al.,& 1998;& Hohl! et! al.,& 1996)& (Figure& 2.4).& Our& group&previously&demonstrated&by&expressing&different&single&chain9Fc&antibody&chains&in&Arabidopsis&seeds,&that&high&expressing&antibodies&were&aberrantly&localised.&A&part&of&the&accumulated&antibody&was&retained&in&the&ER9derived&vesicles&while&antibodies& were& detected& in& the& periplasmic& space& (PS)& between& the& plasma&membrane&and&the&cell&wall.&This&also&disrupted&the& localisation&of&endogenous&ER&chaperons&like&BiP&and&calreticulin,&which&were&atypically&also&found&in&the&PS&(Van& Droogenbroeck& et& al.,& 2007).& Despite& these& complications& in& targeting& of&recombinant&proteins&in&seeds,&using&some&general&strategies&like&signal&peptide&of& endogenous& seed& proteins,& retention& signals& like& KDEL& etc.& several&recombinant&proteins&have&been&successfully&expressed&and&stably&accumulated&in&seed&storage&organelles.&&Addition& of& a& KDEL& tag,& for& retention& within& the& ER& also& leads& to& higher&accumulation&in&seeds&(De&Jaeger!et!al.,&2002;&Peters&and&Stoger,&2011).&Secreting&antibodies&(by&addition&of&N9terminal&signal&peptide),&and&retaining&them&within&the&endo9membrane&system&(C9terminal&KDEL/&SEKDEL&peptide)&in&general&is&a&preferred& strategy& for& in& seed& antibody& production.& The& specific& retention& also&
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enables& for& control& over& the& post& translational& modification& like& addition& of&glycans&(Loos!et!al.,&2011a).&The&glycosylation&of&proteins&until&the&ER,&in&plants&and& animals& (also& yeast& and& basidiomycetes)& is& similar& (Berends! et! al.,& 2009).&Thus& by& retention& in& ER& one& can& refrain& for& addition& of& plant& specific& glycans,&especially&in&cases&where&glycosylation&is&important&for&efficacy&like&ADCC&in&case&of&passive&immunisation&therapy&or&intravenous&administration.&&&&
&
Figure! 2.4:! Schematic! representation! of! protein! trafficking! in! seeds! to! the! storage!
compartments.! The& predominant& destination& of& the& endogenous& storage& proteins& and& most&recombinant& proteins& is& the& protein& storage& vacuoles& (brown)& or& the& endoplasmic& reticulum&derived&protein&bodies&(red).&The&proteins&may&traverse& in&vesicles& through&various&alternative&paths& in&the&endospermic&and&embryonic&tissue,&either&through&the&Golgi&apparatus,&or& forming&multi9vesicular& bodies& (MVB)& (green),& or& pre9vascular& compartment& PVC& (,blue),& or& through&precursor9accumulating&vesicles&PAC&(yellow).&For&some&examples&and&more&details&see&the&text.&The&figure&has&been&adapted&from&Khan!et!al.,&2012.&&Further& it& has& been& suggested& through& oral& feeding& experiments& that& the& bio9encapsulation&in&endomembrane&protects&from&the&harsh&gastric&environment&on&oral& delivery& of& crude& or& semi& processed& seed& meal& (Takagi! et! al.,& 2010;&Zimmermann! et! al.,& 2009).& Protection& at& the&mucosal& surface& can& be& achieved&
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effectively& by& topical& in& feed/food& administration& of& antibodies& (Streatfield,&2006).& The& protective& role& of& oral& feed& based& passive& immunisation& has& been&proven& for& coccidiosis& in& chicken& and& post9weaning& diarrhoea& in& piglet,& both&these& animal& disease& bearing& high& economic& burden& (Saalbach! et! al.,& 2007;&Zimmermann!et!al.,&2009).&A&protozoan&of&Eimeria&genus&causes&the&coccidiosis&in&chicken.&When&pea&seeds&bearing&anti9Eimeria!ScFv&were&forced&fed&to&chicken&it& protected& them& from& subsequent& Eimeria! challenge.& It& was& noticed& that& the&protection&was&only&conferred&by& in& feed&administered&antibody,&while&purified&antibodies& (produced& from& tobacco& leaves)& failed& to&achieve& similar&protection.&This&discrepancy&was&due&to&the&protection&offered&by&the&pea&seed&matrix&from&gastric&proteases&which&resulted&in&1009fold&gain&in&ScFv&stability&(Zimmermann!
et! al.,& 2009).& Similarly& protective& effect& or& in& feed& based& prophylaxis& was& also&reported& for&prevention&of&ETEC&caused&post9weaning&diarrhoea& in&piglets.&The&piglets& were& not& only& protected,& but& a& detailed& autopsy& revealed& that& the&antibodies&were&retained&at&the&gastric&mucosal&surface&and&were&not&detected&in&other& organ& like& heart,& lungs& etc.& (Saalbach! et! al.,& 2007).& Crude& crushed& seed&based&passive&oral& immunisation& is&an&attractive&strategy&for& farm&animals,&and&though&not&explored&yet&for&humans&would&be&interesting&application&in&future.&A&few&examples&of&antibodies& for&human&application& (therapeutic&and&diagnostic)&are&listed&in&Table&2.7.&Seed&made&antibodies&are&yet&to&reach&the&clinical&phase,&given&the&current&regulatory&framework&this&might&take&some&time,&and&perhaps&in&comparison&seed&made&antibodies&for&animal&use&might&be&available&before&the&ones&for&human&application.&&
Conclusion!!Despite& the& several&merits& of& plants& as& antibody& expression& systems& there& are&only& a& few& antibodies& that& have& made& it& through& clinical& trial& phase& of& which&tobacco& produced& CaroRXTM& the& chimeric& secretory& IgA& antibody& has& been&approved&for&clinical&use&in&E.U.&(Obembe!et!al.,&2011).&One&of&the&chief&reasons&for&delay&in&bringing&plant&made&therapeutic&antibodies&to&the&market&can&be&due&to&regulatory&issues&associated&with&genetically&modified&plants,&and&the&already&established&mammalian&systems&for&monoclonal&mAb&systems&(Paul!et!al.,&2011).&Due& to& which& most& big& pharmaceutical& companies& have& been& hesitant& in&
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investing.& Contamination& of& the& environment& with& GM& plants& can& be& a& serious&issue.& In& the& past& there& has& been& an& unfortunate& event& involving& Prodigene&(Texas,& US),& a& plant& biotechnology& company,& which& had& a& promising& vaccine&produced& in& maize& against& transmissible& gastroenteritis& virus& of& piglet,& which&had&reached&to&phase&I&status&(Basaran&and&Rodríguez9Cerezo,&2008).&However,&following& contamination& of& non9GM& corn& crop& the& company& was& charged& of&violating& the& plant& protection& act& (Fox,& 2003)(see& the& article& ‘The& Prodegene&incident’7),& consequentially& the& company& winded& up& its& activities.& This& had& an&undesired& negative& effect& on& the& community& at& large.& However& things& are& now&changing&mostly&due& to& the&development&of& latest& expression& technologies& that&have&enabled&transformation&of&several&different&plants&some&of&which&can&grow&fast& and& produce& large& amount& of& biomass& in& short& time.& Along& with& this,& the&expression&vectors&have&been& improved&which& enable&high& levels& of& antibodies&production&from&reasonably&small&plant&biomass&(Paul&and&Ma,&2011;&Whaley!et!
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Introduction!!Enterotoxigenic&Escherichia!coli&(ETEC)&caused&post9weaning&diarrhoea&(PWD)&is&a&common&piglet&disease,&which&mainly&occurs&in&the&first&week&of&weaning,&but&is&common&until& the&3rd&weak&post&weaning& (Amezcua! et!al.,&2002;&Fairbrother! et!
al.,& 2005).& Suckling& piglets& are& protected& from& the& ETEC& infection& by& the& anti9ETEC&specific&antibodies& in&the&sow’s&milk.&The&placenta& in&pig&does&not&permit&the& transfer&of& immunoglobulin& from&pregnant&sow&to& the&developing&pig& fetus.&Thus& the& maternal& colostrum& and& milk& are& the& only& source& of& protective&antibodies.& At& weaning& this& lactogenic& immunity& is& lost& and& in& addition& the&weaning& period& induces& several& stresses& on& the& young& piglet.& These& basically&include&psychological&stress&of&separation&and&physiological&stress&due&to&change&of&diet;&both& these& conditions& consequentially&negatively& influence& the& immune&status& of& the& piglet.& It& has& been& reasoned& that& the& ETEC& infection& in&conglomeration& to& these& stresses& leads& to& PWD.& Severely& affected& piglets& often&die&preceding&short&illness&(Vanbeersschreurs!et!al.,&1992),&most&newly9weaned&piglets& however& suffer& from& a& benign& form& of& the& disease& (symptoms& in& Table&3.1).&Piglets,&who&recover&from&this&morbidity,&have&lower&feed&consumption&and&weight& gain& (Fairbrother! et! al.,& 2005).& Both,& the& death& and& lower& weight& gain&results& in&heavy&economic& loss&(Amezcua! et!al.,&2002).&Porcine&derived&product&have& far& reaching&applications&beyond& its&primary&consumption&as&human& food&(Christien,& 2010);& thus& a& set& back& to& the& pork& production& has& global&repercussions.&In&the&western&hemisphere&where&porcine&farming&is&practised&at&an&industrial&to&semi9industrial&scale,&PWD&can&lead&to&losses&of&millions&of&dollar&per&annum.&In&Belgium&it&has&been&estimated&that&a&mortality&rate&of&2%&leads&to&an&annual&loss&of&EUR&15&million,&which&significant&affects&the&profit&margin&and&earnings& of& porcine& farmers.& While& on& the& other& side& of& the& globe,& in& the&developing&world—&post9weaning&diarrhoea&can&have&detrimental&effect&on& the&basic&livelihood&of&a&subsistence&farmer.&It&has&been&envisioned&that&encouraging&rural& household& porcine& farming& will& help& in& eradicating& rural& poverty& in&countries&with&developing&economies&e.g.&Vietnam&in&Southeast&Asian,&and&Kenya&in&Sub9Saharan&Africa&(Costales!et!al.,&2005;&Githigia!et!al.,&2012).&Post9weaning&diarrhoea& is& a& hurdle& in& reaping& these& economic& benefits.& The& economic& losses&
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The!ETEC!Pathogen!The&two&important&hallmarks&of&PWD&causing&ETEC&strains&are&that&they&produce&adhesins&and&enterotoxins.&The&adhesins&are&important&for&attachment&to&specific&intestinal& receptors;& this& attachment& facilitates& the& colonisation&of& the&bacteria,&followed& by& secretion& of& the& enterotoxin& in& the& intestine& that& consequentially&leads& to& diarrhoea& (Fairbrother! et! al.,& 2005;& van& Beers9Schreurs! et! al.,& 1992)&(Figure& 3.2).& The& most& common& isolated& ETEC& strains& from& piglets& with& PWD&either&bear& the&F4&and&at& times&the&F18& fimbriae,& these&serve&as&both&virulence&
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markers& and&virulence& factors& (Fairbrother! et! al.,& 2005).&The& fimbriae& are& long&flexible&proteinaceous&appendages&that&extensively&cover&the&ETEC&surface.&The&fimbriae&are&expressed&at&37°C&and&not&at&18°C,&i.e.&on&infection&in&piglet&gut&and&not&in&the&environment&(Fairbrother!et!al.,&2005).&&The&F18&fimbriae&have&a&zigzag&pattern&and&are&about&1&to&2&µm&long&(Hahn!et!al.,&2000).&There&are&5&genes& that&encode& for& the&F18& fimbria&and&are&present&on&a&plasmid,& these&genes&are–& fedA,!(which&codes& for& the&major&pilus&subunit),& fedB!(outer& membrane& protein& usher),& fedC! (chaperone),& fedE! (minor& protein)& and&
fedF! (adhesin,& present& on& the& tip& of& the& fimbria)& (Imberechts&et! al.,& 1996).&The&F18& fimbriae& occur& in& two& antigenic& variants& F18ab& and& F18ac,& which& can& be&distinguished&in&epidemic&samples&by&serology&(Nagy&and&Fekete,&1999).&The&tip&adhesion&FedF&encoded&by&the&fedF!gene&is&highly&conserved&and&hence&the&FedF&adhesin& is& suggested& as& suitable& target& for& vaccine& development& (Smeds! et! al.,&2003)&or&an&anti9FedF&antibody&as&a&passive&immunisation&therapy&might&also&be&worth&evaluating&for& impeding&F18&bearing&ETEC&(F18+ETEC)&infection.&Both&of&these& variant& of& F18+ETEC& strains,&most&predominantly&bear&heat9stable& toxins&STa& and& STb& and& only& rarely& the& heat9labile& toxin& (LT)&were& isolated;&while& in&case&of&F4&bearing&ETEC&strains&LT&is&the&predominant&toxin&(Fairbrother!et!al.,&2005;& Rippinger! et! al.,& 1995).& The& receptors& for& the& attachment& to& these& F18&variants&are&present&on&the&intestinal&epithelium&of&piglets&older&than&3&weeks&of&age.&Hence&F18+ETEC&are&associated&with&PWD.&&The&F4&bearing&ETEC&infections&unlike&F18&are&seen&in&neonatal,&nursing&piglets&and&post&weaning.&The&F4& fimbriae&occur& in&3&variants& classified&as&F4ab,&F4ac&and&F4ad& according& to& the&major& subunit& and& adhesion–& FaeG.& The& FaeG&has& a&constant&antigenic&subunit&‘a’&and&variable&domains&‘b’,&‘c’&or&‘d’&(van&Zijderveld!et!
al.,&1990).&The&three&variants&of&F4&are&not&just&serotypically&distinct&but&they&also&show&differential&specificity&to&intestinal&receptors.&Some&piglets&are&susceptible&to&all& the& three&variants,&while&others&can&be&susceptible& to&either& two&variants&(either&F4ab&and&F4ac&or&F4ab&and&F4ad)&or&a&single&variant&(Francis!et!al.,&1999).&Though& all& the& three& variants& have& been& reported& in& different& epidemiological&survey,&over&all&the&F4ac&variant&is&globally&most&predominant&(Fairbrother!et!al.,&2005;&Osek,&1999).&&
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A& large,&non9conjugative&plasmid&bears& the&operon&of&10&genes& that&encode& the&F4&fimbriae,&which&are&named&FaeA&to&FaeJ,&of&which&the&gene&faeG&is&coding&for&the&major&adhesion&protein&FaeG.&The&other&fimbrial&proteins&encoded&by&this&F4&fimbrial& gene& cluster& include—& FaeD,& which& is& an& outer& membrane& usher& and&also& serves& as& the& anchor&molecule;& FaeC,& FaeH,& FaeF& are& the& other& structural&units,& and&are& regarded&as& the&minor&units&while&FaeE& is& the&chaperon&protein.&The&research&in&the&field&of&these&F4&fimbriae&in&the&last&3&decades&has&helped&in&unravelling& their& structure& and& biosynthesis,& which& has& been& summarised& by&Verdonck&et!al.!(2004),&a&brief&description&of&which&is&as&follows.&&The&biogenesis&of&the&F4&fimbriae&is&influenced&by&several&environmental&factors&like&temperature,&pH,&carbon&source,&oxygen&level,&osmolarity,&etc.&The&optimum&conditions&for&F4&fimbriae&expression&are&at&37°C,&towards&the&end&of&exponential&growth&phase&and&when&within&the&pH&range&of&6.5&to&8&(Verdonck!et!al.,&2004a).&&
&
Figure!3.1:!Biogenesis!of!F4!fimbriae.!Each&of&the&fimbrial&subunits&(FaeC9&green,&FaeF9brown,&FaeG9red,& FaeE9blue,& FaeH9orange,& FaeI9pink)& has& been& represented& as& an& oval.& The& fimbrial&assembly&starts&at& the&outer&membrane&FaeD&usher&with& the& translocation&of&FaeC,&which& form&the&tip&followed&by&FaeF.&The&major&subunit&and&adhesin&FaeG&forms&the&predominant&part&of&the&filamentous& F4& fimbriae.& Previous& models& suggest& that& the& multiple& FaeG& adhesion& are&interspersed& with& limited& units& of& FaeH& and& FaeF,& however& recent& structural& data& argues& the&incorporation&of&FaeF&and&FaeH&among&the&multiple&FaeG&units.&The&free&FaeE&occurs&as&a&dimer&in& the& periplasm& and& as& monomer& it& acts& as& the& chaperon& which& transports& the& Fae& subunits&across&the&periplasm&as&indicated&with&arrows.&The&involvement&of&FaeI&in&the&fimbrial&biogenesis&is& suggested& but& its& exact& involvement& is& uncertain& yet& (indicated& by& ‘?’&mark).& Figure& adapted&from&Van&den&Broeck!et!al.,&2000;&Van&Molle!et!al.,&2009.&&&
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Under&apt&conditions,& the&fimbrial&assembly&starts&with&the&translocation&of&the&fimbrial& subunits& across& the& inner& membrane.& The& conserved& characteristic&signal&peptides&on&the&N9termini&of&these&Fimbrial&units&(Fae)&enable&their&transit&through& the& secretory& pathway& into& the& periplasmic& space.& The& FaeD& unit& is&82,126& Da& protein& that& anchors& into& the& outer& membrane& and& acts& as& the&assembly&platform.&Next& the&usher&FaeD& translocates& the&FaeC& subunit& (16,900&Da),&which& is&destined& to& form& the& tip&of& the& fimbria,& after&which&FaeF& (15,200&Da)& follows.& The& FaeF& provides& as& an& adapter& molecule& for& attachment& of& the&major& subunit& (also& adhesin)& FaeG& to& the& FaeC& at& the& tip.& Predominantly& the&major&subunit&FaeG&and& few&molecules&of&minor&subunits&FaeF&and&FaeH&make&up&the&prominent&portion&of&the&F4&fimbrial&shaft&(Figure&3.1).&The&FaeE&(24,768&Da),&which& occurs& as& a& dimer& in& solution,& chaperons& the& FaeG,& FaeH,& and& FaeF&units&(Mol&and&Oudega,&1996;&Mol!et!al.,&1996).&One&after&the&other&several&units&of& FaeG& are& brought& to& the& FaeD& by& the& FaeE& (E9G& assembly);& FaeD& then&translocates& the&FaeG&molecule,&progressively&protruding& the& (FaeC9FaeF9FaeG9FaeG…&)&tip&assembly&(Mol!et!al.,&2001).&The&Fae&subunit9subunit&connections&are&achieved& by& donor& strand& exchange& mechanism& and& are& very& specific,& the&protruding&N9terminal&from&an&incoming&Fae&extends&in&place&of&the&‘G’&β9strand&of& the& preceding& Fae& molecule& (Barnhart! et! al.,& 2003).& The& N9terminal& donor&peptide& is& very& specific,& and& determines& the& specific& FaeC9FaeF,& FaeF9FaeG& or&FaeG9FaeG&connection.&Since&the&interaction&of&FaeG9FaeG&units&is&very&specific&it&is&not&know&how&stoichiometrically&FaeF&and&FaeH&units&would&be&interspersed&among& the&multiple& FaeG& units,& as& it& has& been& suggested& in& the& traditional& F4&fimbriae& model& (it& is& probable& that& some& units& of& FaeI& are& also& incorporated&(Bakker!et!al.,&1992b)).&The&process&is&schematically&represented&in&Figure&3.1&The&combination&of&the&virulence&factors&inclusive&of&the&fimbriae&and&the&toxins&define& the& serotypes& of& ETEC& associated& with& PWD.& Diarrhoea& causing& ETEC&strains& may& have& other& virulence& factors& as& well,& like& the& presence& of& alpha9hemolysin.&This&cytotoxin&can&damage&a&wide&range&of&cells&and& its&presence& is&detected& in& most& recent& isolated& PWD& samples& (Heo! et! al.,& 2012;& Smith& and&Linggood,&1971;&Wu!et!al.,&2007).&The&serotype&O149&bearing&the&F4&fimbriae&is&the&most&frequently&isolated,&other&predominant&serotypes&are&listed&in&Table&3.2&(Heo! et! al.,& 2012).&The&prevalence&of&different& serotypes&differs&geographically,&
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and& also& the& pathogenicity& of& the& same& serotype& may& differ.& For& instance& the&serogroup& O139& is& isolated& in& different& epidemiological& studies& globally;& in&Australia&the&serogroup&is&associated&with&PWD&while&in&Europe&it&is&reported&to&cause&oedema&disease&(Fairbrother!et!al.,&2005).&
Table!3.2:!Some!commonly!isolated!ETEC!serotypes!from!piglets!with!PWD!
&Table&reused&from&Heo!et!al.,&2012&
Pathogenesis!and!factors!affecting!ETEC!related!PWD!in!piglets!The&ETEC&related&PWD&disease&is&a&multifactorial&disease,&where&ETEC&infection&among& the& several& predisposed& weaning& induced& stresses& (described& later)&causes& acute& post&weaning& diarrhoea.& There& are& three& important& steps& for& the&ETEC& to& cause& PWD9& they& are–& attachment,& followed& by& proliferation& and&secretion&of&toxins&(Heo!et!al.,&2012;&van&Beers9Schreurs!et!al.,&1992)&(Figure&3.2).&&
&
!
Figure! 3.2:! Overview! of! the! steps! in! the! pathogenesis! of! ETEC! caused! PWD.!The& various&cofactors&that&influence&the&establishment&of&ETEC&are&indicated&(in&red).&More&details&are&in&text.&The&figure&is&adapted&from&Fairbrother!et!al.,&2005;&van&Beers9Schreurs!et!al.,&1992.&
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The& ETEC& pathogen& seemingly& spread& through& feed,& or& by& other& piglets,& or&animals,& contaminated& faeces& or& even& through& aerosols.& The&ETEC&bacteria& are&usually&present&in&the&immediate&environment&of&the&pig&farm;&getting&rid&of&the&ETEC&is&very&difficult&to&impossible.&ETEC&in&dung&can&survive&for&up&to&6&months,&fumigation&techniques&does&not&affect&the&bacteria&beyond&the&depth&of&a&quarter&of& an& inch& (0.6& cm)& (van& Beers9Schreurs! et! al.,& 1992).& Also& the& ETEC& can& be&transmitted& through&aerosols;& it&has&been&seen& that& temperature& influences& the&half& life& of& the& bacteria& and& the& concentration,&which& is& higher& at& 15°C& than& at&30°C& (van& Beers9Schreurs! et! al.,& 1992).& The& concentration& of& the& ETEC& is& very&important& in& disease& presentation.& In& experimental& model& 109& to& 1010& ETEC&bacteria& are& needed& to& induce& diarrhoea& (Cox! et! al.,& 1991).& In& another& study&artificial&contamination&of&the&floor&with&106&colony9forming&units&(cfu/cm2)&did&not& lead& to& diarrhoea& (Melin! et! al.,& 2000).& The& environment& of& the& piglets& in&natural& setting& does& not& have& a& high& titer& of& ETEC.& It& is& on& infection& and&attachment& that& the& ETEC& bacteria& proliferate& in& the& intestine& (van& Beers9Schreurs!et!al.,&1992).&Once&the&ETEC&colonise&the&intestine&they&secrete&one&or&more& toxins.& The& LT& toxin& consists& of& an& A& subunit& and& five& B& subunits;& the& B&subunits& bind& to& the& intestinal& GM1& ganglioside& and& enables& a& pore& formation&through&which&the&A&subunit&penetrates&the&host&cell&(Field!et!al.,&1989).&The&LT&toxin& leads& to& activation& and& increased& production& of& the& cyclic& adenosine&monophosphate& (an& intercellular& messenger& molecule),& and& further& leading& to&increase& in& the& secretion& of& sodium& chloride,& bicarbonates& and& water& into& the&intestinal&lumen&(Heo!et!al.,&2012;&van&Beers9Schreurs!et!al.,&1992).&The&ST&toxin&on& the& other& hand& leads& to& absorption& of& liquids& and& salts& by& activating& the&production& of& cyclic& guanosine& monophosphate.& The& net& effect& of& both& these&toxins& is& the& hyper& secretion& of& salts& and& water& in& the& intestine.& Under& such&situations,& the& distal& part& of& the& alimentary& canal& is& incapable& of& reabsorbing&these&high&amounts&of& liquids&and&salts&which&results& in&diarrhoea&(Figure&3.2),&along&with&other&symptoms&as&mentioned&in&Table&3.1.&&Though&ETEC& is& the& key& element& in& PWD,& its& colonisation& leading& to& disease& is&only& possible& under& the& presence& of& certain& predisposed& elements& (marked& in&red& in& Figure& 3.2).& Most& important& is& the& presence! of! serotype! specific!
receptors.& As& mentioned& above,& the& F4+ETEC& serotypes,& each& has& a& unique&
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receptor& in& the& small& intestine& (Van& den& Broeck! et! al.,& 2000),& likewise& the&F18+ETEC& bacteria& also& have& its& specific& receptors.& In& nature& piglets& devoid& of&one& or&more& of& these& receptors& exist;& such& piglets& are& naturally& insensitive& to&F4+ETEC& infections.& The& phenotypic& difference& has& been& demonstrated& to& be&genetic& in& nature,& which& is& inherited& in& accordance& with&Mendelian& laws,& as& a&dominant&allele&(Sellwood,&1979).!Hence,&in&principle&determination&of&receptor&negative&or&positive&pigs&should&be&possible&for&all&variants&of&ETEC.&Jørgensen&et.!
al.& developed& a&DNA&marker& test& based&on& the&Mucin4& gene&polymorphism& for&genotyping& of& the& F4ac/ac& resistant& or& susceptible& piglets& (Patent& no.&WO2004/0486069A2).!However& a& later& study& by& another& group& compared& the&sensitivity& of& this& test& with& in! vitro& villous& adhesion& test& (which& is& a& gold&standard)& and& showed& that& the& result& were& 100%& affirmative& for& F4ab& but&correlated& only& for& 24%& in& case& of& F4ac& (Rasschaert! et! al.,& 2007).& In& addition&involvement&of&more&than&one&receptor&for&variant&specific&F4+ETEC&sensitivity&is&suggested.& Overall& determination& of& resistant& or& susceptible& piglets& is& not& that&straightforward.& Along& with& adhesive& and& non9adhesive& phenotype,& week&adhesive&phenotypes& also& exist& (Van&den&Broeck! et! al.,& 2000).& Probable& reason&for&this&variation&in&phenotypic&expression&of&receptors&is&said&to&be&due&to&gene&epistasis,&or&inhibition&of&or&alteration&of&receptor&expression&(Bijlsma&and&Bouw,&1987).&The&expression&of&F4&receptors&also&varies&with&age.&In&an&earlier&report&it&was& shown& that& susceptible& newborn& piglets& expressed& only& 1/16th& of& the&amount&of& receptors&expressed& in&35&day9old&unweaned&piglets& (Conway! et!al.,&1990).&However&Willemsen&and&de&Graaf’s&report&published&in&1992&contradicted&the&previous&observation,&stating&no&difference&was&noted&between&the&piglets&of&7&day&and&35&days&of&age&(Willemsen&and&de&Graaf,&1992).&Van&den&Broeck&et!al.&summarised&several&such&studies&comparing&the&susceptibility&and&the&extent&of&receptors,& over& all& it& seems& that& the& highest& number& of& receptors& are& usually&detected&in&piglets&195&weeks&of&age&(Van&den&Broeck!et!al.,&2000).&&In&addition&to&the&variable&expression&of&the&receptors,&and&perhaps&involvement&of&more&than&one&putative&receptor&for&F4+ETEC&infection,&‘the&receptor(s)’&as&per&traditional&physiological& definition&of& a& receptor& (capable&of& inducing& signal& on&binding)& for& F4+ETEC& is& not& yet& fully& characterised.& There& are& more& than& 30&publications&investigating&the&putative&receptors;&some&of&the&general&consensus&
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remain&that&the&F4&fimbriae&interact&with&a&glycolipid&or&the&glycolipid&is&a&part&of&the&receptor&present&on&the&mucosal&surfaces,&especially&the&small&intestine.&The&receptor&characterisation&work&until&early&2000&has&been&reviewed&by&Van&den&Broeck&et!al.!(2000),&which&basically&concluded&that&a&‘β9galactose&is&involved&in&the&binding&of& the&F4& fimbriae’&and& that& the&glycan& is&either& linked& to&a&surface&glycolipid& or& a& glycoprotein.& Further,& the& glycoprotein& that& interact& with& F4ab&have&a&molecular&weight&of&25,&30,&40942&and&60&kDa&in&intestine&while&16,&40970,&74,& 210& and& 240& kDa& in& brush& border& membranes.& The& glycoproteins& that&recognise& F4ac& have& a& molecular& weight& of& 25,& 30& and& 60& kDa& in& intestinal&mucosa;&40970,&210&and&240&kDa& in&brush&border&membranes.&While& the& third&variant& F4ad& recognised& 45970& kDa& glycoproteins& in& brush& border& membrane&(Van&den&Broeck!et!al.,&2000).&Some&of&the&recent&progress&made&in&deducing&the&exact& interacting& glycoconjugates,& employs& state& of& the& art& mass& spectrometry&techniques& in& complement& with& thin9layer& chromatography& and& affinity&chromatography.& To& identify& the& minimal& recognition& segment& for& F4ac,& F4ab&and& F4ad& fimbriae,& Granger& et! al.& used& porcine& serum& transferrin& (pSTf)& and&purified&glycosphingolipids&(GSL)(Grange!et!al.,&2002).&They&discovered&that&only&the&F4ab&binds&with&high&affinity&to&pSTF,&in&which&it&binds&to&a&single&N9glycan&and& more& precisely& to& a& core& N9acetylglucosamine.& While& results& with& GSL&interaction& study& showed& that& all& three& variants& bind& to& a& β9linked& NHacetylhexosamine,& and& that& the& presence& of& a& β9linked& terminal& galactose& (N9acetylglucosamine& or& NHacetylgalactosamine)& resulted& in& stronger& adhesion&(Grange!et!al.,&2002).&In&another&study&by&Coddens&et!al.;&the&authors&discovered&distinct&carbohydrate&binding&pattern&to&the&three&variants&of&free&F4&fimbriae&as&well& F4+ETEC,& using& glycosphingolipids& from& erythrocytes& and& from& porcine&small& intestinal& epithelium.& The& F4ac& (fimbriae& as& well& as& bacteria)& bound&galactosylcermide& (Galβ1Cer)& with& spingosine& and& hydroxyl& 24:0& fatty& acid,&while&F4ab&(Fimbriae&and&bacteria)&bound&to&galactosylceramide&sulfatide&(SO393Galβ1Cer),& sulf9lactosylceramide& (SO393Galβ4Glcβ1Cer),& and&globotriaosylceramide& (Gala4Galβ4Glcβ1Cer)& with& phytosphingosine& and&hydroxy& 24:0& fatty& acid.& While& the& F4ad& bound& to& gangliotriaosylceramide&(GalNAcβ4Galβ4Glcβ1Cer),& gangliotetraosylceramide&(Galβ3GalNAc4Galβ4Glcβ1Cer),&isoglobotriaosylceramide&(Gala3Galβ4Glcβ1Cer),&
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and&neolactotetraosylceramide& (Galβ4GlcNAcβ3Galβ4Glcβ1Cer)& (Coddens! et! al.,&2011).& Recently,& by& comparative& proteomic& analysis& of& brush& border& proteins&from&resistant&and&sensitive&piglets&one&of&the&F4&receptors&has&been&identified&to&be&an&aminopeptidase&N&(pAPN)&(Melkebeek!et!al.,&2012).&The&sialic&acid&bearing&carbohydrates& on& the& pAPN& seemingly& determine& the& attachment& and& its&subsequent& clathrin9mediated& endocytosis& (Melkebeek! et! al.,& 2012).& Future&determination&of&all&the&other&F4&receptors&would&help&in&developing&anti9ETEC&therapeutics&or&even&developing&of&convenient&non9invasive&or&minimal&invasive&test& methods& for& selection& of& resistant& piglets& for& breeding& programs;& but& the&issue& of& variation& of& phenotypic& expression& of& these& different& receptors& might&prove&it&to&be&a&difficult&task.&Then& there& are& other! factors& that& are& equally& vital& for& establishing& ETEC&infection.&According&to&the&current&pig&rearing&practices&the&piglets&are&weaned&at&394&weeks&of&age&(body&weight&495&kg)&as&compared&to& the& traditional&weaning&age& of& up& to& 5& weeks& (body& weight& 5910& kg)(different& countries& have& their&stipulated&minimum&suckling&period)8.&The&incentive&for&early!weaning&is&that&it&enables&higher&piglet&production&per&sow&per&annum.&This&separation&of&piglets&from& sow& and& deprival& of& milk& is& a& dramatic& transition& for& the& young& piglets&leading& to& psychological,& physiological& and& immunological& stress.& The& gut& of&piglets,&weaned&at& this&age,& show&villous&atrophy& (i.e.& erosion&of& the&absorptive&villous& surface)& and& crypt& hypertrophy& as& a& result& of& the& changes& in& diet& and&stress& (Kenworthy,& 1976).& Reduction& in& villous& height,& and& increase& in& crypt&depths,& leads& to&compromising&of& the&barrier& function&and& the&general&mucosal&immune&status&of&the&intestine.&In&addition&to&this,&the&unavailability&of&protective&factors&from&the&milk&including&ETEC&specific&antibodies,&iron&binding&lactoferrin&and&transferrin&that&impede&bacterial&growth,&provides&opportunity&for&ETEC&to&colonise& the& small& intestine.& Rotavirus& co9infection& with& ETEC& is& another&important&cofactor&in&PWD&(Lecce,&1983;&Pluske!et!al.,&1997).&In&fact&in&a&certain&experimental& piglet& disease& model& to& study& ETEC& and& PWD,& the& piglets& are&deliberately&inoculated&with&rotavirus&(Harmsen!et!al.,&2005).&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&8http://www.thepigsite.com/&&
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In&addition& to& these,& other&major& cofactors&enabling& the&ETEC& infection&are& the&
dietary! composition! and! the!housing! conditions.& Piglets&when&weaned& at& 3&weeks&of&age&do&not&have&the&necessary&enzymes&to&digest&the&solid&feed&resulting&in& proliferation& of& saccharolytic& or& saccharo9proteolytic& flora,& which& leads& to&increase&in&haemolytic&E.!coli&in&the&gut.&Also&hypersensitivity&to&feed&components&has&been&reported,&which& lead&to&villous&atrophy&and& intestinal&alterations.&The&temperature& in& piglet& housing& units& also& influences& the& ETEC& growth,& stability&and& thus& infection& pressure.& After& the& ban& on& prophylactic& antibiotic& use,&protective& therapy& in& case& of& ETEC& related& PWD& is& predominantly& focused& on&either&modulating&these&cofactors&or&developing&specific&anti9ETEC&molecules,&as&described&in&subsequent&section.&&
Prevention!strategies!for!ETEC!related!PWD!The& predominant& prophylaxis& until& a& decade& ago& was& the& use& of& growth&promoting& antibiotics.& The& regular& use& of& sub9therapeutic& dose& of& these&antibiotics&was&suggested&to&control&ETEC&infection,&also&addition&of&these&in&feed&was& seen& to& have& a& positive& effect& on& the& overall& feed& intake& and&weight& gain.&However& now& the& prophylactic& use& of& such& growth& promoting& antibiotics& is&banned& in& the&EU&and&discouraged& in&many&countries&globally.&This&prohibition&has&had&two&detrimental&consequences,&the&increase&in&PWD&incidences&and&the&increase& in& therapeutic& use& of& antibiotics& (Heo! et! al.,& 2012).& The& risk& of&introducing& antibiotic& resistance& has& led& to& the& need& for& development& of& a&suitable&safe&alternative&(Adjiri9Awere&and&Van&Lunen,&2005;&Vondruskova!et!al.,&2010).& To& this& avail,& several& anti9ETEC& specific& approaches& like& vaccines& and&passive& immunisation&therapies,&as&well&as&other&non9antimicrobial&compounds&have& been& tested.& However,& there& has& been& no& ‘magic& bullet’& to& combat& ETEC&related&PWD&yet&(Fairbrother!et!al.,&2005;&Heo!et!al.,&2012).&Some&of&the&major&products&experimented&with&for&preventing&PWD&include&the&use&of&metallic&compounds&like&zinc&oxides,&organic&acids,&different&composition&of& dietary& proteins,& probiotics,& prebiotics,& anti9ETEC& antibodies& and& subunit&vaccines&(Fairbrother!et!al.,&2005;&Heo!et!al.,&2012;&Katouli!et!al.,&1999;&Melin&and&Wallgren,&2002;&O'Doherty! et! al.,& 2005;&Roselli! et! al.,& 2005;&Vondruskova! et! al.,&2010).&
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Zinc& is& an& essential&micronutrient& in& the& piglet& diet,& the& deficiency& of&which& is&suggested& to& have& retarded& growth& and& reduction& of& several& enzyme& (e.g.& zinc&metaloenzymes,& alkaline&phosphatase)& (Katouli! et! al.,& 1999;&King,&2011;&Heo! et!
al.,&2012)(Katouli!et!al.,&1999)(Katouli!et!al.,&1999)&(Katouli!et!al.,&1999)&(Katouli!
et!al.,&1999).&Though&the&dietary&recommended&level&of&zinc&is&100&mg/kg&body&weight&of&weaned&piglets,&the&use&of&zinc&up&to&30&times&higher&has&shown&to&have&an&effect&on&the&prevention&of&PWD&(Heo!et!al.,&2012;&Højberg!et!al.,&2005).&It& is&suggested& that& the& action& of& zinc& in& preventing& PWD&might& be& due& to& it& direct&antimicrobial& action& e.g& through& interaction& with& sulphur& atom& in& bacterial&proteins,&along&with&provoking&the&host&system,&like&stimulation&of&anti9microbial&peptide& secretion& in& the& small& intestine,& or& influence& on& the& commensal& gut&microbiome&that& is&advantageous& in&prevention&ETEC&colonisation,&or&Zn&might&inducing&growth&factors,&etc.&The&actual&mechanism&of&zinc&in&relation&to&PWD&so&far& remains& speculative& (Heo! et! al.,& 2012).& There& is& also& a& concern& about& the&excessive&use&of&zinc,&in&regards&to&the&toxicity&and&the&effect&it&would&bear&on&the&environment,& hence&many& countries& have& reservations& on& the& excessive& use& of&zinc&in&the&feed&of&newly&weaned&piglets&(Carlson!et!al.,&2004).&&&The&other&important&factor&for&the&establishment&of&ETEC&infection&is&the&gastric&pH.& It&has&been& suggested& that& incorporating&organic!acids& like& citric,& fumaric,&lactic&and&formic&acid&might&help&in&reducing&the&ETEC&bacteria&and&also&improve&the&digestibility&of&feed.&Taube&et&al.!(2009)&showed&that&addition&of&formic&acid&and& propionic& acid& in& the& feed& reduced& the& count& of& experimentally& infected&
Salmonella& and&E.! coli& in& piglet& gut& (Taube! et! al.,& 2009).& Exploration&of& organic&acids&might&be& an&option&worth& considering,& especially& since& the&production&of&most&of&these&organic&acids&is&inexpensive.&The&mode&of&action&of&organic&acid&in&preventing& PWD& is& probably& due& to& the& direct& action& of& acids& on& the& ETEC&bacterium.&The&acids&are&capable&of&defusing&into&the&bacterium.&This&would&have&lethal& consequences&on& the&ETEC&bacterium,&denaturing& the&essential& enzymes,&jeopardising& the& integrity& of& purine& bases& and& dramatically& altering& the& turgor&pressure&in&the&cell&(Heo!et!al.,&2012;&Warnecke&and&Gill,&2005).&&
Probiotic! and! prebiotic& approaches& have& also& been& experimented& with& as&alternative& safe& prophylaxis& against& PWD.& However& there& are& no& general&
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consensuses& in& the& use& of& probiotics& yet.& It& is& believed& that& a& more& regulated&dosage& and& temporal& feeding& regimen& has& to& be& streamlined& to& attain& high&consistent& efficacy& (Bontempo! et! al.,& 2006).& For& instance,& administration& of&
Lactobacillus! plantarum& once& at& weaning,& at& a& dose& of& 3& x& 109& resulted& in&significant& reduction& of& challenged& ETEC& (O149:& K91:& F4ac).& The& authors&conclude&that&this&dose&and&treatment&regimen&leads&to&better&results&than&other&combination& of& regimen& and& doses& evaluated& (when& higher& dose& of& 5& x& 109& or&when& L! plantarum& was! administrated& 3& days& before& weaning).& In& another&example& Setia& and& co9workers& demonstrated& the& inhibitory& activity& of& colicin&producing& E.! coli& in& inhibiting& ETEC& in! vitro& (Setia! et! al.,& 2009).& Along& with&secretion& of& antimicrobial& substances& like& bacteriocin& or& pH& altering& organic&acids& and& short& fatty& acids,& it& is& suggested& that& some& probiotics& themselves&inhibit&the&ETEC&adherence&by&steric&hindrance&and&competitive&exclusion&(Heo!
et! al.,& 2012;& Roselli! et! al.,& 2005).&Enterococcus! faecium& in& an& in! vivo& assay& and&
Lactobacillus!fermentum&strains&104R&in&an&in!vitro&system&have&shown&to&exhibit&such&inhibitory&effect&against&ETEC,&the&exact&mechanism&of&their&action&though&is&unknown&(Blomberg!et!al.,&1993;&Jin!et!al.,&2000).&&As& prebiotics,& the& use& of& non9starch& polysaccharide& hydrolysis& products& from&wheat& and& flax& (Kiarie! et! al.,& 2010)& and& in& another& study& with& hydrolysis&products& from&soybean&and&canola&(Kiarie! et!al.,&2008)&have&showed&to&protect&against&ETEC&infection&related&fluid&loss,&by&segment&perfusion&test.&In&an&in!vivo!ETEC& challenge! experiment& the& use& of& raw& potato& starch& in& feed& had& positive&effect& on& faecal& consistency,& comparable& to& the& results& obtained& on& feeding&antibiotic&bearing& feed& (Bhandari! et!al.,&2009).&Some&researchers& in& the& field&of&probiotics&and&prebiotics&also&suggest&the&a&synergistic&effect&might&be&obtained&by&combination&of&the&two&principles&in&feed&(Heo!et!al.,&2012).&&
The! diet,& particularly& the& protein& content& influences& the& digestibility& and&nutrition;&thus&the&susceptibility&of&ETEC&and&progression&of&PWD.&Over&the&years&there& has& been& different& feed& formulation& tested& for& better& growth& and& with&additive& effect& on& maintain& gastric& physiology& to& preventing& ETEC& infection.&Proteins& in& the& feed&are& sourced& from&plants&as&well& as& animals.& Some&of& these&plant&proteins&might&also&have&specific&inhibitory&function.&Becker&et!al.&(2011),&
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demonstrated&in&an&in!vitro&inhibition&assay&that&the&pea&hulls&and&faba&bean&hulls&impaired& the& F4+ETEC& interaction& with& receptors& and& their& LT& enterotoxin’s&binding&to&the&GM1&ganglioside&receptor&(Becker!et!al.,&2011).&However&overall,&it&is& seen& that& animal& proteins& are&much& better& digested& than& plant& protein,& this&could&be&due&to&the&anti9nutritive&factors&in&many&protein&rich&plant&sources&like&soybean& (Heo! et! al.,& 2012).& The& effect& of& better& digestibility& and& nutrition& are&immediately&reflected&in&better&weight&gain,&and&also&in&preventing&the&severity&of&ETEC&infection&(Owusu9Asiedu!et!al.,&2002b;&Sola9Oriol!et!al.,&2011).&A&positive&effect&of&spray9dried&animal&plasma9based&diet&is&probably&due&to&the&antiHETEC!
antibodies! in! the!plasma! fraction& (Owusu9Asiedu! et! al.,& 2002a).& Similar& feed&based&passive&protection&can&be&achieved&with&spray9dried&egg!yolk!antiHETEC!
antibodies& from& immunised& hens& (Vila! et! al.,& 2010;& Yokoyama! et! al.,& 1992).&However& there& are& concerns& about& the& use& of& animal& plasma& due& to& fear& of&introducing& pathogens& (like& viruses& and& prions),& while& processing& the& animal&protein& and& autoclaving& them& before& feeding& does& not& render& similar& efficacy&(Owusu9Asiedu! et! al.,& 2002a).& The& egg& yolk& antibodies& on& the& other& hand& are&comparatively&safe&but&are&very&expensive,&at&the&cost&of&EUR&65/kg&of&egg&yolk&protein& (Chernysheva! et! al.,& 2004).& Harmsen& et! al.& (2005)& suggested& cost&effective&production&of&antiHETEC!antibodies! in!yeast!expression! system& for&oral& passive& immunisation& and& produced& anti9FaeG,& antigen& binding& variable&domains& of& a& heavy& chain& only& lama& antibody& (VHH)& (Harmsen! et! al.,& 2005).&Though&the&in!vitro&segment&perfusion&tests&results&of&these&anti9FaeG&VHHs&were&promising,& piglets& when& fed& with& this& VHH& producing& yeast& broth& failed& to&protect&in!vivo&on&F4+ETEC&challenge.&The&proteolysis&in&gastric&environment&or&the& monovalency& of& VHH& could& be& the& reasons& for& failure& to& prevent& ETEC&infection&and&diarrhoea&(Harmsen!et!al.,&2005).&On&the&same&lines&of&cost&effective&production,& a& company& called& Novoplant& (Germany)& developed& antiHF4! single!
chain!antibodies!called,!BA11!in!pea!seeds&(Saalbach!et!al.,&2007).&Production&of&antibodies&in&seeds&and&its&retention&in&the&(seed)&endomembrane&protects&the&plant&made&antibodies&from&the&harsh&gastric&environment&(Zimmermann!et!al.,&2009).& Perhaps& due& to& such& bio9encapsulation,& Novoplant’s& in& pea&made& orally&delivered&BA11&effectively&protected&the&piglets& from&F4+ETEC&challenge.&Sadly,&in& 2008& Novoplant& filed& for& bankruptcy& and& seemingly& since& then& the&
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development&of&BA11&has&ceased.&&Apart& from& passive& immunisation,& oral! active! vaccination& has& also& been&investigated.&To&prevent& the&ETEC&bacteria& from&attaching,& colonising&and& thus&establishing& infection& a& local& mucosal& immunity& is& needed& (Fairbrother! et! al.,&2005).& Intramuscular&vaccination& leads& to&good&systemic& immune&response&but&does&not&elicit&mucosal&immunity&(Van&den&Broeck!et!al.,&1999a;&Van&den&Broeck!
et!al.,&1999b;&Van&der&Stede!et!al.,&2003).&Oral&vaccination&with&either&attenuated&ETEC& strain& or& with& purified& fimbriae& in& contrast& to& needle9based& vaccination&gives&rise&to&a&significant&mucosal&IgA&and&IgM&response&(Snoeck!et!al.,&2003;&Van&den&Broeck!et!al.,&1999a).&&However& there& are& two& hurdles& in& oral& vaccination.& In& order& to& have& immune&response&at&weaning,&the&piglets&need&to&be&immunised&at&least&one&week&prior,&i.e.&when&they&are&suckling.&However&the&maternal&anti9ETEC&antibodies&in&milk&present&a&risk&of&neutralise&the&vaccine&fimbriae&or&the&attenuated&strain&before&it&can&stimulate&the&immune&system&(Fairbrother!et!al.,&2005).&Secondly&the&gastric&pH—& it& has& been& demonstrated& by& in! vitro& simulations& in& gastric& fluid& that&purified& fimbriae& get& completely& digested& at& pH& 2& by& 3& hours& (Snoeck! et! al.,&2004).&In&this&regard&enteric9coated&pellets&or&encapsulated,&or&fimbriae&in&tablet&format& might& be& better& protected& in& the& gastric& juices& (Calinescu! et! al.,& 2005;&Huyghebaert!et!al.,&2005;&Snoeck!et!al.,&2003).&Snoeck&et&al.!(2003)&evaluated&the&efficacy& of& such& orally! delivered! entericHcoated! F4! fimbriae& in& challenge&experiment;& though& a& clear& mucosal& and& systemic& immune& response& was&achieved& the& treatment& did& not& protect& against& ETEC& colonisation,& and& only& a&marginal&significant&reduction&in&F4+ETEC&shedding&titer&was&observed.&As&a&cost&effect& mass& production& system& for& encapsulated! vaccine! development,& the&FaeG&antigen&was&expressed&in&alfalfa,&tobacco&and&barley&(Joensuu!et!al.,&2004;&Joensuu! et! al.,& 2006a;& Joensuu! et! al.,& 2006b).& The& plant& made& FaeG&molecules&were&functional&in!vitro&and&led&to&production&of&neutralising&antibodies&in&mice.&Of&these,&the&alfalfa&produced&FaeG&when&fed&to&piglets&along&with&cholera&toxin&reduced&the&shedding&of&challenged&F4+ETEC&strain&(Joensuu!et!al.,&2006b).&The&general&methods& and& strategies& used& for& F4+ETEC& vaccination& should&work& for&F18+ETEC& as& well& (Fairbrother! et! al.,& 2005).& However& for& each& of& the& three&
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Abstract9:!Plants& can& be& used& to& produce& a& plethora& of& recombinant& therapeutic& proteins& at&fraction&of&a&cost&as&compared&to&conventional&production&platforms.&Plant&seeds&in&particular& are& natural& protein& producing& and& storage& organs,& which& enable&production& of& abundant& recombinant& protein& in& stable& confined& environment.& The&seed9based& expression& system& is& particularly& interesting& for& oral& passive&immunisation& against& veterinary& diseases,& such& as& enterotoxigenic&Escherichia! coli&(ETEC)&causing&post9weaning&diarrhoea.&We& therefore& investigated& the&production&of& anti9ETEC& antibodies& in& seeds& of& the&model& plant&Arabidopsis! thaliana,& to& later&transfer& the& technology& to&a&grain& crop& that& can&be&used& in&piglet& starter& feed&and&produced&in&sufficient&quantities.&&In& the&pilot&phase,&we& focused&on& the&F4& fimbriae&bearing&ETEC&(F4+ETEC)&strains&that& are& most& predominantly& isolated& from& diseased& piglets.& For& successful& seed9based&anti9F4+ETEC&passive&immunotherapy&it&is&imperative&that&the&antibodies&are&produced&in&abundant&amounts&and&that&they&survive&gut&transit.&We&hence&aimed&at&designing& a& robust& antibody& by& fusing& the& antigen& binding& domains& of& camelid&antibodies&(VHH)&with&the& fragment&crystallisable&(Fc)&region&of&porcine&IgG3.&The&anti9F4+ETEC&VHHs&were&panned& from&a& lymphocytic& library&derived& from&a& lama&immunised& with& purified& FaeGac& adhesin,& building& up& the& F4& fimbriae.& Four& such&VHH’s&were&selected&from&the&three&clusters&representing&the&total&diversity&of& the&library.& The& VHHs& were& grafted& to& the& Fc,& then& inserted& into& a& seed& specific&expression&cassette&and&transformed& in&A.! thaliana.&Each&antibody&expressed&to& its&own&particular&accumulation&level,&the&highest&being&3%&of&seed&weight.&&These&highly&expressed&anti9F4+ETEC&porcinised9camelid&antibodies&were&correctly&folded& in! planta& and& recognised& all& the& serotypes& of& the& FaeG& adhesins.& The&disulphide& bond& within& the& hinge& enabled& production& of& dimeric& antibodies& that&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&9Published& online& as& a& conference& abstract& (oral& presentation)9& Virdi& V& (2012).& Recombinant& plant& made&antibodies& against& fimbriae& of& enterotoxigenic& Escherichia! coli& inhibit& in! vitro& binding& to& villous& enterocytes.&Front.& Immun.&Conference&Abstract:&ECMIS& 9&E.! coli!and& the&Mucosal& Immune&System:& Interaction,&Modulation&and&Vaccination.&&doi:&10.3389/conf.fimmu.2012.01.00008&
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agglutinate& the& F4+ETEC& bacteria.& Moreover& the& crude& seed& extract& bearing&antibodies& inhibited& F4+ETEC& attachment& to& gut& villous& enterocytes& in& an& in! vitro&assay,& making& the& seed& mix& very& interesting& to& evaluate& protection& in& a& piglet&challenge&experiment&
Introduction!!Plants&have&been&used&to&produce&a&plethora&of&different&recombinant&proteins&(Paul&and& Ma,& 2011;& Xu! et! al.,& 2011a).& Over& the& last& two& decades& there& has& been&tremendous& improvement& in& the& plant& expression& strategies,& leading& to& high& level&expression& of& complex& proteins& (Rybicki,& 2010;& Streatfield,& 2007),& even& with&engineered& glycans& (Loos! et! al.,& 2011a;& Saint9Jore9Dupas! et! al.,& 2007),& enabling&plants& to&produce&not& just&bio9similar&products&but&superior&quality&products&with&enhanced&features&(Faye&and&Gomord,&2010).&Plants&can&effectively&produce&complex&proteins& like& assembled& secretory& IgA& (Ma! et! al.,& 1995)& and& complex& virus& like&particles&such&as& the&blue& tongue&virus&particles10& (Thuenemann&and&Lomonossoff,&2010).&Production&of&molecules&like&these&would&be&very&difficult&via&mammalian&or&other& conventional& expression& systems,& and& far& from& being& a& commercially& viable&option& (Paul& and&Ma,& 2011),& thus& plant& expression& systems& are& carving& their& own&niche& among&other& protein& production& systems.& Together&with& this& flexibility,& it& is&the& cost9effective& scalability& of& plant9made& proteins& that& makes& them& such& an&attractive&platform&(Obembe!et!al.,&2011;&Xu!et!al.,&2011a).&&Production& platforms& that& have& the& capacity& of& providing& globally& affordable&therapeutic& proteins& are& imperative& for& combating& human& diseases,& but& such&promising& platforms& also& provide& opportunities& for& developing& veterinary&therapeutic&proteins.&The&cost&of&production&for&a&marketable&veterinary&therapeutic&protein&has&to&be&significantly&low,&particularly&for&farm&animals&since&large&numbers&of& animals&need& to&be& treated&often&at& fairly& regular& interval&of& time.&Thus& the&net&capacity& to& manufacture& a& veterinary& therapeutic& protein& needs& to& be& very& high&without& adding& to& the& cost&per&dose.&Cost& effective&plant&production& systems&have&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&10&Conference&abstract&book&available&at&http://goo.gl/z7MdS&
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given&an&impetus&to&development&of&new&and&orphan&veterinarian&pharmaceuticals&(Rybicki,& 2010),& however& their& full& potential& for& producing& therapeutics& against&animal&diseases&is&still&to&be&realised.&Moreover,&oral&immunisation&(passive&as&well&as&active)&can&be&achieved&by&direct&in9feed&production&of&therapeutics.&This&in9feed&oral& delivery& system& adds& to& the& ease& of& administration,& limiting& the& necessity& of&trained& personnel& for& administering& the& therapeutics& (Boothe! et! al.,& 2010;&Streatfield,& 2006).& In9feed,& oral& immunisation& with& antigen& or& oral& passive&immunisation& with& antibodies& is& particularly& advantageous& for& developing&treatments& against& enteric& disease& like& enterotoxigenic& Escherichia! coli! (ETEC)&related&post9weaning&diarrhoea&(PWD)&in&piglets;&as&it&is&can&provide&local&mucosal&immunity&(intestinal)&against&ETEC,&which&is&needed&for&prevention&of&PWD&(Bianchi!
et! al.,& 1996;&Moon&and&Bunn,&1993;&Van&den&Broeck! et! al.,& 1999b;&Verdonck! et! al.,&2004b).&&Quite&a& few&strategies&have&been&experimented&with& to&provide&protection&against&ETEC&at&the&intestinal&surface;&this&is&primarily&because&of&the&disease&burden.&ETEC&related&PWD&leads&to&heavy&economic&losses&to&the&global&porcine&rearing&industry&(Amezcua! et! al.,& 2002;& Fairbrother! et! al.,& 2005;& Hong! et! al.,& 2006).&Moreover,& the&urge& to& find&prophylactic&measures& is& increasing&because&of& the& increasing&ban&on&the&traditionally&used&antibiotic&prophylaxis&(Berghman!et!al.,&2005).&Of&the&different&ETEC& strains,& the& ones& bearing& the& F4& fimbriae& (F4+ETEC)& are& predominantly&isolated& from&piglets&with&acute&diarrhoea& (Osek,&1999).&However,& currently& there&are&no&commercially&available&specific&therapeutics&against&F4+ETEC&and&until&very&recently,&antibiotics&were&the&only&treatment&extensively&utilised&in&several&parts&of&the& world& (Fairbrother! et! al.,& 2005).& Attempts& so& far& to& develop& suitable& anti9F4+ETEC& therapeutics& have& broadly& focused& on& three& strategies,& first9& vaccine&development,& including& plant& based& vaccine& (Joensuu! et! al.,& 2004;& Joensuu! et! al.,&2006a;& Joensuu! et! al.,& 2006b);& second9& passive& immunisation& with& spray9dried&animal&plasma&or&immunised&egg&protein&(Chernysheva!et!al.,&2004;&Marquardt!et!al.,&1999;&Yokoyama!et!al.,&1992),&and&third&the&use&of&natural&ETEC&inhibitors&in&piglet&starter& feed& (Becker! et! al.,& 2011;& Mynott! et! al.,& 1996).& Of& the& three,& passive&
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immunisation& strategies& have& fared& relatively& well,& as& passive& immunisation&provides&instant&protection&against&ETEC.&However&there&are&limitations&to&each&of&these&passive& immunisation&strategies&(Owusu9Asiedu!et!al.,&2002a).& Immunisation&of& the& sow& induces& lactogenic& immunity,& producing& large& amount& of& anti9F4+ETEC&antibody& in& the& milk,& but& this& protection& is& lost& soon& after& weaning.& Passive&immunisation& with& serum& antibodies& obtained& from& animal& plasma& is& difficult& to&regulate&and&be&consistent&in&the&content&of&anti9F4+ETEC&antibody.&Immunised&egg&antibodies& though& have& the&merits& of& regulating& and&maintaining& consistency;& the&cost& of& such& therapy& is& very& high& which& makes& it& an& economically& unrealistic&treatment&(Chernysheva!et!al.,&2004;&Harmsen!et!al.,&2005).&We& explored& an& economic& viable& solution& to& produce& specific& antibodies& against&ETEC,&by&producing&them&in&seeds&that&can&be&incorporated&into&the&starter&feed&of&weaned&piglets.&Production&of&anti9ETEC&antibodies& in&seeds&also&has&the&merits&of&ease&of&storage&and&obtaining&high&concentrations& in&confined&space&(Lau&and&Sun,&2009;& Van& Droogenbroeck! et! al.,& 2007),& which& further& adds& to& the& ease& of&administration,& particularly& for& large& herd& of& piglets.& However& oral& passive&immunisation& has& two& important& pit& falls,& first& the& harsh& acid& environment& of& the&gastrointestinal& tract&and& the&necessity&of&high&amounts&of&antibody,&usually&being&milligrams&of&antibody&per&individual&per&day&(Streatfield,&2006).&&To& circumnavigate& these& two& issues,& we& aimed& at& designing& a& robust& but& simple&antibody,&based&on& the&camelid&heavy&chain&only&antibody&structure.&The&camelids&have&a&unique&kind&of&antibodies& that&are&devoid&of& light&chain&and& the& light&chain&assorted& (first)& constant& heavy& domain& one& (CH1).& These& heavy& chain& antibodies&have& a& variable& antigen&binding&domain& (VHH),& nick&named&Nanobody®,& followed&by&a&hinge&and&the&CH29CH3&domains&(Harmsen&and&De&Haard,&2007).&The&VHHs&are&very& robust& and& have& been& described& to& survive& harsh& chemical& and& temperature&conditions& and& still& remain& functional& (Muyldermans,& 2001).& It& is& this& property& of&VHH&that&makes&them&particularly&attractive&for&designing&anti9F4+ETEC&antibodies&for&oral&passive&immunisation&therapy.&Monomeric&VHHs&against&the&F4&fimbriae&of&pathogenic& ETEC& have& been& shown& to& prevent& ETEC& binding& to& gut& villous&
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enterocytes&and&even&reduce&the&intestinal&fluid&loss,&in!vitro!(Harmsen!et!al.,&2005).&However& agglutination& of& ETEC& bacteria& by& bivalent& antibodies& prevents& biofilm&formation&by&cross9linking&ETEC&and&is&a&crucial&element&in&preventing&diarrhoea.&&VHHs&can&be&made&bivalent&by&fusing&them&to&the&fragment&crystallisable&(Fc)&region&of&immunoglobulins.&These&bivalent&VHH9Fc&fusions&have&an&increased&half&life&and&also& an& increased& avidity& (Hmila! et! al.,& 2008).& Additionally,& Fc& as& a& fusion& tag& has&been& shown& to& boost& the& expression& of& several& heterologous& proteins& in& seeds&(Sylvie& De& Buck11& and& Robin& Piron12,& personal& communication)& and& in& leaves&(Obregon! et! al.,& 2006).& The& choice& of& a& specific& Fc& can& further& impart& important&attributes&required&for&protective&immunity.&There&are&6&putative&subclasses&of&the&porcine& IgG& antibodies.& Of& these,& the& porcine& IgG3& has& the& longest& hinge& with&additional&cysteine&residues.&From&the&sequence&analysis,&the&porcine&IgG3&has&been&predicted& to& be& most& likely& to& activate& the& complement& and& bind& to& the& Fcγ&receptors.&And&most&importantly,&porcine&IgG3&might&also&be&relatively&insensitive&to&pepsin& cleavage& (Butler! et!al.,& 2009).&These&properties& suggested& to&us& that& the&Fc&fragment&of&porcine&IgG3&might&be&an&ideal&fusion&partner&for&ETEC&binding&VHHs&to&be&used&for&oral&passive&immunotherapy.&&
&
Figure!4.1:!Schematic!diagram!of!the!customised!porcinisedHlama!antibody,!consisting&of&VHHs&(anti9FaeGac)&grafted&on&to& the& long& flexible&hinge&(23&amino&acid),&constant&heavy&domain&2&(Cγ2)&and&constant&heavy&domain&3&(Cγ3)&of&the&porcine&IgG3.&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&11&VHH&grafted&to&human&IgG&Fc&12&Viral&capsid&protein&in&fusion&to&porcine&Fc&
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With& this& rational,& 4& anti9F4+ETEC& VHH& domains& were& isolated,& engineered& into&customised& VHH9IgG3& ‘porcinised9lama’& (PoLa)& antibodies& (Figure& 4.1)& and&produced&in&the&seeds&of&the&model&dicot&plant&Arabidopsis!thaliana&(ecotype9&Col&0),&to& deliver& a& proof& of& feasibility& of& in& seed& expression.& Here&we& describe& the& PoLa&antibody& expression& results& and& present& evidence& of& their& functionality& in&preventing&F4+ETEC&attachment&to&villous&enterocytes&in!vitro.&
Results!and!Discussion!
Selection! of! functional! VHHs! that! agglutinate! all! three! serotypes! of! F4+ETEC!
bacteria!in!multivalent!form!!For& isolating& robust& antigen& binding& domains,& suitable& for& oral& passive&immunotherapy,& VHH’s& were& panned& against& FaeG,& the& major& adhesin& protein&present& on& the& proteinaceous& fimbriae& of& F4+ETEC.& Attachment& of& FaeG& to& the&porcine& gut& villous& enterocyte& receptors& is& the& first& step& in& establishing& ETEC&infection,& followed&by& colonisation,& toxin& release& and& the& consequential& diarrhoea.&Specific& VHHs& that& inhibit& bacterial& binding& can& in& principle& prevent& the& onset& of&diarrhoea&(Harmsen!et!al.,&2005).&Serologically&the&FaeG&adhesin&can&be&classified&as:&FaeGab,& FaeGac& and& FaeGad&depending& upon& the& variable& epitope& of& the& adhesion&molecule&FaeG&(see&review&by&Van&den&Broeck!et!al.,&2000).&Of&these&three&variants,&predominantly&isolated&F4+ETEC&bearing&FaeGac&adhesin&on&the&fimbriae,&has&often&been& associated& with& acute& diarrhoea& in& piglets& (Gonzalez! et! al.,& 1995).& Purified&recombinant&FaeGac&was&used&to&immunise&a&healthy&lama&to&develop&FaeG9specific&VHHs& against& this& major& adhesin.& Six& weeks& post& immunisation,& the& lymphocytic&cDNA&immune&library&was&made.&Using&phage&display&technology,&the&VHHs&from&the&immune& library&were&panned&against& the& antigen&FaeGac& and&FaeGad& for& isolating&VHHs& specific& for& the& variable& epitope& (‘c’& of& predominantly& occurring& F4+ETEC&FaeGac)&as&well&as&against&the&conserved&epitope&(‘a’)&common&to&all&3&serotypes&of&F4+ETEC.&This&enabled&the&selection&of&a&panel&of&79&VHHs&recognising&specifically&the& FaeGac& along&with& broad& spectrum&VHHs& recognising& all& the& three& variants& of&FaeG.&These&VHHs&specifically&recognised&FaeG&as&well&as&purified&F4&Fimbriae&in&an&enzyme9linked& immunosorbent& assay& (ELISA).& To& eliminate& similar,& redundant&
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VHHs,& we& used& the& restriction& fragment& length& polymorphism& (RFLP)& technique.&&Whereby,& the& VHH& coding& sequence&was& amplified& by& PCR& using& specific& primers,&which& resulted& in& a& 680& bp& amplicon.& This& PCR& product& was& then& digested& with&restriction& enzyme& HinfI& or& RsaI& and& the& pattern& of& digested& fragments& was&visualised&by&agarose&gel&electrophoreses.&VHHs&representing&similar&patterns&were&clubbed&into&RFLP&groups&and,&the&DNA&of&representative&VHHs&from&each&of&these&RFLP&groups&were&sequenced.&&&
&
Figure!4.2:!Amino!acid!sequence!divergence!between!the!four!anti!FaeGac!VHHs.&The&neighbour&joining,&1000&replicates&bootstrapped&tree&represents&the&three&clades&of&VHHs&isolated.&The&scale&bar&indicates&the&number&of&difference&in&amino&acid&composition.&The&boot&strap&value&(100)&is&denoted&at&the&node.&&
V1  QVQLQESGGG LVQAGGSLRL SCEASGNVDR IDAMGWFRQA PGKQREFVGY ISEGGILN-Y  [ 59]  
V2  .......... ...P...... ..T...SISS .N....Y... ..SK....AH .TNT.VTE-F  [ 59]  
V3  .......... .......... ..A...LTFD TY........ ...K..Y.AA ..WT..STY.  [ 60]  
V4  .......... .......... ..A...LTFD TY........ ...K..Y.AA ..WT..STY.  [ 60] 
  
                                                                          
    
V1  GDFVKGRFTI SRDNAKNTVY LQMSNLKSED TGVYFCAASH WGTLLIKGIE HWGKGTQVTV  [119]  
V2  A.S....... ......T..D ...NS..P.. .A..Y...TD .........D ..........  [119]  
V3  A.IA...... ........L. ...DS..P.. .A..Y...QK SLNVPAP-WD Y..Q......  [119]  
V4  A.IA...... ........L. ...DS..P.. .A..Y...QR SLNVPAP-WD Y..Q......  [119]  
           
   
                                                                 
V1  SS [121]                                                                  
V2  .. [121]                                                                  
V3  .. [121]                                                                  
V4  .. [121]  




Figure! 4.3:! Amino! acid! sequence! alignment! of! the! 4! selected! antiHF4! VHH.& The& 4& amino& acid&sequences&of&VHH&V194&are&compared&between&one&another,&the&sequence&of&VHH&V1&is&at&the&top&of&this& alignment,& in& reference& to& which& amino& acid& changes& in& the& other& three& VHH& sequences& are&indicated;&identical&amino&acid&residues&are&represented&with&a&dot.&The&4&framework&regions&(FWR)&interspersed&with&the&3&complement&determining&regions&(CDRs)&are&indicated&above&the&alignment.&The&single&amino&acid&difference&Lys91009Arg&between&the&VHH&sequence&of&V3&and&V4&in&the&CDR3&region& is&bold& face.&Reference& to&amino&acid&position& is& indicated& in&parenthesis&at& the&end&of& each&line.&
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A& typical& sequence&of& a&VHH& shows& structurally& conserved& regions& in&which& three&distinct& hypervariable& regions& are& embedded& called& complementarity& determining&regions& (CDRs)& (Muyldermans! et! al.,& 2001).& Of& the& three& CDRs,& the& CDR3& loop& is&regarded&most& important& in& interaction&with& the& antigen.&Often& the& CDR3& forms& a&protrusion&that&interacts&with&deep&clefts&of&antigen&(Transue!et!al.,&1998).&It&is&this&convex&structure,&unique&to&the&VHH,&that&together&with&the&CDR1&provides&the&VHH&with& an& enhanced& repertoire& of& antigen& binding& paratopes& (Muyldermans! et! al.,&2001).& From& the& deduced& amino& acid& sequence& and& the& divergence& in& CDR3,& all&isolated& 79& VHH& sequences& could& be& divided& into& three& clades.& Four& VHHs&representing&these&three&clades&were&selected&and&named&V1,&V2,&V3&and&V4&(Figure&4.2).&The&VHHs&V3&and&V4&belonged&to&the&third&clade&and&differed&by&a&single&amino&acid&substitution&Lys91009Arg&within&the&CDR3&loop&(Figure&4.2&and&4.3).&&To& investigate&the& interaction&of&VHHs&with&F4+ETEC&bacteria,& the&simple&bacterial&agglutination& test& was& used.& Bacterial& agglutination& test& is& a& standard& serological&test,& where& presence& of& antibody& or& antigenic& variant& can& be& determined& by&visualising& the& agglutination& formed& on& a& glass& slide& by& cross9linking& bivalent&antibody.& Since& VHHs& themselves& are& monovalent& and& incapable& of& crosslinking&bacteria,& purified& VHHs& were& covalently& linked& to& magnetic& beads& making& them&multivalent.&The&dark& colour&of& these&magnetic&beads& also&helps& in& visualizing& the&results&of&the&agglutination,&as&compared&to&colourless&resin&beads.&The& anti9FaeGac& VHH9coated& magnetic& beads& with& each& of& the& 4& VHHs& when&incubated&with& different& serotypes& of& F4+ETEC& bacteria& showed& agglutination.& On&the&contrary,&the&same&beads&did&not&show&agglutination&with&the&negative&control&E.!
coli&strain&K514&(Colson!et!al.,&1965;&Johansen!et!al.,&1999),&which&does&not&produce&any& fimbriae& nor& with& K514& transformed& with& plasmid& pIH120& expressing& F18&fimbriae&(K5149pIH120)&as&non9specific&fimbriae&control.&In&Figure&4.4&the&results&of&the&agglutination&tests&are&shown&for&beads&coated&with&V2&and&V3.&&Thus&all&4&VHHs&isolated&in&this&study,&in&multivalent&format&were&able&to&agglutinate&the&three&variants&of&F4+ETEC.&
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4.1.9 Agglutination assays 
 
To test for the ability of the anti-F4 nanobodies to agglutinate F4+ E. coli bacterial cells, two 
agglutination assays were performed. In the first instance, the VHHs were conjugated directly 
with magnetic Dynabeads and the conjugates used in the agglutination assay. The result of this 
assay (Figure 23) was positive for all anti-F4 – Dynabeads conjugates against F4+ E. coli strains, 
as expected. The two negative controls using an unrel ted nanobody Nb226 and a F4-negative E. 
coli K514 (pIH120), and anti-F4 Nb488 against pIH120 (h) were negative as expected. 
 
 
Figure 23 Agglutination of F4+ E. coli by conjugated VHH-magnetic Dynabeads 
Test VHHs (anti-F4 VHH) are Nb488 and Nb489a. Nb226 is negative control. The phenotypes of 
different E. coli strains used are; C585-80: F4ad; C95-72: F4ac; C1023-78: F4ab; pIH120 (K514 
(pIH120) - negative control): F4 (-). Slides a, b, c, e, f and g are positive for agglutination. Slides 
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F4ad F4ac F4ab Negative control 
&Figure&4.4:&Anti9F4+ETEC&VHH&V2&and&V3&in&a&multivalent&form&coupled&to&magnetic&beads&specifically&agglutinates&all&the&3&serotypes&of&F4+ETEC.&Bead&coated&VHH&V2&and&V3&show&specific&agglutination&when& incubated& with& F4+ETEC& strain& C585980& expressing& F4ad& fimbriae& (a& and& e& respectively),&F4+ETEC& strain& C95972& expressing& F4ac& (b& and& f& respectively)& and& F4+ETEC& strain& C1023978&expressing&F4ab&(c&and&g&respectively);&while&not&with&negative&control&strain&K5149PIH120&(d&and&h).&(Similar&results&obtained&with&VHH&V1&and&V4&are&not&shown.)&The&interaction&of&anti9ETEC&VHHs&was&specific&and&no&agglutination&was&observed&with&an&unrelated&VHH&(Nb226)&used&as&control& in&the&above&test&(not&shown&in&the&figure).&Figure&ad pted&from&M ster&thesis&(Okello,&2010).&&&
Production! of! high! accumulating! porcinisedHlama! divalent! antibodies! in!
Arabidopsis!seeds!The& agglutination& potential& of& the& 4& VHHs& in& multivalent& form& mak s& th m&promising& candidates& as& anti9F4+ETEC& therapeutic& for& oral& feed& based& passive&immunisation.& H nce& we& further& focused& on& strategies& that& would& enable& high&production&of&the&envisaged&recombinant&antibodies&in&seeds&and&devised&screening&methods&to&identify&the&high&expressing&transgenic&plants.&&Firstly&the&native&sequence&of&all&four&anti9F4+ETEC&monovalent&VHHs&i.e.&V1,&V2,&V3,&and&V4&were&grafted&on&the&codon&optimised&sequence&of&porcine&IgG3&Fc&to&produce&divalent& porcinised9lama& heavy& chain& only& antibodies& (PoLa),& which& were& named&V1G,&V2G,&V3G&and&V4G&respectively.&The&coding&regions&of& these& four& fusion&PoLa&antibodies&with&an&N9terminal&2S2&signal&peptide&of&seed&storage&protein,&and&a&C9terminal&endoplasmic&retention&tag&(KDEL)&were&cloned&within&the&pPhas&GW&vector&(Figure&4.5)&(Morandini!et!al.,&2011),&bearing&the&5’&β9Phaseoline&promoter&and&the&3’& arceline& terminator& bearing& regulatory& sequences& to& enable& dicot& seed9specific&high&expression&of&heterologous&proteins&(Loos!et!al.,&2011a;&Loos!et!al.,&2011b;&Van&Droogenbroeck!et!al.,&2007).&
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Further,& by& Agrobacterium9mediated& floral& dip& transformation& all& the& 4& PoLa&antibodies& were& transformed& in& A.! thaliana& Col& 0.& Five& plants& were& dipped& per&antibody&construct,& for&which&a& transformation&efficiency&of&1.3%&of&T1&seeds&was&observed&on&an&average.&At&least&24&selected&T1&transformants&were&grown&for&each&of&the&PoLa&antibodies&and&T2&seed&stocks&were&harvested,&and&characterised&for&the&antibody&expressed.&&
&
Figure! 4.5:! Schematic,! to! scale! representation! of! the! THDNA! construct! used! for! in! seed!
expression! of! antiHF4+ETEC! porcinisedHlama! VHHHIgG! antibodies.! LB9& left& border;& RB9& right&border;&VHH9IgG39fused&coding&sequence&of&the&VHH&and&porcine&IgG3&Fc;&Omega&leader9&5’&tobacco&mosaic&viral&UTR;&2S2&9&signal&peptide&sequence&of&the&2S2&seed&storage&protein;&KDEL9&endoplasmic&retention&motif;&attB1,attB2&9&gateway&recombination&site&sequences&(Invitrogen);&Pphas9&Phaseolin&promoter;&3’arc5I9&3’&arcelin&regulatory&sequence;&nptII9&neomycin&phosphotransferase&II&gene;&Pnos9&nopaline&synthase&gene&promoter;&3’ocs9&octopine&synthase&terminator.!!!!&To& evaluate& the& relative&VHH9IgG&antibody&accumulation& levels& in& the&different&T2&seed& stocks& and& to& identify& the& high& antibody& expressing& transformants;& a& high9throughput&functional&ELISA&was&setup&with&antigen9coated&wells&(FaeGac).&Within&the&24& transformants&screened& for&each&VHH9IgG&antibody,& the&range& for&variation&for&the&V2G&was&the&highest&followed&by&V1G,&while&V3G&and&V4G&antibodies&had&a&relatively&low&range&of&variation&in&accumulation&of&functional&antibody&(Figure&4.6).&From&the&ELISA&read&outs,&the&relative&accumulation&of&functional&antibodies&in&the&respective&transformants&could&be&classified&as&highest,&medium&and&low&expressers.&The&top&5,&antibody&expressing&transformants,&along&with&2&medium&expressing&and&a& low&expressing&plant& for& each&PoLa&antibody&were& characterised& further& (Figure&4.6).& Under& reducing& condition& all& the& transgenic& seed& extracts& showed& a&heterologous&band&migrating&at&~49&kDa,&this&band&was&also&confirmed&as&PoLa&by&immunoblot& using& the& anti9pig& IgG& specific& polyclonal& serum& (Figure& 4.6).& Under&non9reducing&conditions&the&PoLa&antibodies&migrated&at&~80&kDa,&thus&confirming&that& they& form& perfect& dimeric& antibodies& in! planta& (Figure& 4.7).& However& the.&
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calculated& molecular& weight& of& a& single& PoLa& antibody& chain& was& ~40& kDa,& the&higher&molecular&weight& could&probably& be&due& to& posttranslational&modifications&viz.&presence&of&plant&N9linked&glycans.&&
&
Figure! 4.6:! Inter! transformant! variation! in! accumulation! of! the! 4! different! VHHHIgG!
antibodies.!The&panel&a,&b,&c&and&d&show&results&of&antibodies&V1G,&V2G,&V3G&and&V4G,&respectively.&The& graph& in& each& panel& shows& the& functional& ELISA&OD&405& values& of& serially& diluted& 24&T2& seed&extracts,& as&1:100& (blue),&1:200& (red),1:400& (brownish9yellow)&and&1:800& (green);& indicative&of& the&comparative& functional& antibody& accumulation& levels.& Underneath& each& of& the& graphs& is& the&corresponding& Coomassie& stained& SDS9PAGE& and& immunoblot& of& the& seed& extracts,& the& respective&transformants&are&annotated&above&the&get&picture.&On&the&right&hand&side&of&the&marker&are&wild&type&(WT)&seed&extract,&followed&by&the&seed&extracts&from&the&5&top&antibody&expressing&plants&according&to& the& functional& ELISA& graph& have& been& loaded& in& descending& order,& followed& by& two& medium&expressers&and&one& low&expressing& line.&One&microgram&of& total& soluble&seed&protein&was&added& in&each&well,& the&antibody&bands&are& indicated&with&an&arrow& (~49&kDa).&These&VHH9IgG&bands&were&quantified& using& purified& standards& as& indicated& (left& had& side& of& marker).& (t9& the& purified& V2G&antibody&produced&transiently&in&Nicotiana&benthamiana&leaves&was&used&as&standard&reference).&&&&
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The&relative&accumulation&of&this&49&kDa&VHH9IgG&antibody&chain&was&in&affirmation&with& the& functional& ELISA& results,& thus& showing& that& the& most& of& the& correct&molecular&weight& protein&was& also& functional& against& FaeGac& (Figure& 4.6)Further,&the&4&VHH9IgGs&in&divalent&format&also&recognise&the&other&two&variants&of&FaeG,&i.e.&FaeGab&and&FaeGad& in&a& similar&ELISA& setup,& reiterating&previous&broad9spectrum&interaction&results&with&VHH&coated&on&magnetic&beads&(Figures&4.4&and&4.10)&&
&
Figure!4.7:!All!4!VHHHIgGs!form!dimeric!antibodies!in!seeds.!Purified&(500&ng/well)&VHH9IgG&as&well&as&seed&extract&(1&µg&of& total&soluble&protein& in&each&well)& from&lines&V1G924,&V2G921,&V3G918&and& V4G91& expressing& high& amounts& of& antibody& were& separated& on& 7%& SDS9PAGE& under& non9reducing&conditions,&and&stained&with&Coomassie&(upper&panel)&or&immunoblotted&(lower&panel)&and&developed&with& polyclonal& anti9porcine& IgG& serum.& The& arrows& indicate& the& high&molecular&weight&dimeric&VHH9IgG&(~80&kDa).&All&the&lanes&and&the&reference&molecular&weight&bands&are&annotated&in&the& image;& WT& indicates& wild& type& Arabidopsis& seed& extract& (t9& purified& standard& produced& in&N.&
benthamiana&leaves).&&
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Using& purified& V2G& produced& in& Nicotiana& benthamiana& leaves& as& standard&reference,& the& accumulation& of& the& different& antibodies& was& quantified.& V2G& was&noted& as& the& highest& expressing& PoLa& antibody& construct& (15%& of& TSP& i.e.& total&soluble& protein,& Figure& 4.6a)& closely& followed& by& V1G& (10&%& of& TSP,& Figure& 4.6b),&where& as& the& antibodies& V3G& and& V4G& which& differed& by& a& single& amino& acid,&belonging& to& the& same& clade& (Figures& 4.2& and& 4.3)& expressed& to& identical& levels&(about&2&%&of&TSP&each,&Figure&4.6,&c&and&d)&which&was&7&to&5&times&lower&than&the&other&two&PoLa&antibodies.&&&
&&















The&4&different&PoLa& antibodies& only&differing& in& the& amino9terminal&VHH&domain&showed&difference&in&their&maximum&protein&accumulation&levels,&ranging&from&3%&of& seed& weight& (V2G)& to& 0.4%& of& seed& weight& (V3G& and& V4G)& (Figure& 4.8).& This&variability&might&be&contributed&by&several&factors,&which&for&the&sake&of&discussion&can&be&broadly& classified&as&pre9translation&and&post9translation& factors&or& events.&Given&that&the&T9DNA&regulatory&elements&within&the&expression&cassette&used&were&identical,& and& that& for& each& PoLa& antibody& 24& different& lines& were& screened,&normalizes& for& the& position& effect& and& copy& number& influence& in& variation.& The&variability& observed& here,& thus& is& most& likely& due& to& translational& or&posttranslational&influences.&&Along& with& the& regulatory& elements,& codon& optimisation& is& another& factor& that& is&often&advocated&for&attaining&higher&protein&expression&(Geyer!et!al.,&2010).&Initially,&within&all&the&4&PoLa&antibodies,&only&the&coding&sequence&of&the&identical&porcine&Fc&region& (~&2/3rd&of& the&PoLa&coding&sequence)&was&optimised& for&Arabidopsis& seed&codon& usage.& To& evaluate& if& higher& accumulation& can& be& attained& by& further&additional&codon&optimising&of&also&the&VHH&domain,& the& lama&codon&usage&within&the&VHH&coding&frame&was&also&optimised&to&Arabidopsis&seed&codon&usage.&Native&VHH& codons& of& high& expressing&PoLa& antibody&V1G& and& low&expressing&V4G&were&thus& exchanged&with& the& codon& preferences& of& Arabidopsis& seed& storage& proteins.&However& this&did&not& result& in&any& change& in& the&protein&accumulation:& the& codon&optimised& version& V1cG& (of& V1G)& showed& 10%& TSP& accumulation& while& V4cG&(optimised& V4G)& accumulated& to& 2%& of& TSP,& each& similar& to& its& unoptimised&counterparts&(Figure&4.8&and&4.9).&Thus&as&per&our&observation,&codon&optimisation&and& the& introduced& changes& in& the& transcript& sequence& did& not& affect& the&accumulation&of& the&2&PoLa&antibodies.& In&all,&our& results& from&codon&optimisation&reiterate& Ed& Rybicky’s& conclusion& drawn& from& observations& in& his& group& and& of&others&that,& it& is&naive&to&assume&plant&codon&usage&to&be&always&optimal&(Rybicki,&2010).&Rather,&a&high&GC&content&typically&seen&in&human&codon&usage&is&suggested&
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to&influence&accumulation&of&heterologous&proteins&in&plants&(Biemelt!et!al.,&2003)13.&However& the& GC& content& in& all& of& the& 4& PoLa& transcripts& is& higher& than& 50%& and&reasonably&similar&(52.5%&for&V1G,&53.7%&for&V2G,&53.6%&for&V3G,&53.8%&for&V4G,&53.5%&for&V1cG&and&53.9%&for&V4cG).&Thus&also&the&GC&content&in&our&case&does&not&explain&the&observed&inter&antibody&variation.&
&
Figure!4.9:!VHH!codon!optimisation!did!not!affect!the!accumulation!of!respective!antibodies.&The& above& two& immunoblots& show& accumulation& levels& of& the& top& 5,& two& medium,& and& a& low&expressing&line&among&the&24&lines&screened&by&ELISA;&of&the&V1cG&bearing&codon&optimised&version&of&V1,&(compare&accumulation&with&V1G),&in&top&panel&and&that&of&V4cG,&with&codon&optimised&version&of& V4& (compare& accumulation& with& V4G)& bottom& panel& are& sequentially& loaded.& The& names& of& the&transformants& have& been& annotated& in& the& image,& where& the& black& arrow& points& to& the& respective&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&13&Discussed&by&Catherine&Pineo&at&the&Plant&based&Vaccine&and&Antigen&conference,&Porto,&2011. Expression&and&optimisation&of&human&papillomavirus&type&16&(HPV916)&chimaera&candidate&vaccines&in!Nicotiana!benthamiana’&Catherine&Pineo,&Inga&I&Hitzeroth,&Gillian&de&Villiers&and&Edward&P.&Rybicki.&
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antibody&revealed&by&a&polyclonal&anti9porcine&IgG&serum.&The&small&grey&arrows&indicate&the&in!seed&proteolytically&cleaved&fragment&(NB:&This&proteolytic&fragment&was&seen&in&all&VHH9IgG).&Often&modulation/&substitution&of& certain&amino&acid& residues&of& the&heterologous&protein&improves&the&assembly&and&accumulation&of&heterologous&protein&in&plants&(Waheed! et! al.,& 2011),& since& it& might& influence& the& protein& stability& and& thus& the&accumulation&in&a&given&tissue.&The&sequence&of&the&4&PoLa&antibodies&expressed&in&the&Arabidopsis&embryo&is&identical&in&the&Fc&region,&and&variable&exclusively&in&the&VHH& domain.& Thus& inferring& that& the& amino& acid& sequence& of& the& VHH& might&influence& the&VHH9Fc& accumulation& in& seeds,& and&different&VHH&sequence& leads& to&variability&in&expression.&However& lama& VHHs& show& up& to& 94%& identity,& with& high& similarity& within& the&structural& framework& regions,& and& the& variability& is& rather& limited& to& the& three&hypervariable& CDRs;& the& same&was& also& observed&within& the& 4&anti9ETEC&VHHs& in&this& study& (Figure&4.3).& The&V3G&differs& from&V4G&by& one& amino& acid& in& the&CRD3&region;& the& V3G& is& 37& amino& acids& different& from& the& V2G,& and& 30& amino& acids&different&from&V1G&(Figure&4.3).&From&these&results&it&appears&that&not&just&the&whole&protein& composition& but& especially& the& amino& acid& composition& towards& the& N9terminal& end&of& the&protein& (here& the&VHH)& influences& its& accumulation.&Arguably,&this& could& just& be& an& isolated& case& of& the& VHH9IgG& in& this& study,& where& average&accumulation& pattern& for& 24& transformants& of& V1cG& and&V1G&was& similar& (highest&10%&of&TSP)&and&so&was&true&for&V3G,&V4G,&and&V4cG&(highest&2%&of&TSP).&&VHHs& when& expressed& in& E.! coli! cells& by& themselves& as& monomers& also& show&variability& in& production,& and& also& differ& in& their& physical& properties.& In& order& to&build& chimeric& VHH& with& high& stability& and& production& levels,& Saerens& and& co9workers&(2005)&identified&a&universal&VHH&framework.&Grafting&the&antigen&binding&loop& onto& this& identified& framework& led& to& improved& accumulation& in& E.! coli& and&increased&thermodynamic&stability&compared&to&the&original&VHH&domain&(Saerens!
et! al.,& 2005).& Further& investigation,& in& the&N9end& rule&of& seeds&and&by&determining&VHH& frame& work& suitable& for& in9seed& production& will& help& in& designing& VHH9Fc&which&might&have&higher&accumulation.&&
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&&
&
Figure! 4.10:! All! VHHHIgGs! recognise! the! three! variants! of! FaeG! in! the! F4! fimbriae! namelyH!
FaeGac!(left),!FaeGad!(middle),!and!FaeGab!(right)!in!ELISA.!
!
!Along& with& the& amino& acid& sequence,& the& abundance& of& a& heterologous& protein& is&influenced& by& the& interplay& between& the& host& machinery& (e.g.& chaperon,& post&translation& modification& enzymes& etc.)& and& the& heterologous& protein& itself&(myristylation& in& membrane9associated& proteins,& presence& or& absence& of& putative&glycosylation& sites)& (Nuttall! et! al.,& 2002;& Rybicki,& 2010).& Antibodies& are& generally&regarded&as&better&accumulators&as&their&proper&folding&and&assembly&is&facilitated&by&the&ER&resident&chaperon&proteins&like&the&Calreticulin,&BiP&(binding&protein)&and&ERp57& (Nuttall! et! al.,& 2002).& Proteins& that& fail& to& comply& with& the& endogenous&protein& production& machinery,& are& often& miss9folded,& or& bear& incorrect&glycosylation.&Such&proteins&are&usually&degraded&by&the&ER9associated&degradation&(ERAD)& mechanism& (Clerc! et! al.,& 2009;& Hirsch! et! al.,& 2009).& This& mechanism& for&degradation&of&in&seed&produced&single&chain&antibodies&was&also&suggested&by&Loss&
et! al.& on& studying& the& degradation& of& the& anti9HIV& single& chain& antibody& 2G12&expressed&in&Arabidopsis&seeds&(Loos!et!al.,&2011b).&Such&excessive&degradation&or&specific& proteolytic& fragmentation& of& V3G& and& V4G& (bearing& just& one& amino& acid&difference),& compared& to& V1G& and&V2G&would& explain& lower& accumulation& of& fully&
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functional&assembled&antibodies.&However,&the&immunoblot&analysis&with&polyclonal&anti9Pig& IgG& antibodies& did& not& reveal& excessive& proteolitic& fragmentation& for& V3G&and&V4G&as&compared&to&the&other&two&PoLa&antibodies&V2G&and&V1G.&In&fact&all&the&4&PoLa& antibodies& showed& an& identical& and& specific& proteolytic& cleavage& product& of&~37&KDa&and&15&KDa,&suggesting&a&proteolytically&sensitive&amino&acid&sequence&in&the& common& Fc& element& (Figure&4.9).& Seemingly& this& fragmentation& is& dose&dependent,& as& the& amount& of& cleaved& fragment& was& proportional& with& the& total&antibody&amounts;&on&an&average&transformants&having&production&level&more&than&~3%&of&TSP&showed&high&amount&of&degradation&(Figure&4.9).&Dried&matured&seeds&being& an& end& point& system,& only& proteolysis& fragments& presumably& generated& by&specific& proteases& can& be& seen& and& analysed,& however& degradation& of& an& unfit&protein&could&be&due&to&the&ERAD&pathway.&Investigation&of&the&VHH9IgG&during&seed&filling& (maturation)& phase& might& shed& more& light& into& mechanisms,& and& its&involvement&in&accumulation.&&Further,& differential& glycosylation& as& another& hallmark& of& posttranslational&modifications&was&seen&in&the&highest&expressing&lines&of&V2G&and&V1G&(higher&than&10%&of&TSP)&as&a&faint&band&migrating&underneath&the&~49&kDa&PoLa&antibody&band&(Figures& 4.6& and& 4.8).& This& band& appears& to& be& the& unglycosylated& variant& of& the&highly& expressed& VHH9IgG,& such& unglycosylated& bands& of& ScFv9Fc& expressed& in&Arabidopsis&seeds&have&also&been&reported&earlier&in&high&accumulating&ER9retained&single&chain9Fc&(ScFv9FC)&antibodies&(Loos!et!al.,&2011b;&Van&Droogenbroeck!et!al.,&2007).& However& unlike& in& our& study,& the& ratio& of& glycosylated& to& unglycosylated&bands&were& almost& similar& (approximately& equimolar& doublet),& irrespective& of& the&accumulation& attained.& The& results& of& Van& Droogenbroeck& et& al.& (2007)& suggested&that& the& doublet& of& equal& ratio& visible& under& reduced& condition& could& be& due& to&glycan&attachment&to&only&one&of&the&chain&of&ScFv9Fc&antibody.&Our&results&do&not&show&this&equiratio&doublet&of&band.&Rather&the&occurrence&of&a&faint&unglycosylated&band& suggest& overwhelming& of& the& glycosylation& machinery;& where& under& high&production& and& accumulation& pressure& a& minute& fraction& of& PoLa& is& left&unglycosylated& (hence& seen& only& in& high& expressing& lines).& We& did& not& study& the&
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glycosylation&of& these&antibodies& in&detail,& glycosylation&can&be&very& important& for&ensuring& functionality& and& stability& of& an& antibody& and& hence& needs& to& be&characterised.& In& case& of& parenteral& administration& plant& glycan& can& lead& to&undesired&glycan&specific& immune&reaction,& this& issue&however& is&not&of&an&equally&impending&nature&for&oral&passive&immunisation.&&&&
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Figure!4.11:!All!the!VHHHFcs!were!stable!in!crushed!seed!for!weeks!at!room!temperature.&The&titre&of&the&antibody&V3G&and&V4G&begins&to&decline&after&10&weeks&later.&&&
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Seed! produced! antiHF4! antibodies! inhibit! bacterial! binding! to! gut! villous!
enterocytes!!Protein&extracts&from&seeds&producing&the&anti9F4+ETEC&antibodies&were&tested&for&their& ability& to& inhibit& F4+ETEC& (serotype& FaeGac)& attachment& to& gut& villous&enterocytes&in&an&in!vitro&adhesion&test&(Coddens!et!al.,&2009).&Same&quantity&of&total&soluble& seed& protein& (identical& seed& weight)& was& incubated& with& the& F4+ETEC9FaeGac&bacteria&[field&isolate9&GiS26,&(Cox&and&Houvenaghel,&1993)]&and&then&added&to& the& porcine& gut& villous& enterocytes.& All& seed& extracts& with& the& four& antibodies&inhibited& the& binding& of& the& bacteria& to& the& gut& villous& enterocytes& (Figure& 4.12).&However,&due& to& the&semi&quantitative&nature&of& the& functional& test,& the& functional&capacity& of& the& 4& antibodies& could& not& be& compared& (Figure& 4.12).& The& test& was&repeated& with& purified& antibodies& and& gave& the& same& result& (data& not& shown),&confirming&that&the&antibodies&specifically&inhibit&binding&to&the&gut&villi&and&not&an&element& of& the& seed& extract.& Also,& for& any& particular& anti9F4+ETEC& PoLa& antibody&higher& dilution& in& dose& had& consequential& lower& reduction& in& inhibition& of& the&bacteria;&thus&dually&confirming&the&biological&relevance.&&&&&&& & &
&Figure&4.12:&All&seed&made&antibodies&agglutinate&the&pathogenic&bacteria&and&inhibits&its&attachment&to& gut& villous& enterocytes.& The& bars& represent& the& average& number& of& bacteria& bound& per& 250& µm&length& of& the& villous& surface,& as& determined& by& porcine& villi& binding& inhibition& test.& In& this& semi9quantitative& assay& 100& µl& of& seed& extract& made& from& the& pool& of& seeds& expressing& each& of& the& 4&antibodies&V1G&(expression&in&pooled&seeds&~&10%&of&TSP),&V2G&(expression&in&pooled&seeds&~15%&of&TSP),&V3G&(expression&in&pooled&seeds&~&2%&of&TSP)&and&V4G&(expression&in&pooled&seeds&~&2%&of&TSP)&showed&inhibition&of&Gis26&F4+ETEC&bacteria&to&F4R&positive&piglet&gut&villous&enterocytes;&as&compared& to& same& concentration& of& wild& type& seed& extract& (Col& O)& or& 100& µl& of& phosphate& buffer&(PBS)&as&control.&All&the&seed&extracts&were&made&by&suspending&8&mg&of&crushed&seeds&in&200&µl&of&extraction& buffer.& The& bound& bacteria& were& counted& under& phase& contrast& microscope& at& a&magnification& of& 600& times.& Additionally,& the& presence& and& absence& of& bacterial& agglutination&observed&is&indicated&in&parenthesis.&&
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To&summarise&the&in!vitro&efficacy,&all&the&four&anti9F4&PoLa&antibodies&were&folded&correctly&in&plant&and&formed&dimeric&antibodies&(Figure&4.7)&which&bound&to&all&the&three& antigenic& variants& of& surface& adhesin& FaeG& (Figure& 4.10),& agglutinated&F4+ETEC&bacteria&and& inhibited& the&bacterial&attachment& to& the&porcine&gut&villous&enterocytes& (Figure&4.4&and&Figure&4.12),& suggesting& that&all& the&4&VHH9Fc&bind& to&epitopes& common& to& the& three& variants& of& FaeG,& i.e.& FaeGac,& FaeGab& and& FaeGad.&Contradictory& to& our& results,& previous& results& from& Harmsen& et! al.& (2005)& with&monomeric& anti9F4ac& VHHs& suggested& that& binding& to& the& variable& epitope& is&necessary& for& inhibiting& the& attachment& of& the& respective& FaeG& variant& bearing&F4+ETEC& bacteria.& VHHs& are& predominantly& known& to& interact& with& non9linear&conformational&epitopes&(Lauwereys!et!al.,&1998;&Muyldermans!et!al.,&2001);&all&the&4&anti9F4+ETEC&PoLa&antibodies&that&we&produced&do&not&recognise&the&antigen&FaeG&under& denatured& condition& in& immunoblots& (data& not& shown),& implying& that& the&broad&spectrum&merit&of&the&4&PoLa&in&inhibiting&the&F4+ETEC&binding&to&gut&villus&is&perhaps& achieved& by& binding& to& certain& common& epitope& that& is& inaccessible& to&conventional&monoclonal&antibodies&or& the&VHH&isolated&by&Harmsen&et!al.& (2005)&which& did& bind& to& FaeG& in& immunoblots.& In& all& providing& that& the& novel& PoLa&antibodies&can&target&previously&hidden&epitopes,&and&thus&further&this&strategy&can&be&used&for&designing&antibodies&against&other&orphan&porcine&enteric&diseases.&&In&conclusion,& the& results&of& this& chapter&demonstrate& the& feasibility& for&producing&‘disease& customised’& antibodies& for& specific& prophylaxis& against& F4+ETEC& infection&designed& for& oral& delivery.& The& VHH&panning& strategy& against& two& antigens& led& to&isolation& of& VHHs& that& recognised& all& three& serotype& of& the& F4+ETEC& bacteria.&Further,&high&level&accumulation&of&dimeric&VHH9IgG&‘porcinised9lama’&antibody&was&attained.&Our& insights& about& accumulation& from&our& results& and& related&discussion&will& help& in& planning& and& designing& future& functional& antibody& to& ensure& high&accumulation&in&seeds.&The&most&important&merit&of&these&antibodies&is&the&effective&prevention&of&adhesion&of&pathogenic&F4+ETEC&bacteria& in! vitro.!Most& importantly,&the& PoLa& antibodies& expressed& in& seeds& are& promising& candidates& for& developing&anti9F4+ETEC& oral& prophylactic& therapeutics.& Further& in& Chapter& 6& we& assess& the&
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Immunisation!and!construction!of!immune!library!!Enterotoxigenic&Escherichia!coli& (ETEC)&strains&bearing&F4& fimbriae&(F4+ETEC)&can&be&serologically&classified&into&three&variants,&depending&upon&the&variable&domain&of& the&adhesion&molecule&FaeG,&as&FaeGab,&FaeGac&and&FaeGad&(Van&den&Broeck! et!
al.,&2000).&Each&of&these&variants&has&a&common&epitope& ‘a’&and&respective&variable&epitope& ‘b,& c& or& d’.& Of& these& three& variants,& ETEC& bacterial& bearing& FaeGac& are&predominantly& isolated& from& diseased& piglets& (~60%)& (Chen! et! al.,& 2004;& Osek,&1999).&Hence&the&FaeGac&was&chosen&as&antigen&for&immunising&the&lama&to&generate&antigen& binding& variable& domains& of& heavy& chain& only& antibody& (VHH).& Purified&recombinant& FaeGac&molecule& was& used& to& immunise& a& lama.& Six& weeks& later& the&lymphocytic&cDNA&library&was&made.&Primers&specific&to&the&variable&domain&of&the&heavy&chain&only&antibody&(VHH)&were&used&to&amplify&the&VHHs&coding&sequences.&These&amplicons&bearing&VHH&coding&sequences&were&then&cloned& into& the&pMES4&vector&and& transformed& into&TG1&cells&and& thus&a&VHH& library&was&generated.&The&different& steps& are& elaborated& in& detail& below.& For& detailed& step&wise&protocol& see&Hassanzadeh9Ghassabeh!et!al.,&2011.&
Phage!display!A& 100& μl& aliquot& of& the& VHH& library&was& inoculated& in& 100&ml& of& 2& x& TY&medium&(bacto9tryptone&16&g,&bacto9yeast&extract&10&g,&NaCl&5&g&per& litre;&at&pH&7&adjusted&with& NaOH;& sterilised& by& autoclaving& at& 1& bar& pressure& for& 20& minutes)&supplemented& with& 100& μg/ml& ampicillin& and& 1%& glucose.& When& the& OD600& was&approximately&0.1,&the&inoculated&medium&was&incubated&at&37°C,&on&a&shaker&with&250&rotations&per&minute&for&293&hours&until&the&OD&reached&0.590.6,&indicative&of&the&exponential& growth& phase& of& bacterial& cells& expressing& F9pilus.& At& this& point& 1012&plaque& forming&units&of& the&M13K07&helper&phages&were&added& to& the&cell& culture&and&maintained& stationary& at& room& temperature& for& 30&minutes;& this& enables& the&phage&particles& to& infect& the&bacterial&cells&via& the&F&pilus.&Post& incubation,& the&cell&
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culture&was&centrifuged&at&2000&rpm&(eppendorf,&5810&R&centrifuge,&Germany),&the&medium&was&removed&and&the&pellet&was&then&resuspended&into&300&ml&of&the&2&x&TY&medium&now&supplemented&with&100&μg/ml&ampicillin&and&70&μg/ml&kanamycin&to&select&for&phage&infected&cells,&which&in&turn&produce&phage&particles&displaying&VHH&on&their&surface.&This&culture&was&incubated&overnight&at&37°C&on&a&shaker&with&250&rotations& per& minute;& subsequently& the& phage& particles& displaying& VHH& were&harvested&and&used&for&panning.&&Harvesting&phage&particles&&The& 300& ml& bacterial& cell& culture& infected& with& M13K07& phage& particles& grown&overnight& was& centrifuged& at& 8000& rpm& at& 4°C& (Beckman& coulter,& Avanti& J920&centrifuge,& USA)& to& pellet& the& bacterial& cells& from& the& supernatant&with& the& phage&particles.&The&phage&particles& from&the&supernatant&were&precipitated&by&adding&1&part&sterilized&20%&polyethylene&glycol&(PEG6000)&with&2.5&M&NaCl&to&every&4&part&of&supernatant&(e.g.&10&ml&PEG9NaCl&to&40&ml&supernatant)&and&mixed&by&inverting&and& then&maintained& on& ice& for& 30&minutes.& This&mixture&was& then& centrifuged& at&4000& rpm& (JA& rotor)& for&30&minutes& at& 4°C& to&obtain&pellet& of& phage&particles,& the&supernatant& was& removed& and& the& pellet& was& air9dried.& This& pellet& was& re9suspended&in&limited&volume&of&phosphate&buffered&saline&(PBS)&(8&g&NaCl,&0.2&g&KCl,&1.44& g& Na2HPO4,& 0.24& g& KH2PO4& in& one& litre& distilled& water,& pH& 7.4,& sterilised& in&autoclave)& (approximately& less& than& 1& ml)& and& centrifuged& at& 14000& rpm& for& 2&minutes& (Eppendorf& desktop& centrifuge)& to& clear& any& bacterial& debris& and& phage&aggregates.& The& phage& particles& (supernatant)& were& then& transferred& to& fresh&microcentrifuge&tube&and&the&concentration&of&the&phage&particles&was&measured&by&determining& the& OD& at& 260& nm,& where& OD& of& 1& accounts& for& 3& x& 1010& phage&particles/ml.&&
Antigen!panning!!Using& phage& display& technology& (Smith,& 1985;& Winter! et! al.,& 1994),& the& phage&particles& displaying& the& VHH& on& their& surface& were& panned& against& the& antigen&FaeGac&and&FaeGad& for&detecting&VHHs& specific& for& the&predominant& ‘c’& epitope&as&
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well&as&the&common&‘a’&epitope&of&the&three&FaeG&variants.&Wells&of&microtiter&plates&were&coated&with& the& recombinant&adhesion&proteins&FaeGac&and& the&FaeGad,&at&a&concentration& of& 100& ng& per& well& in& 100& μl& carbonate& buffer.& These& plates& were&incubated&at&4°C&overnight,& and& the&next&day& the&wells&were&washed&5& times&with&PBS& containing& 0.05%& Tween20.& After& washing,& the& wells& were& blocked& with& 2%&skimmed&milk& solution& in& PBS,& for& 2& hours& at& room& temperature.& Apart& from& the&wells& coated& with& antigen,& additional& uncoated& wells& were& blocked& as& negative&control&to&determine&the&unspecific&bound&phage&particles.&After&blocking,&the&wells&were& washed& again& 5& times& with& PBS& containing& 0.05%& Tween20.& Then& the& 1011&phage& particles& displaying& the& VHH& on& their& surface& were& added& per& well& (both&coated& and& uncoated),& and& incubated& for& an& hour& at& room& temperature.& Then,& the&unbound&phage& particles&were& removed& (discarded& in& bleach)& and& the&wells&were&washed&15& times&with&PBS&containing&0.05%&Tween20,& to&remove&non9specifically&bound&phage&particles.&The&bound&phage&particles&were& then&eluted&out&by&adding&100& μl& of& 1%& (130& mM)& triethylamine& (pH& 10)& (Sigma9Aldrich)& in& the& wells,&incubating&for&20&seconds&and&the&100&μl&elution&was&immediately&transferred&into&vials& containing& 100& μl& 1& M& Tris& buffer& pH& 7.4& to& neutralise& the& eluted& phage&particles,& this&was& called& ‘T9elution’.& The&wells&were& also& immediately& neutralised&with&1&M&Tris&pH&7.4&and&then&washed&5&times&with&PBS&containing&0.05%&Tween20.&To&these&wells,&200&μl&of&TG1&cells&(grown&overnight&in&TY&medium)&in&exponential&growth& phase& (OD6009& 0.5& to& 0.6),& were& added& and& incubated& at& 37°C& for& 30&minutes.&During& this& incubation& any&phage&particles& still& bound& in& the&well& infects&the&TG1&cells,&which&ensures& further&elution&of&any&remaining&phage&particles;& this&elution& was& called& ‘C9elution’.& From& both& elusions,& 10& μl& was& utilised& for&determination&of&enrichment&factor.&&&The& remaining& fraction& of& both& the& C9elution& and& T9elution& were& used& to& further&amplify& the& selected& phages& and& thus& enriched& for& specific& binders& in& every&subsequent&panning& rounds.&The&T9elution&was&added& to&2&ml&TG1&cells&and& the&C&elution&to&1&ml&2x&TY&medium&and&incubated&for&30&minutes&at&37°C.&Subsequently,&8&ml&of&2xTY&medium&supplemented&with&100&μg/ml&ampicillin&and&20%&glucose&was&
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added&to&both&the&cell&cultures&and& incubated&for&another&30&minutes&at&37°C.&The&re9amplification& of& the& phages& was& done& similarly& as& described& in& section& phage&display&above&and&is&elaborated&in&detail&in&next&section.&The&eluted&phage&particles&were&used&in&subsequent&round&of&panning.&The&panning&was&repeated&until&specific&phages&were&enriched.&To&determine&the&enrichment&factor&an&aliquot&was&kept&from&each&round&and&evaluated&by&ELISA&and&colony&count.&Re9amplification&of&eluted&phage&particles&for&successive&round&of&panning&The&eluted&phage&particles&(~190&μl)&were&added&to&2&ml&of&TG1&cells&(OD600=&0.590.6)&in&a&15&ml&Falcon&tube,&and&incubated&at&37°C&for&30&minutes;&to&these&infected&TG1&cells&8&ml&of&2xTY&medium&(with&100&μg&ampicillin&and&1%&glucose)&was&added&and&incubated&at&37°C&on&a&shaker&for&30&minutes.&Then&107&M13K07&helper&phages&were&added&to&the&cells&and&incubated&at&room&temperature&for&20&minutes&without&shaking.& Subsequently,& the& cells& were& pelleted& by& centrifuging& at& 2000& rpm& in& a&swing9out& rotor& to& remove& glucose& from& the& medium& (glucose& removal& prevents&leakage& from& lacZ& promoter,& upstream& on& VHH& gene).& The& cell& pellet& was& then&resuspended& in& 2xTY& medium& with& ampicillin& (100& μg/ml)& and& kanamycin& (70&μg/ml)& in&250&ml&volume&and& incubated&on&a&shaker&with&250&rpm&at&37°C&during&the&night;&this&overnight&culture&was&then&used&for&panning.&&&&Determination&of&enrichment&factor&by&colony&count&To&determine&the&enrichment&factor&after&each&round&of&panning,&10&μl&of&the&eluted&phage&particles& (t9elution)& from& the&wells& coated&with& antigen& and&uncoated&wells&were& taken& and&diluted& 10& fold& serially&with& PBS& in& a&microtiter& plate.& In& another&round&bottom&microtiter&plate&TG1&cells&were&seeded&in&90&μl&of&TY&medium&(OD600&was&around&0.590.6).&To&these&cells&(90&μl)&10&μl&of&each&of& the&phage&dilution&was&added&and&incubated&at&37°C&for&1&hour&to&infect&the&TG1&cells.&After&incubation,&10&μl& of& these& infected& cells& corresponding& to& each& dilution& were& plated& on& LB9agar&(Lysogeny&broth&media9&0.5&g/L&yeast&extract,&1%&tryptone,&1%&NaCl&and&1.5%&agar)&plates&with&100&μg/ml&ampicillin&and&1%&glucose.&As&negative&control&10&μl&of& the&uninfected& TG1& cells& were& also& plated& on& LB9agar& culture& plates.& On& the& same&
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Selection!of!independent!FaeG!binding!VHH!Expression&of&VHH&From&the&LB9agar&plates&used&for&determining&enrichment&factor,&individual&colonies&were& picked& from& each& dilution,& replicated& on& a& fresh& LB9agar& plate& (for& further&reference)& and& inoculated& in& wells& of& a& 24& well& titer9plate& filled& with& 1.5& ml& LB&medium& supplemented&with&100&μg/ml& ampicillin.& These& inoculated&24&well& titer9plates&were& incubated& for& 3& hours& at& 37°C& (until& a& clear& pellet&was& formed& at& the&bottom&of&the&wells).&Then&the&VHH&expression&was&induced&by&adding&isopropyl&β9D919thiogalactopyranoside& (IPTG,& Fermentas)& to& a& final& concentration& of& 1& mM;&these& induced&cultures&were& incubated&wile& shaking&at&28°C&overnight.&Within& the&expression& cassette,& the&periplasmic& signal&peptide&PelB&was&attached& to& the&VHH,&leading&to&the&accumulation&of&VHH&in&the&periplasmic&space&of&the&bacterial&cell.&The&next&day& the&24&well&plates&were&centrifuged& for&15&minutes&at&2800&rpm&(A94981&MTP/flex&rotor,&Eppendorf,&5810&R&centrifuge,&Germany),&at&4°C.&The&medium&was&removed,&and&the&pellet&were&resuspended&in&150&μl&TES&buffer&(0.2&M&Tris,&0.5&mM&EDTA,&0.5&M&sucrose9&pH8)&and&incubated&on&a&shaker&for&30&minutes&at&4°C.&After&which,&250&μl&of&TES/4&buffer&(0.25%&TES)&was&added&per&well&and&incubated&again&while&shaking&for&30&minutes&at&4°C.&The&24&well&plates&were&then&centrifuged&for&15&minutes& at& 2800& rpm& (A94981& MTP/flex& rotor,& Eppendorf,& 5810& R& centrifuge,&Germany)&at&4°C.&This&change&in&concentration&of&sucrose&(TES)&leads&to&an&osmotic&shock& and& the& periplasmic& extract& bearing& the& VHH& is& released.& This& periplasmic&extract&was&then&used& in&the&ELISA&plates&coated&with&antigen&as&described&below,&for&confirmation&of&its&specific&binding&to&the&target&antigen.&VHH9antigen&ELISA&The& antigenic& variants& of& FaeGac& and& FaeGad&were& coated& in& 2& individual& 96&well&multi9titer&plates.&Each&of&the&antigenic&variant&was&diluted&to&1&μg/ml&concentration&in& 1&M& carbonate& buffer& (pH&8.2);& 100& μl& of& this& solution&was& added&per&well& and&incubated& at& 4°C& overnight.& The& following& day,& the& coating& solution&was& decanted&and&the&plates&were&washed&5&times&with&PBS&containing&0.05%&Tween20&(washing&
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solution).&The&wells&were&then&blocked&for&2&hours&at&room&temperature&with&200&μl&of&2%&skimmed&milk&in&PBS.&After&blocking,&the&wells&were&washed&5&times&with&the&washing& solution& and& then& 100& μl& of& the& periplasmic& extract& (bearing& VHH)& was&added&into&the&wells&and&incubated&at&room&temperature&for&1&hour.&The&wells&were&washed&5&times&with&washing&solution,&and&then&100&μl&of&primary&antibody&diluted&1/1000& in& 2%& skimmed& milk& was& added.& In& the& wells& coated& with& FaeGac& anti9Haemagglutinin9tag& monoclonal& (mouse)& antibody& (BABCO)& was& used& as& the&primary&antibody.&While&in&the&wells&coated&with&FaeGad,&the&primary&antibody&used&was&anti9his9tag&monoclonal&(mouse)&antibody.&The&plates&were&incubated&at&room&temperature&for&1&hour&with&the&primary&antibodies,&and&then&washed&5&times&with&washing& solution.& Subsequently,& 100& μl& of& a& 1/1000& dilution& of& anti9mouse&monoclonal&antibody&conjugated&to&alkaline&phosphatase&(Sigma)&was&added&to&both&the&plates&and& incubated& for&1&hour.&Finally,& the&wells&were&washed&again&5& times&with& washing& solution& and& the& ELISA& was& developed& by& adding& 100& μl& of& the&substrate&–&2&M&disodium9p9nitrophenyl&phosphate&(dNPP,&Sigma)&in&each&well.&After&10& to&20&minutes,& the&OD405&of& the&wells&was&measured.&The&wells&with& signal& at&least&twice&the&signal&of&the&control&wells&were&accepted&as&being&FaeG9specific&VHH.&The&colonies&producing&these&specific&VHHs&were&further&screened&by&PCR.&&Confirmation&by&PCR&The&colonies&corresponding&to&the&VHH&that&gave&positive&signal&in&the&ELISA&screen&were& further& tested& by& amplifying& the& VHH9gene,& to& identify& and& select& distinct&VHHs.&The&positive&colonies&from&the&reference&LB&medium&plate&were&dissolved&in&50&μl&sterile&water&and&5&μl& from&this&dilution&was&added&to&the&PCR&mixture&[PCR&mixture:&11,75&μl&sterile&filtered&water,&5&μl&ex&TaKaRa&10x&buffer&(TAKARA&Bio&Inc,&Japan),&1&μl&10&mM&dNTP&(TAKARA&Bio&Inc.,&Japan),&1&μl&10&μM&GIII&primer,&1&μl&10&μM&MP57& primer& and& 0.25& µl& TAKARA& ExTaq& enzyme& (TAKARA& Bio& Inc.,& Japan)].&PCR& was& performed& on& a& GeneAmp& PCR& system& 9700& (Applied& Biosystems,& USA)&with& the& program& as:& initial& denaturation& at& 94°C& for& 2& minutes,& followed& by& 30&cycles&of&(1st)&denaturation&step&at&94°C&for&30&sec,&(2nd)&annealing&step&at&55°C&for&30&sec,&(3rd)&elongation&step&at&72°C&for&45&sec,&and&then&a&final&elongation&step&for&5&
Porcinised&lama&fusion&antibodies&prevent&ETEC&binding&in!vitro&
  93 
minutes&at&72°C.&The&amplified&fragments&were&separated&and&analyzed&by&agarose&electrophoresis.& For& this,& 5μl& PCR& product,& together&with& 2& μl& DNA& loading& buffer&were&loaded&on&a&1%&agarose&gel&in&1&x&TAE&buffer&(40&mM&Tris,&20&mM&acetic&acid&and&1&mM&EDTA)&and&separated&at&110&V&for&25&minutes.&As&marker,&5&μl&λ&PstI&or&smartladder&was&used.&The&gel&was&stained&with&ethidium&bromide&and&visualization&under&UV&light&(For&more&details,&and&tips&see&Hassanzadeh9Ghassabeh!et!al.,&2011).&MP57&primer:&5’9TTATGCTTCCGGCTCGTATG93’;&&GIII&primer:&5’9CCACAGACAGCCCTCATAG93’&Restriction&fragment&length&polymorphism&(RFLP)&The&positive&colonies,&which&gave&a&band&of&680&bp&on&agarose&gel&electrophoresis,&were&further&analysed&by&RFLP&to&eliminate&similar&redundant&VHHs.&For&this,&6&μl&of&PCR&product&was&digested&with&3&units& of& restriction& enzyme& for&2&hours& at& 37°C.&The&digested&PCR&fragments&were&separated&on&2%&agarose&gel&as&described&above.&The& patterns& obtained& by& HinfI& digest& (Fermentas)& and& RsaI& digest& (Fermentas)&were&analysed.&Similar&RFLP&patterns&were&clubbed&into&one&category;&several&such&categories&were&defined,&narrowing&down&the&number&of&prospective&distinct&VHHs.&&Confirmation&by&control&ELISA&The& best& positive& colonies& chosen& for& sequencing& were& again& checked& via& ELISA.&These& selected& colonies&were&plated&out& again& to&obtain& individual& colonies.&VHHs&were&produced&from&this&starting&material&and&then&used&in&the&ELISA&as&described&above.&On&dual&confirmation&the&individual&colonies&were&used&to&start&cultures&for&glycerol&stock.&Thus&4&VHHs&were&selected.&These&VHHs&were&named&V1,&V2,&V3&and&V4.&
Agglutination!assay!Covalent&conjugation&of&VHH&to&the&magnetic&beads&To& evaluate& if& the& VHH&were& functional& in& agglutinating& the& bacteria,& the& classical&agglutination& test& was& performed& where& the& VHH& were& covalently& linked& to&magnetic& beads& (Dynabeads& M9270& carboxylic& acid)& in& order& to& make& them&
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multivalent.&Firstly&the&VHHs&(previously&in&PBS)&were&dialysed&with&50&mM&MES&pH&5.0,& using& the& Vivaspin500& columns& (molecular& weight& cut& off& ~5& kDa)& and&concentrated& to& ~1& mg/ml& concentration.& This& buffer& exchanged& VHH& were& then&chemically& conjugated& to& the& magnetic& beads& in& accordance& to& the& manufacture’s&instruction.&Briefly,&the&beads&were&washed&twice&with&0.01&M&NaOH,&and&thrice&with&deionised&water,&using&a&magnet&the&supernatant&could&be&easily&decanted&between&each&washing&step&while&retaining&the&magnetic&beads&in&the&microcentrifuge&tube.&For&every&VHH,&100&µl&of&washed&bead&suspension&(~3&mg)&was&used.&To&this&100&µl&bead& suspension& 200& µl& of& 19ethyl93(39dimethylaminopropyl)& carbodiimide&hydrochloride&(EDC)&was&added&and&incubated&for&30&minutes&on&rotating&wheel,&to&activate& the& ligand.&The&beads&were& then&washed& firstly&with& equal& volume&of& ice9cold& water& followed& by& ice9cold& 50& mM& MES& pH& 5.0.& The& wash& solution& was&decanted,&and&the&activated&beads&were&incubated&with&60&µg&of&respective&VHH&to&be&conjugated&in&100&µl&of&50&mM&MES&pH&5.0,&at&room&temperature&for&30&minutes&on&rotating&wheel.&The&unbound&VHHs&were&then&washed&away&and&the&beads&were&blocked&with&50&mM&Tris&pH&7.4& for&15&minutes& at& room& temperature.& Finally& the&VHH&coated&beads&were&washed&3& times&with&PBS&containing&1%&Tween&20&(v/v),&and&stored&in&this&final&wash&buffer&at&4°C.&&Growing&of&F4+ETEC&bacterial&culture&for&agglutination&assay&The&F4+ETEC& strains& (C585980&expressing&F4ad& fimbriae,&C95972&expressing&F4ac,&C1023978& expressing& F4ab)& and& the& negative& control& strain& K5149PIH120& were&streaked&on&LB&agar&plates&and&from&this&a&single&colony&was&inoculated&in&20&ml&of&liquid&LB&medium&and&the& flask&was&maintained&stationary&at&37°C&for&2&days.&The&bacterial&cells&were&pelleted&and&washed&twice&and&then&resuspended&with&PBS&to&an&OD600&of&16&to&21.&&Agglutination&on&glass&slides&On&a& clean&microscope&glass& slide&10&µl& each&of& the&bacterial& culture&and& the&VHH&coated&magnetic& beads& were& added& at& the& same& spot,& and& the& two& droplets& were&mixed&together.&The&presence&or&absence&of&agglutination&(Figure&4.4)&was&observed&
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and&noted&after&incubation&of&one&minute&during&which&the&slide&was&gently&rocked.&&
Fusion!of!the!VHH!to!Pig!Fc!(PorcinisedHcamelid!chimeric!antibodies!)!!Six& classes& of& porcine& IgG& have& been& identified.& Of& these& the& porcine& IgG3& has& the&longest& hinge& with& three& cysteines& residues& and& is& predicted& resistant& to& peptic&degradation,&hence&the&IgG3&Fc&was&chosen&for&fusion&with&VHH&aiming&at&designing&a& robust& molecule.& The& coding& sequence& of& the& porcine& IgG3& gene& (accession&no.:EU372658)& was& retrieved& and& the& hinge,& CH2& and& CH3& coding& sequence& was&codon& optimised.& The& codon& usage&within& the& native& sequence& of& porcine& IgG3& Fc&was&compared&to&that&of&Arabidopsis&seed&storage&proteins&(2s1:&At4G&27140,&2s2:&At4g& 27150,& 2s3:& At4g27160,2s4:& At4g& 27170,& Cru:& At4g28520,& Cra1:& At5g44120,&CRB:& At1g03880& and& CRU2:At1g03890)& using& Cusp& (European& Bioinformatics&Institute,& UK).& The& codon& usage& of& the& heterologous& protein& was& then& manually&optimised&to&seed&storage&proteins&with&an& intention&to&achieve&high&accumulation&levels.&&
In!silico&the&DNA&sequence&of&VHH&V1&was&fused&with&the&codon&optimised&sequence&of& IgG3& Fc,& upstream& of& this& construction& the& sequence& of& EcoRI& restriction& site,&Kozak& sequence& (CCACC)& and& the& 2S2& seed& storage& signal& peptide& sequence&were&added& in& the& same& order,& while& downstream& of& the& VHH9Fc& fusion& a& KDEL&endoplasmic& retention& signal,& stop& codon& and& BamHI& restriction& site& were&introduced.&This&entire&stretch&of&DNA&sequence&was&chemically&synthesised&flanked&with&the&Gateway&attB1&and&attB2&sites&and&cloned&within&the&multiple&cloning&sites&of& the& pUC57& vector& (Genscript).& In& a& Gateway& BP& reaction,& this& pUC57& vector&bearing&the&construct&within&the&attB&sites&was&recombined&with&the&Gateway&Donor&plasmid& pDon221& (bearing& kanamycin& resistance)& according& to& manufacturers&instruction,&which&results&in&an&entry&clone,&which&was&named&pEV1G.&Plasmid&DNA&from&pEV1G&was&then&transformed&into&chemically&competent&E.!coli&(strain&DH5α),&and&plated&on&LB&medium&with&kanamycin&(50&μg/ml).&Positive&colonies&bearing&the&expected&V19IgG3&fusion&were&screened&by&studying&the&restriction&digestion&pattern&and&confirmed&via&sequencing.&&
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For&cloning&of&other&three&anti9F4+ETEC&VHHs–&V2,&V3&and&V4&in&fusion&with&IgG3&Fc&the&DNA&sequence&for&restriction&site&for&EcoRI&+&Kozak&sequence&+&2S2&seed&storage&signal&peptide&+&each&of&the&three&VHHs&was&chemically&synthesised.&Then&Using&the&EcoRI&and&the&BstEII&(located&in&framework4&of&all&VHHs)&restriction&sites,&the&VHHs&V2,&V3&and&V4&with& the&2S2& signal&peptide&were& swapped&with& the&V1& from&entry&clone&pEV1G.&Thus,&Entry&clones&(E)&pEV2G,&pEV3G&and&pEV4G&were&made.&&
In!seed!expression!of!antiHF4+ETEC!antibodies!Gateway& recombination& into& pPhasGW& vector& and& Agrobacterium& mediated&transformation&All& the&above&describes&entry&clones&were&recombined&via&an&Gateway&LR&reaction&into&the&destination&vector&pPhasGW&(Morandini!et!al.,&2011)&following&the&Gateway&instruction& manual.& The& pPhasGW& destination& vector& bears& a& seed& specific& β9Phaseolin&promoter&and&3’&arcelin&terminator&bearing&regulatory&sequences,&which&enables& high& seed& specific& expression& of& heterologous& proteins& (Morandini! et! al.,&2011).&The&T9DNA&also&bears&the&nptII&gene,&which&confers&for&kanamycin&resistance&in&plants&and&thus&facilitates&screening&of&transformed&plants.&On&LR&recombination&reaction&(Gateway),&expression&clones&were&obtained;&these&clones&were&checked&via&restriction&digestion&and&further&confirmed&via&sequencing.&The&4&expression&clones&(X)&bearing&the&VHH9IgG&fusion&were&named:&pXV1G,&pXV2G,&pXV3G&and&pXV4G.&&All& the& expression&plasmids&bearing& correct& sequence&were& then& transformed& into&the&Agrobacterium&strain&C58C1RifR&with&helper&plasmid&pMP90&(Koncz&and&Schell,&1986)&via&electroporation&of&50&ng&plasmid&DNA&in&40&μl&of&competent&cells&within&a&1&mm&electroporation&cuvette&(Biorad)&at&2.2&kV&pulse.&The&Agrobacterium&colonies&were& then& selected& on& YEB& (0.5%&beef& extract,& 0.1%& yeast& extract,& 0.5%&peptone,&0.5%& sucrose,& 2& mM& solution& MgSO4)& plates& (1.5%& agar& to& YEB& medium)& with&antibiotics&streptomycin&(20&μg/ml),&spectinomycin&(100&μg/ml)&and&rifampicin&(25&µg/ml).& These& colonies& were& further& checked& via& restriction& digestion& and&sequencing&of&plasmid&DNA.&Single&colonies&with&the&correct&plasmids&were&used&to&start& cultures& for& glycerol& stock& and& Agrobacterium& mediated& floral& dip&
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transformation.&&
Agrobacterium&mediated&floral&dip&transformation&of&Arabidopsis&&The&Agrobacterium&strain&bearing&plasmid&with&correct&sequence&was&used&for&floral&dip& transformation& (Clough& and&Bent,& 1998).&A& single& colony&was&picked& from& the&respective& construct& to& be& transformed& and& inoculated& into& 1& ml& of& liquid& LB&medium& with& rifampicin,& gentamycin,& streptomycin& (each& 20& µg/ml)& and&spectinomycin& (100& µg/ml)& as& selection& antibiotics.& This& culture& was& allowed& to&grow&for&8&hours&at&28°C&on&a&rotary&shaker&with&280&rpm,&after&which&10&ml&of&LB&was&added&to&the&culture&and&incubated&overnight&again&at&28°C&and&280&rpm.&The&optical& density& of& the&Agrobacterium! culture&was&measured& at&wavelength& of& 600&nm.&This&OD600&should&ideally&be&1.7.&This&10&ml&culture&was&then&made&up&to&final&volume&of&50&ml&with&dipping&solution&(10%&sucrose&and&0.05%&Silwet&solution& in&water).&The& flowers&of&Arabidopsis&plant&were&dipped& in&respective&Agrobacterium&solutions& for& 10& seconds,& after& which& the& plants& were& covered& with& a& cellophane&wrap&to&maintain&humidity&and&kept&in&growth&room&with&16&hours&light&and&8&hours&dark&regimen.&Five&plants&were&dipped&for&each&of&the&4&VHH9IgG.&After&24&hours&the&cellophane&wrap&was&removed&and& the&plants&were&allowed& to&grow&until& the&ripe&siliques&become&dry&(~6weeks).&The&T1&seeds&were&then&harvested.&&Selection&of&T1&transformant&plants&The&T1&seeds&were&harvested&from&the&floral&dipped&plants,&and&approximately&1000&(~25& mg)& seeds& per& plant& were& sterilized& via& vapour& phase& method.& Seeds& were&weighed&in&a&micro&centrifuge&tubes,&and&the&tubes&were&placed&with&their&lids&open&in&a&bell&jar&of&20&litters&volume&kept&in&the&fume&hood.&Before&closing&the&lid&of&the&bell&jar&a&beaker&with&100&ml&bleach&(12%&sodium&hypochlorite)&was&kept&in&the&jar,&the&lid&of&the&jar&was&then&partially&closed&leaving&as&little&room&for&a&pipette&to&pass.&Through&this&narrow&opening&3&ml&of&concentrated&HCl&was&added&and&the&lid&was&immediately&closed&tight.&The&seeds&were&left&in&the&chlorine&fumes&for&14915&hours,&after& which& the& micro& centrifuge& tubes& were& closed& again& and& brought& to& sterile&laminar&airflow&where&the&lids&were&open&to&let&out&the&chlorine&fumes&for&at&least&an&
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hour.& Sterilised& seeds& were& sown& on& large& Petri& plates& (150& mm& x& 25& mm)& with&sterile&Murashige&and&Skoog&medium&[4.308&g/L&Murashige&and&Skoog&salts,&(Gibco&BRL,&Gaithersburg,&MD)&with&0.5&g/L&of&MES&(Duchefa),&10&g/L&of&sucrose),&pH&5.7].&Prior& to&sterilisation&0.9%&plant&agar&was&added&and&the&medium&was&sterilised&at&121°C&for&20&minutes&at&1&bar&pressure.&After&the&medium&cooled&to&about&60°C,&the&vitamins&and&antibiotics&[B19Vitamins&(1&ml/l),&nystatin&(50&mg/l),&vancomycin&(750&mg/l)&and&50&mg/L&kanamycin&(Duchefa)]&were&added&in&a&sterile&laminar&air&flow,&mixed&by& swirling&and& then&poured& in& the&Petri&plates& to& a&height&of&~1cm.&These&plates& were& then& sealed& with& porous& adhesive& tape& (Milipore),& which& facilitates&exchange&of&gases.&The&plates&were&then&maintained&in&growth&chambers&with&21°C&under&fluorescent&(cool&white)&light&80&μE/m2/s&for&16&hours&light&and&8&hours&dark&photoperiod.& The& temperature& of& the& shelves& was& maintained& at& 19°C& to& prevent&moisture&condensation&on&the&lids&of&the&plates.&By&394&weeks&primary&transformant&seedlings&were&transferred&to&soil.&
Characterisation!of!inHseed!made!antiHF4+ETEC!antibodies!High&through9put&protein&extraction&from&T2&seeds&The& protein& extraction& was& performed& in& strips& of& 8& attached& microtubes;& this&format& is& compatible&with& (8& X& 12)&micro9racks,& allowing& simultaneous& extraction&from& 96& plant& lines.& Five9milligram& seeds& were& weighed& per& plant& in& each& of& the&individually& labelled& microtube.& Intermittently& as& needed& the& tubes& and& the& scale&was& sprayed& with& an& ion& gun,& to& avoid& any& cross& contamination& due& to& static&developed&on&the&seeds.&One&steel&ball&of&4&mm&was&added&into&each&microtube,&the&tubes& were& closed& and& snap& chilled& in& liquid& nitrogen.& The& frozen& seeds& were&crushed&in&a&mill&(Mixer&mill&MM4009Retsch)&for&20&seconds&at&20&Hz&frequency&of&oscillation.& Immediately& 600& μl& of& cold& extraction& buffer& (50&mM&Tris9HCl& pH& 8.0,&200&mM&NaCl,& 5&mM&EDTA,&0.1%&Tween&20)&was& added& to& the& crushed& seeds& and&vortexed& generously& to& suspend& all& the& seed& powder& and& dissolve& the& soluble&fraction.&The&96& tubes&micro9rack&was&centrifuged&at&4°C& for&10&minutes&at&3310g&(Eppendorf9&swing&out&rotor).&The&rack&was&maintained&on&ice&after&centrifugation,&300& μl& of& protein& extract& was& taken& (middle& clear& phase)& without& disturbing& the&
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pellet& at& the& bottom& and& the& oil& layer& on& top.& To& this& 300& μl& protein& extract& 20%&glycerol&was&added&before&storing&at&920°C&.&&&Measurement&of&total&soluble&protein&in&seed&extracts&The&total&soluble&protein&(TSP)&concentration&of&seed&extract&was&measured&by&Bio9Rad&DCTM!protein& assay& kit.& This& is& a& detergent& compatible,& colorimetric& assay& kit&based&on&Lowry&assay,&which&enables&protein&measurement&in&15&minutes.&The&TSP&extracts&from&seed&were&diluted&2.5,&5,&10&and&20&times&in&Mili9Q&grade&water&and&5&μl& of& these& dilutions&were& added& in& 96&well& flat& bottom&microtiter& plates& (NUNC9&269620).& Also& in& the& same& plate,& 5& μl& bovine& serum& albumin& (BSA)& with&concentration&of& 0.2&mg/ml,& 0.4&mg/ml,& 0.8&mg/ml& and&1.6&mg/ml&were& added& as&standard&and&water&as&blank,&negative&control.&To&this&loaded&plate,&25&μl&of&reagent&A& and& 200& μl& of& reagent& B& was& added& per& well& (according& to& the& manufactures&instruction)& and& the& reaction&mix&was& incubated& at& room& temperature& in& dark& for&15&minutes.&Like&Lowry&assay&the&first&step&of&the&reaction&involves&copper9protein&interaction& in& alkaline& medium,& followed& by& subsequent& reduction& of& the& Folin’s&reagent&by&this&copper&treated&protein,&which&leads&to&development&of&blue&colour.&This&colouration&was&measured&using&a&plate&reader&(VERSAmax,&Molecular&Devices,&USA)& at& wavelength& of& 750& nm& and& using& the& versa& max& software& the& protein&concentration&of&the&seed&extract&was&calculated&from&the&slope&of&the&BSA&standard&dilutions.& & For& subsequent&work,& all& the& protein& extracts&were& diluted& to& 1&mg/ml&concentration.&&Determination& of& expression& levels& of& functional& molecules& in& seeds& via& FaeGac&ELISA&&The& multisorb& ELISA& plates& (Nunc& 439454)& were& coated& overnight& with& 1& μg/ml&concentration&of&purified&recombinant&FaeGac&in&NaHCO3&buffer&pH&8.2&in&a&volume&of& 100& μl& per&well& at& 4°C.& Subsequent&morning& the& coating& solution&was& decanted&and&the&wells&were&washed&5&times&by&flushing&and&decanting&the&plate&with&300&μl&of& 0.1%& Tween20& in& PBS& and& finally& knocking& the& plate& on& absorbent& paper& to&remove&residual&droplets.&The&wells&were&then&blocked&with&150&μl&of&2%&skimmed&
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milk&in&PBS&and&incubated&at&room&temperature&(25°C)&for&90&minutes.&Plates&were&washed&again&and&100&μl&serial&dilutions&of&plant&extracts&(typically&1/100,&1/200,&1/400,&1/800)&made&in&2%&skimmed&milk&in&PBS&were&added&to&the&well,&incubated&for&90&minutes&at&room&temperature&and&the&wells&were&washed&again&as&described.&To&detect&the&bound,&seed&produced&monomeric&antibodies&anti9Fc&specific&primary&antibody&was&used.&For&detecting&the&plant&produced&VHH9IgG&antibodies&100&μl&of&polyclonal& anti9porcine& IgG& produced& in& rabbit& (Sigma& A5670)& conjugated& to&horseradish&peroxidise&(HRP)&diluted&1/40,000&in&2%&skimmed&milk&was&used.&After&addition&of&the&primary&conjugated&antibody,&the&plate&was&incubated&for&90&minutes&at& room& temperature.& Finally,& after& washing,& 100& μl& of& substrate& TMB& (3,3’,5,5’&tetramethylbenzidine,&Sigma)&was&added&per&well,&the&plates&were&kept&in&the&dark&for&30&minutes&and&the&intensity&of&the&blue&coloration&developed&was&measured&at&640&nm& (VERSAmax,&Molecular&Devices,&USA).& The& signal& intensity& being& the& read&out& of& the& functional& antibody& enabled& comparison& of& relative& accumulation& in&different& primary& transformants.& These& plant& extracts& were& then& analysed& using&SDS9PAGE& and& immunoblot& techniques,& and& plant& lines& bearing& single& locus& were&determined.&&NB:& The& same& ELISA& set& up& and& primary& conjugated& antibody& was& used& for&determination&of&stability&of&antibody&in&crushed&seeds&over&time&(Figure&4.11)&and&for&evaluation&of&the&4&VHH9IgG&antibodies&binding&interaction&with&the&three&FaeG&variants&(Figure&4.10).&In&this&latter&experiment&the&ELISA&plates&were&coated&with&1&µg/ml&concentration&of&purified,&recombinant&produced,&respective&FaeG&variant&viz.&FaeGac,& FaeGab& and& FaeGad& in& NaHCO3& buffer,& as& described.& The& purified& FaeG&variants&were&provided&courtesy&of&Prof.&Henri&De&Greve.&&SDS9PAGE&and&immunoblot&analysis&The&characterisation&and&quantitation&of& the&seed&produced&antibodies&via& sodium&dodecyl& sulfate& 9polyacrylamide& gel& electrophoresis& (SDS9PAGE)& as& well& as&immunoblotting,&was&done&as&previously&described&(De&Buck!et!al.,&2011).&In&short,&the& seed& proteins& were& electrophoretically& separated& on& a& conventional& 12%&polyacrylamide& gel& (for& 10&ml& 12%& SDS9PAGE:& 4&ml& of& 30%&29:1& Acrylamide/bis,&
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3.75&ml&1&M&Tris9HCl&pH&8.7,&100&μl&10%&SDS,&100&μl&10%&APS,&10&µl&TEMED,&2.05&ml&H2O)&in&Tris9Glycine9SDS&buffer&(25&mM&Tris,&192&mM&glycine,&0.1%&(w/v)&SDS,&pH&8.3)& at& 180& volts& for& an& hour.& On& electrophoreses,& the& gels& were& stained& with&Coomassie&R9250&solution&(0.3&mM&Coomassie&Blue&R9250,&40%&v/v&methanol,&7%&v/v& acetic& acid)& overnight& and& then& destained& with& destaining& solution& (5%& v/v&methanol,& 7%v/v& acetic& acid)& until& the& desired& contrast& of& band& intensity& was&achieved.& The& gels&were& then& documented& using& the& ChemidocTM& system& (Biorad)&and& the& concentration& of& the& proteins&was& determined& from& the& band& intensity& in&comparison&to&purified&antibody&standard&with&Image&lab&software.&&For& immunoblotting& the&SDS9PAGE&separated&proteins&were&blotted&onto&activated&PVDF& membranes,& in& a& Mini9Protean& IITM& wet& blot& system& (Biorad)& with& blotting&buffer&(14.14&g&glycine,&3.024&g&Tris,&15%&methanol)&at&50&V&of&potential&difference&for&an&hour.&The&blotted&membranes&were&blocked&with&2%&skimmed&milk&in&PBS&at&4°C&overnight.&Afterwards,&the&membrane&was&washed&3&times&with&0.1%&Tween20&in&PBS,& incubated&with&primary&antibodies&diluted& in&2%&milk& for&90&minutes& and&washed& again& 3& times.& In& case& the& primary& antibody& was& not& conjugated& to& the&enzyme& then& a& secondary& antibody& was& used& diluted& in& 2%& skimmed& milk& and&incubated& for& 30& minutes.& To& visualise& the& immobilised& target& seed& produced&antibody&the&chemiluminescent&substrate&(Western&LightningTM&Chemiluminescence&Reagent&Plus,&Perkin&Elmer)&was&used&according&to&manufacturers&instruction.&This&substrate& reacts&with& the&HRP& to& produce& a& luminescent& product& indicative& of& the&target&protein,&which&was&documented&either&by&using&photographic&films&in&a&dark&room&or&by&using&the&ChemidocTM&system&(Biorad).&&&For&detection&of&the&seed&produced&VHH9IgG&the&anti9porcine&IgG&produced&in&rabbit&(Sigma&A5670)&diluted&1/4000&in&2%&skimmed&milk&was&used.&
Transient!expression!in!Nicotiana)benthamiana)leaves!The& reference& purified& V2Gt& antibody,& used& for& quantification& (Figure& 4.7,& 4.8& and&4.9)& was& produced& transiently& in& Nicotiana& Benthamiana! leaves& using& the& pEAQ&(Sainsbury! et! al.,& 2009)& vectors.& Briefly,& entry& clones& of& the& EV2Gt& was& made& as&
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described&above&using& the&pDON207&(gentamycin&selection);& this&entry&clones&was&recombined& with& the& pEAQ9HT9Des1& vector& (Sainsbury! et! al.,& 2009)& according& to&Gateway& manual,& the& resultant& expression& plasmids& named9& TXV2G& was&transformed& into& the& Agrobacterium& strain& C58C1& Rif& and& infiltrated& into& N.!
benthamiana& leaves,&the&details&of&this&protocol&and&protein&extraction&method&has&been& described& in& De& Buck! et! al.,& 2011.& The& V2G& antibody&was& purified& from& the&soluble&leaf&proteins&using&protein&A&affinity&chromatography&as&described&above.&
Affinity!purification!of!seed!produced!antibodies!For& purification& of& Arabidopsis& seed& made& antibodies,& commercially& available&affinity&based&resins&were&used.&For&purification&of&the&VHH9IgG&antibodies,&Protein&A&sepharose&columns& (HiTrap&rProtein&A&FF,&GE&healthcare)&were&used& in&AKTATM&liquid& chromatography& system.& All& the& chromatographic& steps&were& performed& at&4°C.& First,& the& column&was& equilibrated&with& about&10& column&volumes&of& binding&buffer&(50&mM&Tris9HCl&pH&8.0,&200&mM&NaCl,&5&mM&EDTA,&0.1%&Tween&20).&Then,&the&seed&extract&made&in&protein&extraction&buffer&(pH&8),&was&filtered&through&0.45&μm&filter&and&loaded&on&to&the&column&at&a&flow&rate&of&1&ml/min&without&exceeding&pressure&of&0.2&Mpa.&After&passing&the&protein&solution,&the&column&was&equilibrated&again&with&10&column&volumes&of&binding&buffer&and&washed& twice;& first&with&100&mM&Tris9HCl&pH&8&followed&by&10&mM&of&Tris9HCl&pH&8&(10&column&volumes&each).&The&bound&antibodies&were&eluted&using&0.1&M&of&Glycine&buffer&at&pH&3.&Fractions&of&450&μl&were& collected& into&microcentrifuge& tubes&pre9dispensed&with&50&μl&of&1&M&Tris&pH&8& to& immediately&neutralise& the&acidic&pH&of& the&eluted& fraction.&Fractions&bearing& the& purified& antibodies&were& identified& by&measuring& the& OD280& and& such&fractions&were& then& pooled.& The& column&was& immediately& neutralised& by&washing&with&100&mM&Tris&pH&8&(10&column&volumes)&and&then&preserved&in&20%&ethanol.&&&&&
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Selection! and! characterisation! of! plant! lines! expressing! high! amount! of!
antibodies!Determination&of&single&locus&For& the& monomeric& VHH9IgG& producing& plants,& the& highest& expressing& lines& were&selected&and&64&surface&sterilised&seeds&from&each&of&these&lines&were&sowed&on&MS&plates& with& kanamycin.& The& plates& with& seeds& were& sealed& with& porous& tape&(Millipore),& kept& in& dark& at& 4°C& for& 48& hours& for& stratification& and& transferred& to&growth& room&at& 21°C&with&16&hours& light& and&8& hour&dark&photoperiod.&After& 293&weeks& the& resistant& plants& could& be& well& distinguished& from& the& sensitive& ones.&These& numbers& were& compared& via& chi& square& test& to& determine& the& lines& with&significant&3:1,&resistant&:&sensitive&segregation&pattern,&which&is&indicative&of&single&locus&insertion&(De&Neve!et!al.,&1997).&&Determination&of&homozygous&plants&&On& determining& the& lines& with& single& locus& insertion& all& the& seedlings& from& such&single& locus&plants&were& transferred& to& the& soil& in& the&green&house& (16&hours& light&and&8&hour&dark&photoperiod).&After&496&weeks& the&T3&seeds&were&harvested& from&the& plants& and& approximately& 1000& seeds& (~25& mg)& were& vapour& sterilised& and&sowed& on& the& K1& media.& Monomeric& VHH9IgG& lines& were& sowed& on& kanamycin&selection,&and&the&plates&were&examined&3&weeks& later,&plates&with&100%&resistant&plants&were&indicative&of&homozygous&lines.&&&
Piglet!villi!binding!inhibition!test!To&determine&if&the&plant&made&antibody&inhibit&the&F4+ETEC&bacterial&binding&to&the&gut,& an& in! vitro& test& was& performed& in& accordance& to& the& protocol& described& by&Coddens& et! al.& (Coddens! et! al.,& 2009).& In& summary,& the& intestinal& gut& villi& were&obtained& from& euthanised& pig,& fixed& (160& mM& Krebs9Henseliet& buffer,& pH& 7.4&containing&1%&(v/v)&formaldehyde&for&30&minutes&at&4°C)&and&a&sample&was&tested&for& the&presence&of& the&receptor&by& incubation&with&F4+ETEC&strain.&Such&receptor&positive&villous&enterocytes&were&then&preserved&in&Krebs9Henseliet&buffer&at&4°C&for&further&use.&&
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secretory IgA in Arabidopsis seeds 
for oral passive immunisation
‘Strengthening the army at mucosal border security post’
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&&H.D.G&and&A.D.&seeded&the&VHH9Fc&fusion&strategy;&V.V.&conceived&development&of&SIgA&based&on&the&VHH9IgA&fusion&by&incorporating&porcine&specific&J&chain&and&secretory&component.&V.V&developed&all&the&clones,&the&transgenic&plant,&devised&the& high& throughput& screening& method–& the& 2& primer& multiplex& PCR& for&transformant& identification& and& screened& the& high& expressing& lines& by& the&functional&ELISA.&H.H.&helped&in&the&screening&of&the&206&transformants&by&ELISA.&S.D.B,&H.D.G&and&A.D&mentored&and& supervised& the&work.&A.C.&performed& the& in!




Abstract!!Mucosal& surfaces& are& one& of& the& chief& portals& for& pathogen& entry.& The&predominant& protective& antibody& at& mucosal& surfaces& is& secretory& IgA& (SIgA).&Topical& application& of& recombinant& SIgA& antibodies& at& the&mucosal& surface& can&offer&immediate&passive&mucosal&immunity,&which&could&be&of&vital&importance&in&prophylaxis& against& many& diseases& for& which& there& are& no& effective& mucosal&vaccines.&However,& recombinant& production&of& therapeutic& SIgA& antibodies& has&been&difficult&primarily&due&to&their&complex&hetero9decameric&structure&of&~400&kDa,&hindering&SIgA’s&clinical&application.&We&hence&conceived&a&novel&strategy&to&synthesise& customised& and& simplified& forms&of& SIgA,& henceforth& abbreviated& as&sSIgA.&These&sSIgA&antibodies&were&expressed& in&seeds&of&Arabidopsis&with& the&aim&to&provide&proof&of&concept& for& later&cost&effective&bulk&SIgA&production& in&seed&crops.&This&was&achieved&essentially&by&using&the&antigen&binding&domains&from& heavy& chain& only& camelid& antibodies& (VHH)& (~15& kDa)& grafted& to& the&fragment&crystallizable&(Fc)&part&of&an&IgA,&such&that&the&simplified&SIgA&would&be&a&hetero9hexameric&complex&with&molecular&weight&of&~230&kDa.&&For& pilot& construction& of& such& novel& sSIgA& antibody,& previously& isolated& four&VHHs& against& the& porcine& pathogen—& F4& fimbriae& bearing& enterotoxigenic&




Introduction!!Most& of& the& pathogenic& invasions& start& at& the& mucosal& surface,& which& is& an&extensively& vast& surface& lining& external& orifice& of& the& body;& namely& the&gastrointestinal& tract,& urogenital& tract,& and& respiratory& tract& surfaces&(Macpherson! et! al.,& 2012;& Strugnell& and& Wijburg,& 2010).& The& total& mucosal&surface& area& is& about& 200& times& larger& than& the& total& surface& of& the& skin& (in&humans& ~400m2)(Brandtzaeg,& 1995;& Corthésy,& 2002).& Protection& at& this& vast&surface,&by&preventing&the&colonisation,&entry&and&invasion&of&pathogens&can&bar&the& elicitation& of& infection.& This& protection& is& provided& by& a& non9specific&component& (inclusive& of& sticky& mucus,& enzyme& like& lysozymes& and& other&molecules& including& lactoferrins& and& defensins)& together& with& a& pathogen9specific& mucosal& immunity& component& (Corthésy,& 2002).& In& case& of& many&pathogens,& the& specific& mucosal& immunity& is& absolutely& necessary& to& combat&infections,& for& example& Vibrio! cholera& infection& in& humans& (Czerkinsky& and&Holmgren,&2010).&In&mammals&(and&birds)&pathogen9specific&mucosal&immunity&is& offered& at& the&mucosal& surface& predominantly& through& its& arsenal& of& specific&secretory& IgA& (SIgA)& antibodies,& hence& no& doubt& that& the& SIgA& are& the& most&predominant& immunoglobulin& isotypes&at& the&mucosal& surfaces;&being&a&part&of&the&‘first&line&of&defence’&(Johansen!et!al.,&2000;&Macpherson!et!al.,&2012;&Wycoff,&2005).&&&Most& vaccines& are& administered& parenterally& and& fail& to& provide& mucosal&immunity,&only&a&hand&few&like&influenza&and&polio&vaccine&in&humans&are&known&to& elicit& an& effective&mucosal& immune& response& (Corthésy,& 2003;& De&Magistnis,&2006;&Holmgren&and&Czerkinsky,&2005).&Even&though&mucosal&immunity&is&much&needed,& the& lack& of& knowledge& and& understanding& of& the& mucosal& immune&system,&the&unavailability&of&safe&mucosal&adjuvants&and&issues&of&delivery&at&the&mucosal&surface&are&some&of&the&reasons&for&the&difficulty&and&delay&in&mucosal&vaccine& development& (Czerkinsky& and& Holmgren,& 2010).& With& passive&immunisation&strategies,&one&can&circumvent&the&priming&of&the&immune&system&and& provide& instant& protection& (Li& and& Zhu,& 2010;& Naz& and& Rajesh,& 2004).&Application& of& disease& specific& SIgA& antibodies& topically& at& the&mucosal& surface&
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can& strengthen& the& defence& borders& and& prevent& infection& of& the& specific&pathogen.& The& bottleneck& in& this& approach& is& the& manufacturing& of& disease&specific&SIgA&(Corthésy,&2002).&&Secretory& IgA& is& a& hetero9decameric& complex& secreted&by& the& epithelial& cells& of&the&mucosal& surface,& typically& consisting& of& 4& heavy& chains,& 4& light& chains,& the&joining& (J&chain)& and& the& secretory& component& (SC)& (Goldsby! et! al.,& 2003).& The&production&of&such&SIgA&in!vivo&requires&orchestrated&functioning&of&two&different&cell& types.& The& plasma& cells& beneath& the& epithelium& (in& the& lamina! propria)&produce& the&polymeric& IgA& (pIgA),&which& is& a& composite& of& two& IgA&monomers&joined&tail9to9tail&by&the&J&chain.&Thus&this&is&a&dimeric&tetravalent&molecule,&with&4& fragment& antigen9binding& domains& (Fabs).& The& pIgA& binds& to& the& polymeric&immunoglobulin& receptor& (pIgR)& present& on& the& basal& surface& of& the& epithelial&cells&(Figure&5.1,&a)..&&After& binding& the& pIgR,& the& pIgA& is& internalized,& and& transcytosed& to& the& apical&surface&where&the&receptor&cleaves&off&and&the&previous&extracellular&domain&is&now&known&as&the&secretory&component&(SC).&The&SC&then&winds&on&to&the&pIgA,&the&entire&assembly&thus&formed&is&called&secretory&IgA&(SIgA)&and&is&secreted&at&the& apical& luminal& surface& of& the& columnar& epithelium14& (Figure& 5.1& a& and&b)(Corthésy,&2002;&Strugnell&and&Wijburg,&2010)&Despite&the& intimidating&complexity&of& the&SIgA&molecule,& the&benefit&of&SIgA&in&mucosal& passive& protection& has& attracted& a& lot& of& attention& for& its& recombinant&production.&Initial&breakthroughs&were&SIgA&molecules&produced&in&test&tubes&by&combining&purified&pIgA& from&hybridoma&cell& lines&with&recombinant&secretory&component& (Crottet! et! al.,& 1999;& Lullau! et! al.,& 1996;& Rindisbacher! et! al.,& 1995).&This& process& was& later& refined& by& stable& transfection& of& the& human& secretory&component& (SC)& in& myeloma& cell& expressing& mouse9human& chimeric& pIgA&(Chintalacharuvu&and&Morrison,&1997).&The&importance&of&using&a&single&cell&was&reaffirmed&by&many&groups;&following&which,&two&of&them&successfully&produced&milligram&amounts&of&SIgA& in&CHO&(Chinese&hamster&ovary)&cells&using&state&of&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&14&Animation&of&SIgA&biosynthesis&and&secretion&at&mucosa&surface&can&be&found&at&http://www.neptunemediaworld.com/proed.htm&&
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the&art&co9transfection&techniques&(Berdoz!et!al.,&1999;&Johansen!et!al.,&1999).&In&this& approach,& all& the& elemental& components& were& derived& from& human& cDNA&libraries& with& the& exception& of& the& variable& regions,& which& were& cloned& from&murine&hybridomas&(Figure&5.3).&In&spite&of&these&commendable&developments&in&the& field,& the& inherent& complexity&of& the&molecule&poses&difficulty& in&producing&cost& effective& SIgAs& in& cell& cultures.& This& has& been& by& far& the& major& hurdle& in&realizing&the&full&potential&of&SIgA&for&clinical&use&(Corthésy,&2002)&both&in&human&and&domesticated&animals.&
mouse models have been conducted with monoclonal
IgG and IgA comprising various amounts of
monomeric and polymeric mixtures, raising the
question as to the optimal molecular form of the
therapeutic antibody was being used.
The lack of SC, whose contribution to the stability
of the molecule is essential when targeting the GI tract
[27,28], has most likely precluded its adequate
evaluation in protocols of in vivo passive
immunization. Moreover, carbohydrate moieties on the
SC have also been reported to compete for the
interaction between pathogens and mucous epithelial
cells. Human SC inhibits the agglutination of human
group A erythrocytes by enterotoxigenic E. coli [29].
The carbohydrate Lewis blood group X antigen on
human SC can compete for Clostridium difficile toxin A
receptor on the surface of epithelial cells [30].
Consistent with this, prevention of Clostridium
difficile toxin A-mediated destruction of T84 epithelial
cell monolayers requires that the glycosylated form of
SC be used (B. Corthésy, unpublished results). SIgA
from colostrum inhibits attachment of Helicobacter
pylori to gastric surface mucous cells through sugar
moieties present on SC [31]. Given that in mature
human milk, the concentration of free SC is 200 µg ml−1
[32], this confers to the molecule a relevant, yet under-
evaluated, biological function as a microbial scavenger.
In addition, passive immunization requires that a
few mg kg−1 is applied topically on a daily basis for up
to two weeks to ensure protection, whereas clearance
of a pre-established infection might demand amounts
ten times higher. This implies that efficient,
dependable expression systems and purification
procedures are required to produce sufficient amounts
of monoclonal antibody/antibodies with appropriate
specificity, isotype and molecular structure.
Moreover, by administering human–animal
chimeric antibodies using the oral or nasal routes, the
patient will be less prone to mount a neutralizing
antibody or an allergic response against the
therapeutic molecule. Indeed, given the repeated
exposure to various peptide and sugar components
found in food and personal care products, the human
mucosal system should not perceive the recombinant
antibody as novel or dangerous. Furthermore, in
contrast to selection for resistant organisms by
repeated use of antibiotics, the presence of monoclonal
antibodies at mucosal surfaces will preclude
replication, and thus mutation of the pathogens.
Should this happen, other monoclonal antibodies can
be rapidly produced against mutated epitopes, or
existing monoclonal antibodies could be administered
as cocktails combining multiple specificities.
Heterologous production of recombinant SIgA
The large-scale production of SIgA is a complicated
task for two main reasons: (1) the molecule is
naturally produced by two distinct types of cells;
(2) the fully assembled dimeric molecule is a complex
of almost 400 kDa, exhibiting post-translational
modifications including intra- and inter-chain
disulfide bridging and extensive glycosylation.
Transgenic plants can be generated that efficiently
assemble complex SIgA retaining specific antigen
recognition. This was accomplished by successive
crossing of four tobacco plants individually expressing
murine κ chain, hybrid murine–human A–G heavy
chain, murine J chain and rabbit SC [33]. In a human
trial, the plant-derived recombinant SIgA prevented
oral colonization by Streptococcus mutans, thus
demonstrating its therapeutic potential [34]. However,
glycosylation patterns in plants differs from those in
mammals and this can affect both antibody activity
[35] and immune exclusion mechanisms in mucus.
To avoid the problems associated with improper
glycosylation and assembly using gene products from
heterologous organisms that in addition lead to
TRENDS in Biotechnology  Vol.20 No.2  February 2002
http://tibtech.trends.com
67Review

























Fig. 2. A schematic representation of a human dimeric secretory
IgA2m(1) w ith N-glycosylation sites drawn as connected yellow blocks
on polypeptides. Two IgA monomers are depicted in a tail-to-tail
arrangement, w ith a J chain (blue box) covalently linked through
disulfide bridges to the tailpiece of the heavy chains of two monomers.
In IgA2m(1), the light and heavy chains are not disulfide bridged,
whereas the light chains are disulfide-bonded to each other (not
drawn). Secretory component (SC) is made of five im munoglobulin-like
domains (red ellipsoids) derived from the extracellular portion of pIgR.
In human SIgA , up to 80% of SC is covalently linked w ith IgA dimers
through a disulfide bridge connecting Cα3 and SC domain V.
Abbreviations: Cα1, α2, α3, the constant domains of the heavy chain;
CL, the constant domain of the light chain; VH, the variable domain of
the heavy chain; VL, the variable domain of the light chain; I–V, the five
im munoglobulin-like domains that constitute SC.
a b 
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Region of differentiated 
lymphoid tissue found in the 
lamina propria of the small 
intestine, containing B cell-rich 
germinal centres separated by 
regions containing T cells. The 
so-called ‘dome’ epithelium 
that overlies the Peyer’s patch 
is rich in ‘microfold’ (M) cells, 
which sample antigen from  
the gut for presentation in 
secondary lymphoid tissues.
Disruption of the pIgR results in the accumulation of 
dimeric IgA in the serum and a reduction of IgA levels 
in faecal samples and bile8,9,11. In contrast to IgA–/– mice, 
the amount of IgM detected in serum and at mucosal 
lumen is not affected by the deletion of pIgR, whereas 
IgG is slightly increased8,11,73. The number of IgA and IgG 
producing cells is substantially increased in Peyer’s patches 
and gut lamina propria of pIgR–/– mice73. These observa-
tions suggest that, in the absence of pIgR, and therefore 
SIg, there is increased translocation of luminal antigens, 
resulting in an increased number of B cells specific for 
luminal antigens. Indeed, increased serum titres of anti-
body specific for commensal flora isolates and food 
can be detected in pIgR–/– mice11,73,74. Further, increased 
antigen-specific proliferative responses of CD4+ T cells 
can be detected in the mesenteric lymph nodes of pIgR–/– 
mice73. Yamazaki et al. found more THY1+CD8αβ+ T cell 
receptor (TCR)αβ+ intraepithelial cells in the intestinal 
epithelium of pIgR–/– mice than in that of wild-type mice, 
owing to increased migration into the epithelium as a 
result of increased exposure to commensal bacteria75. 
Together, these data suggest that pIgR has an important 
role in intestinal homeostasis and in food tolerance76.
Intracellular neut lizatio f pathogens by SIg
Two pri ary protective functions attributed to SIg in the 
context of infection immunity are the inhibition of con-
tact between pathogen or toxin ligands and the mucosal 
epithelial cell surface (referred to as ‘immune exclusion’) 
and the neutralization of viral replication, or toxin activ-
ity, in epithelial cells (known as ‘intracellular neutraliza-
tion’) (FIG. 3). Intracellular neutralization occurs where 
endosomes carrying SIgA from the basolateral surface 
intersect a d then fuse with endoso es from the api-
cal surface containing endocytosed virus or toxins. The 
interaction between the specific SIgA and viral roteins, 
or ba terial toxins, present i  endosomes can lead to 
inhibition of key viral replication steps, such as removal 
of the capsid, and the trafficking of toxins to their intra-
cellular receptors. The relative contributions of immune 
exclusion and intracellular neutralization are difficult 
to differentiate using animal models, but the elegant 
use of viral biology has revealed an important role for 
intracellular neutralization in infection immunity.
Intracellular neutralization by IgA was first described 
by a group using polarized epithelial cells in which 
IgA antibodies, but not IgG antibodies, added to the 
Figure 3 | Protection of the mucosal surface by secretory immunoglobulin through immune exclusion, 
intracellular neutralization or antigen excretion. Secreted antibodies can protect mucosal surfaces. a | Secretory 
immunoglobulins (SIgs) bind to (pathogen-derived) antigens and prevent or inhibit their attachment to and/or invasion of 
epithelial cells. b | The IgA–‘joining’ (J) chain–polymeric-immunoglobulin receptor (pIgR) complex mediates intracellular 
neutralization of pathogens that have invaded the epithelial cells. c | In addition, antigen excretion through the secretion 
of immunoglobulins  maintains homeostasis at mucosal surfaces. Secretory ntibodies mediate r moval of antigens from 
the mucosal lamina propria, in which antigens are bound to dimeric IgA and are subsequently transport d to the luminal 
surface of the epithelial cells following endocytosis of the antigen–dimeric IgA–J chain–pIgR complex and its relea e into 
the mucosal lumen.
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and gut lamina propria of pIgR–/– mice73. ese observa-
tions suggest that, in the absence of pIgR, and therefore 
SIg, there is increased translocation of luminal antigens, 
resulting in an increased number of B cells specific for 
luminal antigens. Indeed, increased serum titres of anti-
body specific for commensal flora isolates and food 
can be detected in pIgR–/– mice11,73,74. Further, increased 
antigen-specific proliferative responses of CD4+ T cells 
can be detected in the mesenteric lymph nodes of pIgR–/– 
mice73. Yamazaki et al. found more THY1+CD8αβ+ T cell 
receptor (TCR)αβ+ intraepithelial cells in the intestinal 
epithelium of pIgR–/– mice than in that of wild-type mice, 
owing to increased migration into t e epithelium as a 
result of incre sed exposure to commensal bacteria75. 
Together, these data suggest that pIgR has an important 
role in intestinal homeostasis and in food tolerance76.
Intracellular neutralization of pathogens by SIg
Two primary protective functions attributed to SIg in the 
context of infection immunity are the inhibiti n of con-
act between pathog n or t xin ligands and the mucosal 
epithelial cell surface ( eferred to as ‘immu e exclusion’) 
a d the neutralizati n of viral rep ication, o  toxin activ-
ity, in epith li l cells (known as ‘intracellular n utraliza-
tion’) (FIG. 3). Intracellular neutralization occurs where 
endosomes carrying SIgA from the basolateral surface 
intersect and then fuse with endosomes from the api-
cal surface containing endocytosed virus or toxins. The 
interaction between the specific SIgA and viral proteins, 
or bacterial toxins, present in endosomes can lead to 
inhibition of key viral replication steps, such as removal 
of the capsid, and the trafficking of toxins to th ir intra-
cellular eceptors. The relative contributions of immune 
exclusion and intracellular neutralization are ifficult 
to differentiate using animal models, but the elegant 
use of viral biology has revealed an important role for 
intracell lar neutralization in infection immunity.
Intracellular neutraliz tion by IgA was first described 
by a group using polarized epithelial cells in which 
IgA antibodies, but not IgG antibodies, added to the 
Figure 3 | Protection of the mucosal surface by secretory immunoglobulin through immune exclusion, 
intracellular neutralization or antigen excretion. Secreted antibodies can protect mucosal surfaces. a | Secretory 
immunoglobulins (SIgs) bind to (pathogen-derived) antigens and prevent or inhibit their attachment to and/or invasion of 
epithelial cells. b | The IgA–‘joining’ (J) chain–polymeric-immun globulin rec ptor (pIgR) complex mediates intracellular 
neutralization of pathogens that have invaded the epithelial cells. c | In addition, antigen excretion through the secretion 
of immunoglobulins  maintains homeostasis at mucosal surfaces. Secretory antibodies mediate removal of antigens from 
the mucosal lamina propria, in which antig ns ar  bound to dimeric IgA and are subsequently transported to the luminal 
surface of the epithelial cells following endocytosis f the a tigen–di eric IgA–J chain–pIgR complex and its release into 
the mucosal lumen.
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Figure!5.1:!Secretory!IgA:!a!complex!heterodecameric!antibody!that!provides!protection!at!
the!mucosal!surface.!(a)&The&plasma&cell &i &the&lamina!p opri ,&produce&J&chain&bound&dimeric&IgA&(dIgA)&which&bind&to&the&polymeric&immunoglobulin&recep or&(pI R)&on&the&basal&surface&of&the&columnar&epithelium&cells,&the&complex&is&internalised,&transcytosed&via&vesicular&trafficking,&the& pIgR& cleaves& off& as& secretory& component& that& wraps& around& the& dIgA& and& th s& for ed&secretory& IgA& (SIgA)& that& is& s cret d& at& the& luminal&muc sal& urface.& Fig.& 5.1,a–& also& shows& the&process&of&immune&exclusion&through&which&the&attachment&of&infectious&agent&(he e&a&bac eria)&is& inhibited& by& SIgA.& (b)& A& detailed& schematic& structure& of& a& conventional& IgA2m& secretory&antibody&in&humans.&Two&heavy&and&two&light&chains&form&a&monomer,&two& uch& onomers&are&joined&together&by&the&J&chain&(blue&block)&via&disulphide&bridges&across&one&of&the&heavy&chain&tails;&the&secretory&component&(red)&with&its&5&domains&(roman&numbers)&wraps&around&the&dIgA&molecule&via&covalent&and&non9covalent&bonds.&The&N9linked&glycans&are&indicated&by&the&yellow&antennary& structures.& The& paired& fra men & antig n9bindi g& dom ins9& F(ab’)2,& the& hing ,& the&fragment&crystallizable& 9Fc& reg o ,& the& J& chain,& an & the&c nstant&Cα1,&Cα2&and&Cα3&dom ins& r &labelled.&Figure&5.1&a&9reused&from&Strugnell&and&Wijburg,&2010&and&b&fr m&Cort ésy,&2002.&&&
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The&only&SIgA&to&successfully&complete&human&clinical&trials&is&the&plant&(tobacco)&made&anti9dental&caries&SIgA&antibody&called&–CaroRx®,&which&is&now&approved&for&use&in&the&European&Union&(Paul&and&Ma,&2011).&This&was&produced&by&stable&transformation&of&the&heavy& chain,& light& chain,& J& chain& and& SC& in& individual& tobacco& lines,& followed& by&successive&crossing&of&the&selected&final&transformant&lines.&Firstly,&by&crossing&the&heavy&chain& and& light& chain,& the&monomeric& IgA& (mIgA)& could& be& produced,& crossing& of& this&daughter& line& with& J& chain& expressing& tobacco& line& led& to& production& of& dimeric& IgA&(dIgA)&and&further&crossing&of&this&dIgA&line&producing&plant&with&the&one&expressing&SC&led&to&a&SIgA&producing&plant&(Ma!et!al.,&1995).&The&success&of&this&CaroRx®&antibody&is&an&evidence&for&the&capacity&of&plants&to&stably&produce&complex&SIgA,&which&are&firstly9&functional&in&preventing&the&disease,&and&secondly9&can&be&scaled&up&for&bulk&production.&However& the& in! planta& production& strategy& as& described,& is& a& lengthy& process.& Co9transformation& of& all& the& elements,& i.e.& IgA9& heavy& chain,& 9light& chain,& J& chain& and& SC&would& help& in& shortening& the& time& required& for& developing& SIgA& expressing& primary&transformants&(Wycoff,&2005).&Co9transformation&can&be&achieved&by&either&cloning&the&respective&elements&in&individual&plasmids&(4&T9DNAs);&or&stacking&of&the&elements&one&after&the&other&in&a&multi&gene&expression&cassette&(1&T9DNA).&&However&at&the&heart&of&all&these&expression&strategies,&be&it&in&mammalian&or&in&plant& systems,& the& daunting& complexity& of& the& SIgA& prevails.& Not& only& the&transformation& and& expression& of& 4& elements,& but& also& their& assembly& is&demanding&for&the&cellular&machinery&of&the&heterologous&expression&system.&As&a&novel&solution&to&this&we&envisaged&engineering&of&a&comparatively&simplified&SIgA&like&antibody&but&maintaining&all&advantages&of&a&traditional&SIgA.&This&was&achieved& essentially& by& using& the& VHH9IgA& fusion& strategy& to& build& the&monomeric&units&of&the&SIgA.&More&explicitly,&instead&of&using&the&antigen&binding&domains&formed&by&the&paired&heavy&and&light&chain&(the&Fab&~55&kDa),&we&opted&for&the&antigen&binding&Nanobody®&(~15&kDa)&which&is&the&variable&domain&of&a&heavy&chain&only&antibody&of& camelids& (VHH)& (summarized& in&Figure&5.3).&This&substitution&also&eliminated& the&necessity&of& light&chain&and& light&chain&binding&Cα1& domain& (the& first& conserved& domain& of& the& α& heavy& chain),& thereby&simplifying& the& otherwise& 400& kDa& SIgA& complex& molecule& to& about& 230& kDa&simplified& SIgA& (sSIgA).& Along& with& the& simplification& of& the& molecule,& the&transformation&would&need&just&three&elements&i.e.&the&VHH9IgA,&the&J&chain,&and&the& SC,& thus& also& easing& the& transformation.&Using& the& strategy& disease9specific&
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simplified& lightweight&monomeric& IgA& (mIgA)&with&paired&VHH9IgA&(Figure&5.2,&a),& dimeric& IgA& (dIgA)&with& 4&VHH9IgA& chains& +& J& chain& (Figure& 5.2,& b)& and& the&sSIgA&with&4&VHH9IgA&chain&+&J&chain&+&SC&can&be&produced&(Figure&5.2,&c).&&
&
Figure!5.2:!Schematic!representation!of!the!simplified!IgA!molecules!where&the&VHH&(red)&fused&to&the&porcine&IgAb&(green)&with&a&short&hinge&forms&a&divalent&IgA&monomer&(mIgA)&(a)&via&interchain&disulphide&bonds& (not& shown);& further&via& incorporation&of& J& chain& (black)& two& such&mIgA& bound& tail9to9tail& form& a& tetravalent& (4& VHHs)& dimeric& IgA& (dIgA)& (b);&while& a& simplified&secretory&IgA&(sSIgA)&is&formed&when&the&secretory&component&(purple&band)&wraps&around&the&dIgA&complex&(c).&Abbreviations:&Cα2,&Cα3&are&the&constant&domains&of&porcine&IgA&heavy&chain.&&To&provide&a&proof&of&concept&for&the&product&as&well&as&efficacy&of&such&sSIgA&in&preventing& disease,& we& used& four& previously& isolated& VHHs& against& the& FaeG&adhesin& of& the& F4& fimbriae& bearing& enterotoxigenic& Escherichia! coli& (F4+ETEC)&(Chapter&4).&F4+ETEC&cause&post9weaning&diarrhea&(PWD)&in&young&piglets,&and&the& disease& leads& to& heavy& economic& losses& to& the& porcine& rearing& industry&(Amezcua!et!al.,&2002;&Hong!et!al.,&2006).&Piglets&from&birth&until&the&weaning&age&are&most&likely&protected&from&the&infectious&ETEC&by&the&milk&derived&maternal&antibodies& against& ETEC& (Porter! et! al.,& 1970;& Riising! et! al.,& 2005;& Wilson& and&Svendsen,&1971).&On&weaning&this&passive&protection&at&the&gastric&surface&is&lost,&hence& they& fall& prey& to& F4+ETEC& infection.& Oral& administration& of& anti9ETEC&antibodies&after&weaning&in&feed,&is&suggested&to&prevent&the&disease&(Marquardt!
et! al.,& 1999;&Niewold! et! al.,& 2007;& Yokoyama! et! al.,& 1992).& Thus& this& disease& in&piglet&model&is&interesting&for&later&evaluation&of&efficacy&and&stability&of&sSIgA&on&
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oral&passive&immunization&in&a&challenge&experiment.&With&this&aim&we&grafted&the&4&anti9F4+ETEC&VHHs&on&the&Fc&fragment&of&porcine&IgAb,&and&co9expressed&it&with&porcine&J&chain&and&porcine&SC,&in&the&seeds&of&the&model&plant&Arabidopsis! thaliana! (Figure&5.3).&The& seed&production&platform& is&advantageous& in& this& disease& model,& as& it& would& also& provide& for& a& delivery&system& for& administration& of& sSIgA& in& feed.& In& addition,& the& seed& expression&system& is&preferred& for& its&ability& to&produce&abundant&amount&of& recombinant&protein& in& a& confined& space& (high& concentration)& and& its& merit& of& convenient&storage& at& room& temperature& enables& decoupling& of& the& harvesting& and& other&downstream& processing& of& the& recombinant& molecule& (Morandini! et! al.,& 2011;&Peters&and&Stoger,&2011).&&&Here& we& present& the& details& of& our& findings& demonstrating& the& feasibility& of&producing&assembled,&functional,&simplified&sSIgA&molecules&in&seeds.&The&results&obtained& in&each&of& the&successive&steps&are&described& in& the& following&order—&starting&from&designing&the&construct,&transformation,&selection,&characterisation,&
in!vitro&efficacy&and&finally&the&quantification&of&efficacious&molecules.&&Since& this& is& the& first& ever& description& of& production& of& simplified& sSIgA,&while&discussing& the& results& we& suggest& prospects& for& future& developments& and&optimisation&of&the&current&strategy,&with&an&aim&to&obtain&higher&accumulation&of&assembled&customized&sSIgA.&&&&&&&&&&&&
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In) silico! sequestration! of! elements! for! porcine! sSIgA! construction! and!
cloning!!Instead& of& the& traditional& PCR& based& sequestration& of& the& immunoglobulin&element& from& the& cDNA& library,& and& then& replacing& the& regulatory& elements&by&molecular& cloning& techniques& (Corthésy,& 2002),& we& opted& for& in! silico& analysis&and& sequestration& followed& by& immediate& chemical& synthesis& of& the& desired&coding&sequences.&
Porcine!J!chain!!The&amino&acid&sequence&of&the&porcine&J&chain&is&not&defined,&however&there&is&a&very&high&degree&of& conservation&noted& in& the& J& chain& throughout& evolution,& as&concluded&from&the&comparative&analysis&of&the&J&chain&amino&acid&sequences&in&an&invertebrate&like&earthworm,&and&in&higher&vertebrates&including&amphibian9like&Xenopus&and&mammals&like–&mouse,&bovine,&rabbit,&horses,&etc.&(Johansen!et!
al.,&2000;&Lewis!et!al.,&2010).&It&was&also&demonstrated&that&the&J&chain&of&humans&was&interchangeable&with&J&chain&of&mouse&and&chicken;&however&the&affinity&to&bind&the&IgA&to&form&pIgA&decreased&with&higher&phylogenetic&distance&between&them&(human&>&mouse&>&chicken)(Johansen!et!al.,&2000).&To& isolate& the& porcine& J& chain& sequence,& we& used& the& human& J& chain& sequence&(Uniprot& accession& no& P01591)& as& bait,& given& the& overall& genetic& similarity&between&humans&and&pigs.&By&a&homology9based&search&with&the&human&J&chain&bait& (accession& no:& NP_653247),& within& the& porcine& EST& (expression& sequence&tag)&database&we&could& identify& the&porcine& J& chain&homologous&sequence& from&the& cDNA& library& made& from& porcine& alveolar& macrophages& (accession& no.:&AK231006).& Within& this& cDNA& sequence& using& BLAST9X& we& could& identify& the&putative& J& chain& coding& sequence& that& started& from& the& 72nd& nucleotide& (ATG)&until&the&stop&codon&(TAA)&at&the&548th&nucleotide.&This&gene&coding&sequence&of&476&bp&was&then&defined&as&porcine&J&chain.&&&The&deduced&amino&acid&sequence&was&aligned&with&mammalian&J&chain&sequence&of& human& (p01591),& mouse& (p01592),& rabbit& (p23108)& and& bovine& (Q3SYR8)&available& in& UniProt& database,& as& reference& (Figure& 5.4).& We& noted& 80.62%&
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identity&between& the&porcine& J& chain&and& the&human& J& chain&sequence.&The&71st&asparagine& residue& (numbering& according& to& human& J& chain),& which& is& the&acceptor&site&for&N9linked&glycosylation&was&conserved&in&all&sequences&analysed&(Figure&5.4)&and&also&present&in&the&porcine&J&chain&and&predicted&to&bear&N9link&glycosylation&as&analysed&with&NetNGlyc&1.0& (with&potential&of&0.7061,&and&9/9&jury&agreement)15&(Gupta!et!al.,&2004).&The&position&of&the&8&cysteine&residues&for&the& inter9& and& intra9chain& disulphide& bonds& and& the&domains& implicated& for& SC&binding&were&highly&conserved&in&the&sequence&analysed&(denoted&in&Figure&5.4&in&accordance&with&(Lewis!et!al.,&2010)).&&
&
Figure!5.4:!Deduced!amino!acid!sequence!of!porcine!J!chain!aligned!with!J!chain!sequence!
of!human,!mouse,!rabbit!and!bovine.&The&8&conserved&cysteine&residues&involved&in&disulphide&bridges&are& indicated&with&arrows,&2&among& these& involved& in& interchain&bonds&with& IgA&heavy&chains&are&indicated&with&arrows&bearing&a&circular&tail.&The&porcine&signal&peptide&is&underlined&with& a& solid& line,& while& the& regions& associated& with& binding& to& the& secretory& component& are&underlined& with& a& dotted& line.& The& N9linked& glycosylation& site& in& human& was& found& to& be&conserved&in&all&the&sequences&analysed&(bold&faced),&this&residue&was&also&predicted&as&putative&N9link&glycosylation&site&in&porcine&J&chain&sequence.&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&15&http://www.cbs.dtu.dk/services/NetNGlyc/&
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Further,& from& the&alignment&and&by&using& the& signal&peptide&predictor& (SignalP&3.0)& (Bendtsen! et! al.,& 2004)& the& native& signal& peptide& of& J& chain&was& identified&(underlined& in& Figure& 5.4)& and& replaced& with& the& signal& peptide& of& 2S2&Arabidopsis& seed& storage& protein.& Thereafter,& the& codon& usage& in& the& entire&coding& sequence& was& optimised& according& to& the& codon& usage& of& the& major&storage& proteins& in& Arabidopsis& seeds.& The& nucleotide& coding& sequence& for& the&endoplasmic& reticulum& retention& signal& (KDEL)&was& added& to& the& (C9terminal)&end&followed&by&a&stop&codon&and&the&DNA&was&chemically&synthesised&within&the&attB1&and&attB2&for&Gateway&cloning&(Invitrogen).&
Porcine!Secretory!Component!The&secretory&component,&which& is& the&resultant&product&of&proteolytic&cleavage&of& the&polymeric&immunoglobulin&receptor&(pIgR),&is&either&found&as&free&SC&form&or&associated&with& the& dimeric& IgA.& Structurally& the& pIgR& has& 5& domains& that& are& connected& to& a&transmembrane& region& by& a& linker& peptide& (Figure& 5.5);& the& cleavage& takes& place&somewhere&in&the&linker&region,&after&the&5th&domain,&and&these&5&extracellular&domains&wrap&around&the&dIgA.&&&
Surprisingly, the CDR2 loop was found to be only two
amino acids in length, with a highly divergent amino acid at
position 53 (Glu in human pIgR) followed by an invariant Gly
at position 54. Given the key role of CDR2 in binding of
human pIgR to pIgM, it is significant that rabbit pIgR has a
deletion at the position corresponding to the surface-exposed
Glu53 residue. Notably, pIgR proteins that bind pIgM (such as
human and cow) have a charged residue at position 53, while
those that bind pIgA exclusively have at that position a polar,
uncharged residue (Asn in mouse and rat) or a deletion
(rabbit) (Fig. 4A). Experiments with chimeric ‘domain swap’
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Fig. 4. Interspecies alignment of amino acid sequences of polymeric
immunoglobulin receptor/secretory component (pIgR/SC).
Numbering of amino acids corresponds to the human sequence, begin-
ning with the first residue of the mature protein. Dashes indicate gaps in
sequence homology. Yellow shading indicates sequence identity among all
species, blue shading indicates sequence identity among six or more
species, and green shading indicates conservative differences from the
consensus sequence. Asterisks denote conserved residues characteristic of
immunoglobulin variable domains. Accession codes for pIgR sequences:
X73079, Homo sapiens (human); AB032195, Sus scrofa (pig); X81371, Bos
taurus (cow); XM537133, Canis familiaris (dog); U06431, Mus musculus
(mouse); X15741, Rattus norvegicus (rat), X00412, Oryctolagus cuniculus (rab-
bit); AF091137, Trichosurus vulpecula (silver-gray brushtail possum);
AF317205, Macropus eugenii (tammar wallaby); and AF303371, Gallus gallus
(chicken). (A) Domain 1. (B) Region of domain 4 corresponding to a
synthetic peptide from human pIgR that binds Streptococcus pneumoniae SpsA/
CbpA. Gaps are introduced to maximize homology with the corresponding
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Fig. 3. Schematic structure of the human polymeric immunoglobu-
lin receptor (pIgR). The pIgR is a type I transmembrane protein, with an
extracellular ligand binding comprising five domains with homology to
immunoglobulin variable regions. The three complementarity-determining
regions (CDRs) in domain 1 form a non-covalent binding surface for dimeric
IgA (dIgA). During transcytosis, a disulfide bridge is formed between
domain 5 of pIgR and the Fca region of dimeric IgA. Peptide motifs in
domains 3 and 4 cooperate to form a binding surface for the SpsA protein of
Streptococcus pneumoniae. A peptide of unknown structure links domain 5 to the
membrane-spanning region and contains site(s) for proteolytic cleavage of
pIgR to secretory component (SC). Seven N-glycan residues on domains 1, 2,
4, and 5 contribute to innate immune functions of SC and may facilitate
transcytosis of pIgR. The cytoplasmic domain of pIgR contains highly con-
served signals for intracellular sorting, endocytosis, and transcytosis.
Kaetzel ! The polymeric immunoglobulin receptor
90 Immunological Reviews 206/2005
&
Figure! 5.5:! Schematic! repr se tation! of! the! polymeric! immunoglobulin! receptor! (pIgR)!bound&to&the&basal&surface&of&the&columnar&epithelial&cells&of&the&mucosal&surfaces.&The&receptor&has&5&domains&with& immunoglobulin9like& folds,& and& is&heavily&glycosylated.&Figure& reused& from&Kaetzel,&200 .&&The&seque ce&of&t e&porcine&SC&was&hence&d rived&from&the&published&sequence&of& porcine& pIgR& (Kumura! et! al.,& 2000)(accession& no.:& NM_214159,& UniProt&accession&no.&Q9N2H7).&The&endogenous&signal&peptide&of&pIgR&was&determined&(supplementary& Figure& 5.S1)& as& described& for& the& J& chain,& using& the& signal&prediction& tool& (Bendtsen! et!al.,& 2004)&and& then& in! silico& replaced&by& the& signal&peptide&of& the&2S2&seed&storage&protein&of&Arabidopsis& seeds&at& the&N9terminal&
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end.&However&the&cleavage&site&and&hence&the&exact&length&of&the&free&porcine&SC&is& not& determined& yet,& moreover,& only& the& length& of& the& free& SC& of& humans& is&known& (Kaetzel,& 2005),& but& there& is& a& discrepancy& in& the& published& C9terminal&residue.& Free& human& SC& from& pooled& colostrum,& suggested& of& having& ragged&C9terminal& end& varying& from& Ala550& to& Lys559& however& Ser552& was& the&prominent&end&(Eiffert!et!al.,&1984),&while&in&another&study&from&a&single&woman,&Arg585&was&determined&as&the&last&residue&of&human&SC&(Hughes!et!al.,&1997).&It&is&difficult& to&accurately&guess& the&cleavage&site&of& the&porcine&SC&since& there& is&little&sequence&identity&in&the&cleavage&linker&peptide&of&different&species.&Over&all&given& that& the& first& 5& domains& of& the& porcine& pIgR& are& important& for&wrapping&around&the&dIgA,&we&selected&and&defined&the&first&579&aa&length9spanning&region&until&the&5th&domain&after&the&signal&peptide&(corresponds&to&the&585&aa&of&human&SC)&as&porcine&SC.&The&nucleotide&sequence&of&this&porcine&SC&(1737&bp)&together&with&the&plant&signal&peptide&at&the&5’&end&(N9terminal&end)&and&a&KDEL&retention&signal& at& the& 3’& end& (C9terminal& end)& was& codon& optimised& and& chemically&synthesised&with&attB1&and&attB2&flanking&sequences.&
Porcine!IgA!Fc!The& VHH9IgA& fusion& forming&monomeric& IgA& is& the& third& element& in& our& sSIgA&strategy.& The& porcine& IgA& has& three& allelic& forms& IgAa,& IgAb& and& the& recently&describes& IgAc&which& basically& occurs& due& to& alternative& splicing& (Brown! et! al.,&1995;&Kunhareang!et!al.,&2009).&Of&these,&the&porcine&IgAb&has&the&shortest&hinge&with& just& 2& amino& acid,& making& it& also& one& of& the& smallest& hinge& reported& yet&among&the&IgA&of&mammals&and&birds&(Brown!et!al.,&1995).&Just&like&human&IgA2,&which& has& a& short& hinge& and& lacks& the& site& for& bacterial& IgA& proteases,& the&occurrence& of& short& hinge& in& pig& is& suggesting& to& be& resistant& to& proteolysis&(Brown!et!al.,&1995).&Hence&the&IgAb&was&chosen&as&the&fusion&partner&for&VHH&as&it& would& be& more& fit& in& the& gastric& tract& and& thus& suitable& for& oral& passive&immunisation;&though&a&short&hinge&usually&implies&a&rigid,&inflexible&hinge.&The&sequence&of&the&hinge9Cα29Cα3&was&retrieved&from&the&NCBI&nucleotide&database&(accession&no.&U12594,&from&the&porcine&IgAa&sequence,&the&coding&frame&of&short&hinge& starts& from& the& 312th& base& pair).& The& codon& usage& in& this& nucleotide&sequence&was&then&optimised&to&Arabidopsis&seeds&and&the&previously&isolated&4&
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anti9F4+ETEC&VHHs&viz.&V1,&V2,&V3&and&V4&(Chapter&4)&were&grafted&onto&the&pig&IgAb&hinge9Cα29Cα3&domains&(Figure&5.2,&a);&the&resultant&fusion&antibodies&were&called& V1A,& V2A,& V3A,& V4A& respectively.& We& also& grafted& the& codon& optimised&version&of&V1&i.e.&V1c&and&V4&i.e.&V4c&onto&the&porcine&IgA,&however&this&construct&did& not& bear& any& difference& in& expression,& or& any& of& the& parameters& measure&hence&they&are&not&elaborated&the&difference&in&this&chapter.&&&
&
Figure! 5.6:! Schematic! representation! of! the! THDNA! constructs! for! in! seed! expression! of!
antiHF4+ETEC!secretory!IgA!antibodies.!Abbreviations:!LB9&left&border;&RB9&right&border;&VHH9IgA9fused& coding& sequence& of& the& VHH9IgA;& SC9porcine& secretory& component,& J& chain9coding&sequence&of&the&porcine&J&chain;&Omega&leader9&5’&tobacco&mosaic&viral&UTR;&2S2&9&signal&peptide&sequence&of&the&2S2&seed&storage&protein;&KDEL9&endoplasmic&retention&motif;&attB1,&attB2,&attB3&and&attB4&9&Gateway&recombination&sequences&(Invitrogen);&Pphas9&Phaseolin&promoter;&3’arc5I9&3’&arcelin&terminator&(4100&bp);&3‘arc6H5I9&600&bp&long&3’&arceline&terminator&bearing&regulatory&sequence;&nptII9&neomycine&phosphotransferase&II&gene;&Pnos9&nopaline&synthase&gene&promoter;&3’ocs9& octopine& synthase& terminator;& bar9& phosphinothricin& herbicide& resistant& gene;& 3’nos9&nopaline&synthase&terminator.&!&The& KDEL& endoplasmic& retention& signal& was& attached& to& all& the& elements,& to&facilitate& in!situ&assembly&of&the&sSIgA&molecule&(Figure&5.6).&Using&the&gateway&recombination&technology&(Invitrogen)&V1A,&V2A,&V3A,&V4A&and&SC&were&cloned&into& pPhasGW&expression& vector& (Morandini! et! al.,& 2011),& under& the& control& of&the& seed& storage& β9phaseolin& promoter& and& arcelin& (4100& bp)& terminator&
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sequence,&bearing&the&kanamycin&resistance&on&the&T9DNA.&While&the&J&chain&was&cloned& together& with& the& β9phaseolin& promoter& and& short& arcelin& (600& bp)&terminator& (De& Wilde,& 2012)& via& the& Multisite& Gateway& technology& into& the&pBm43GW,0& (Karimi! et! al.,& 2005)& plasmid,& the& T9DNA& of& which& bears& the& bar&gene& that& confers& for&phosphinothricin& (PPT)& resistance,& enabling& selection&of& J&chain&expressing&plants.& In&order& to&produce&4&different&SIgA,&each&of& the&VHH9IgA,&i.e.&V1A,&V2A,&V3A&and&V4A&were&co9transformed&with&the&J&chain&and&SC.&&
Production!and!selection!of!functionalH!monomeric,!dimeric!and!secretory!
IgA!antibody!expressing!plants!from!pool!of!coHtransformants)Ten&Arabidopsis&(Col&0)&plants&were&transformed&by&floral&dip&method,&for&each&of& the& 4& sets& of& triple& co9transformation& (V1A+SC+J;& V2A+SC+J;& V3A+SC+J;&V4A+SC+J)& to& produce& different& formats& of& IgA& antibodies& bearing& 4& different&antigen&binding&domain.&
&&Figure& 5.7:& Identified& monomeric9IgA& (mIgA),& dimeric9IgA& (dIgA)& and& simplified& secretory& IgA&(sSIgA)&expressing&lines&after&triple&co9transformation&of&VHH9IgA,&J&chain&and&porcine&secretory&component& (as& determined& by& 2PM9PCR).& The& table& (a)& indicated& the& number& of& primary&transformants&from&each&of&the&4&sets,&expressing&single&element,&VHH9IgA&(mIgA);&two&elements,&VHH9IgA& and& J& chain& (dIgA);& or& three& elements,& VHH9IgA,& J& chain& and& SC& (sSIgA).& The&transformation& frequency& is& indicated& in& parenthesis.& The& Venn& diagram& (b)& shows& the&classification&of&the&206&primary&transformants&obtained&on&co9transformation.&Where&n.d.&stands&for&not&determined.&&From& each& transformed& plant& ~1000& T1& seeds& were& first& sown& on& kanamycin&bearing&Murashige&and&Skoog&medium,&and&a& total&of&206& lines&were& identified&(86&for&the&V1A&set,&43&for&the&V2A&set,&51&for&the&V3A&set&and&63&for&the&V4A&set).&
& In&seed&produced&simplified&secretory&IgA&&
 121 
Leaves& from& these& 206& primary& transformants& were& then& placed& on& callus&induction&medium&with& phosphinothricin& (PPT)& selection,& induction& of& healthy&callus&from&60&of&these&206&T1&leaves&identified&J&chain&expressing&plants&(25&of&the&86&from&the&V1A&set,&6&from&the&43&of&the&V2A&set,&16&from&the&51&of&the&V3A&set&and&13&from&the&63&of&the&V4A&set&were&identified&for&the&presence&of&J&chain).&However& this& does& not& allow& distinction& between& VHH9IgA& and& SC& expressing&plants&since&both&T9DNAs&confer&kanamycin&resistance.&Further&using&a&multiplex&PCR& set& up& with& just& 2& primers& (2PM9PCR)& compementary& to& the& regulatory&elements&on&the&T9DNA,&the&presence&of&the&respective&transformed&genes&were&determined& in& a& single& reaction& per& primary& transformant& plant.& From& these&results,& T2& plant& transformed& with& different& permutation& of& the& three& T9DNA&were& classified& (Venn& diagram,& Figure& 5.7);& the& most& interesting& of& these&combinations&were&monomeric&transformant&plants–&with&only&VHH9IgA&bearing&T9DNA,&dimeric& IgA&plants–&with&IgA&and&J&chain&bearing&T9DNAs&and&the&sSIgA&transformant&plants–&with&all& the&three&T9DNA&inserts&bearing&VHH9IgA,& J&chain&and& SC& coding& sequence& (Venn& diagram,& Figure& 5.7).& [Nomenclature:& on&classifying&the&plants& into&the&three&groups,&a&small& letter& ‘m’& for&mIgA&lines,& ‘d’&for&dIgA&lines,&and&‘s’&for&secretory&IgA&lines&was&written&before&the&name&of&the&individual&transformant&plant]&!Thus&unlike&previous&plant&made&SIgA&(Ma!et!al.,&1995)&as&introduced&earlier,&our&method&of&co9transformation&demonstrates&fast&production&and&isolation&of&lines&expressing& all& three& intermediate& forms& of& sSIgA& antibodies.& The& 2PM9PCR&approach& especially& facilitated& the& fast& screening.& Immunodot& blot& as& an&alternative&method&of&fast&screening&was&ineffective&as&it&led&to&high&false&positive&results& (data&not& shown).&The& results&of&2PM9PCR&on& the&contrary&had&no& false&positive& results,& and& a& few& false& negatives.& Overall& the& screening& results& were&more& than& 95%& in& agreement& with& results& observed& from& plants& grown& on&selection& plates& and& callus& induction& test.& For& the& interesting& population&identified&among&the&pool&of&206&primary&transformants,&the&presence&of&all&the&respective&elements&could&be&confirmed&with&SDS9PAGE&separated&immunoblots.&Hence& 2PM9PCR& approach& could& be& used& for& future& identification& of& sSIgA&elements.&
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Stacking&of&all& the&three&sSIgA&elements&in&tandem&on&one&T9DNA&might&further&speed&up&the&selection&process,&as&it&would&eliminate&the&need&of&such&multiplex&PCR,&and&additionally&would&also&ease&in&identifying&single&locus&insertion&lines.&However,&since&each&of&these&triple&tandem&elements&bearing&transformants&will&ideally& express& all& their& elements,& the& strategy& does& not& allow& for& selection& of&individual& transformant& lines& exclusively& expressing& mIgA& (VHH9IgA)& or& dIgA&(VHH9Iga& +J& chain).& Thus& for& example,& for& production& of& exclusive& dIgA&expressing& line& new& expression& cassettes&with& VHH9IgA& and& J& chain& in& tandem&will&have&to&be&cloned.&Depending&on&the&application,&a&suitable&strategy&could&be&used,&however&isolation&of&different&lines&from&a&pool/library&might&be&of&interest&for&pilot&/&proof&of&concept&studies.&&
Selection! of! lines! expressing! high! amounts! of! functional! IgAs! and!
characterisation!of!the!complexes!To& assess& the& accumulation& of& the& assembled,& functional& IgA& antibodies& in& the&plants&classified&as&mIgA,&dIgA&and&sSIgA,&we&used&an&ELISA&based&approach&with&immobilised&antigen–&FaeG.&The&T2& seed&extract& from& the& respective&plant&was&added& into& the& wells,& any& functional& IgA& molecules& that& were& bound& to& the&antigen,& were& characterised& further& using& antibodies& specific& against& each& of&respective& 3& elements,& thus& the& bound& functional& IgA& antibodies& were&characterised&in&solution.&Such&an&ELISA&based&strategy&is&apt&for&determination&of& functional& sSIgA& complexes,& since& the& SC& interaction& with& the& dimeric& IgA&molecule& is& not& strictly& covalent& in& nature.& Previously&Ma& et! al.& also& utilised& a&similar&methodology&to&characterise&the&tobacco&made&SIgA&(Ma!et!al.,&1995).&&
Monomeric!IgA!!Using& anti9porcine9IgA& polyclonal& antibody,& the& functional& monomeric& IgA&specifically& recognising& the& antigen& could& be& identified& by& ELISA.& The& overall&accumulation&of&functional&VHH9IgA&was&reasonably&similar&for&all&the&four&VHH9IgAs,&i.e.&the&range&of&variation&was&very&low&(Figure&5.8)&hence,&among&the&pool&of& 50& monomeric& VHH9IgA& expressing& T2& plants,& 15& high& expressing&transformant&plants&were&selected&for&further&characterisation&and&up&scaling.&Of&these& 15,& 5& were& mV1A,& 2& were& mV2A& and& 4& each& of& the& mV3A& and& mV4A&(indicated&with&dotted&line&in&Figure&5.8).&Among&these&lines,&9&had&single&locus&
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insertion&of& the&VHH9IgA&gene&and&a&germination& frequency&of&more& than&40%.&The& VHH9IgA& in& these& 9& selected& lines& was& analysed& further& by& immunoblot&under&reducing&conditions&with&purified&standards&as&reference&(Figure&5.8).&&
&
Figure! 5.8:! Selection! and! characterisation! of! monomeric! IgA! producing! plant! lines.! The&accumulation&of& functional&mIgA&as&determined&by&ELISA& in& the&50&primary& transformants&was&reasonably&similar&with&very&little&range&in&variation,&and&extremely&low&accumulation&detected&in&just&5&lines&(top&graph,&extreme&right&samples)&The&OD&was&determined&for&seed&extracts&diluted&1/10,&1/20&and&1/40&(see&key).&The&15&highest&expressing&transformants&(underlined&in&graph)&were& selected& for& further& analysis,& 9& of& these& has& single& locus& insertion.& Under& reducing&conditions& (lower& immunoblot)& the& VHH9IgA& in& these& single& locus& high& expressing& mIgA& lines&showed&occurrence&of&4&bands&about&the&expected&molecular&weight&of&37&kDa&and&proteolitically&cleaved& lower&molecular&weight&bands&around&25& to&20&kDa.&Each& lane&contained&10&µl&of& seed&extract&made&by&suspending&every&milligram&of&crushed&seeds&in&100&ml&of&buffer&representative&of& identical& seed& weight& and& separated& on& a& 12%& SDS9PAGE,& the& individual& transformant& are&indicated& above& the& immunoblot,& where& WT& stands& for& wild& type& seed& extract.& As& reference&standard,&the&seed&made&mV2A&antibody&was&purified&from&mV2A17&seeds&using&(SSL7)&affinity&chromatography,&and&120&ng,&80&ng,&60&ng&and&40&ng&of&this&was&loaded&in&wells&as&on&the&left&side&of&the&marker.&The&anti9porcine&IgA&antibody&conjugated&to&HRP&was&used&to&detect&the&VHH9IgA&bands.&&
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Surprisingly,&instead&of&the&expected&single&39&kDa&VHH9IgA&band,&4&heterologous&bands& were& seen& from& 37& kDa& until& 50& kDa& (Figure& 5.8),& additionally& lower&molecular&weight&bands&of&~20&kDa&and&~27&kDa&were&observed.&These& lower&molecular& bands& could& presumably& be& the& result& of& in& seed& proteolysis& (rather&than&during&sample&preparation&as&higher& than&recommended&dose&of&protease&inhibitor&cocktail&was&used&in&the&sample&buffer).&These&bands&were&not&seen&in&the&wild&type&control&seed&extract&and&were&hence&indicative&of&specific&porcine&IgA&Fc&expression&and&proteolysis.&Duplex&of&heterologous&protein&bands&are&not&uncommon&(also&reported& in&Chapter&4),&and&have&been&reported&by&our&group&previously&on&expression&of& IgG&and& IgG&composite&or&derived& fragments,& these&duplex&bands&usually&result& from&differential&glycosylated&IgG&heavy&chain&(Van&Droogenbroeck!et!al.,&2007).&The&IgA&Fc&bears&comparatively&more&putative&sites&for& glycosylation& (Figure& 5.1,& b& and& supplementary& Figure& 5.S2),& and& aberrant&glycosylation& in& the& VHH9IgA& could& explain& the& quadruplet& bands.& We&investigated&this&hypothesis&further,&and&later&in&this&manuscript&we&report&and&discussed&these&findings&in&more&detail&(see&section&glycosylation&and&proteolytic&cleavage).&&






































































































































(a) Anti-SC ELISA 
(b) Porcine SC 
(c) VHH-IgA 
(e) Anti-J chain ELISA 
(d) Porcine J chain ~15kDa 
&
Figure! 5.9:! Characterising! sSIgA! produced! in! Arabidopsis! seeds.! The& functional& anti9SC&ELISA&(a)&shows&the&comparative&accumulation&of&assembled&sSIgA&in&the&9&high&expressing&lines&in&descending&order&of&accumulation&followed&by&three&lines&that&had&very&low&signal.&The&same&order&of&samples&has&been&maintained& in&all& the&5&panels.&Three&of& these&9& lines&also&expressed&functional,& assembled& dIgA& as& seen& in& the& anti9J& chain& ELISA& (e).& The& production& of& these&assembled,&functional&molecules&detected&by&ELISA&depended&on&the&individual&accumulation&of&each& of& the& elements–& the& SC& (b)& (detected&with&monoclonal& anti9porcine& SC),& the&VHH9IgA& (c)&(detected&with&polyclonal&anti9porcine&IgA&serum),&and&the&J&chain&(d)&(detected&with&anti9J&chain&monoclonal& antibody)& as& detected& under& reducing& immunoblots.& The& three& elements& were&determined& from&a&single&blot,&by&successive&stripping&of& the&previous&detection&antibody.&Each&lane&contains&10&µl&of&seed&extract&made&by&suspending&every&milligram&of&crushed&seeds&in&100&µl&of&extraction&buffer&(i.e.&each&lane&is&representative&of&100&µg&of&seed&weight).&&&&The&ELISA&with& the& anti9J& chain& antibody&detected& functional&molecules& in&3&of&these&9&sSIgA&lines&of&which&sV1cA36&had&a&much&higher&titer&as&compared&to&the&other& two& lines& sV1A8& and& sV1A2& (Figure& 5.9,& e).& The& SDS9PAGE& immunoblot&analysis&under&reduced&condition&on&these&9&sSIgA9producing&lines&confirmed&the&
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accumulation&of&J&chain&in&all&of&these&seeds&(Figure&5.9,&d).&This&suggests&that&the&presence& of& the& SC& in& sSIgA& antibody&masks& the& interaction& of& the&monoclonal&anti9J& chain& antibody& in& 6& of& the& 9& sSIgA& lines,& while& in& the& other& 3& lines& the&comparatively&higher&expression&of&J&chain&than&the&SC&might&have&led&to&surplus&of& J&chain&bearing&dimeric&IgA&(especially& in&sV1cA36).&Thus& in&these&3& lines&bi9species& of& IgA& as–& dIga& and& sSIgA& antibodies& were& produced.& The& bi9species&producing& line&sV1cA36&was&also& the&highest&producer&of&both& functional&sSIgA&and&dIgA&antibodies&among&all&the&plants&(Figure&5.9).&This&high&expression&might&be& the& reason& for& the& overall& lower& germination& frequency& of& about& 50%&observed&in&this& line.&We&further& investigated&the&relative&accumulation& level&of&each& of& the& elements& of& sSIgA& under& reducing& conditions& via& immunoblot&analysis.&The&results&showed&that&indeed&the&expression&of&the&SC&in&these&9&sSIgA&lines&correlates&with& the&relative&expression&of&assembled&sSIgA&determined&by&ELISA&(Figure&5.9,&a&and&b).&The&expression&of&VHH9IgA& in&all& these&9& lines&was&reasonably& similar,& and&was& not& the& rate9limiting& factor& for& assembly& of& sSIgA&(Figure& 5.9,& c).& The& levels& of& J& chain& expressed& in& the& 9& sSIgA& lines&was& rather&variable,&and&comparatively&high&in&line&sV1A8,&sV1A2&and&sV1cA36&which&might&explain&the&co9detection&of&both&the&sSIgA&and&dIgA&antibody&formats.&Our&data&also&implies&that&the&molar&accumulation&of&each&of&the&elements&in&sSIgA&has&an&effect&on&the&final&accumulation&of&assembled&sSIgA&antibodies.&Precise& molar& expression& of& each& constituent& element& for& maturation& and&assembly&of&complex&heterologous&polyproteins&has&been&reported&previously&for&complex& Blue& tongue& virus& (BTV)& like& particles& produced& in& tobacco&(Thuenemann&and&Lomonossoff,&2010).&BTV&is&a&complex&of&4&different&proteins;&random&accumulation&of&these&4&proteins&leads&to&inefficient&production&of&BTV&like& particles,& with& lots& of& unassembled& monomers& being& wasted.& This& group&showed&that&by&fine&tuning&the&regulatory&elements&the&precise&molar&expression&of& each& component& can& be& achieved,& which& in& turn& led& to& efficient& high& level&expression& of& assembled& BTV& like& particles& (Thuenemann& and& Lomonossoff,&2010).& Similar& strategies& to&modulate& the&molar& expression&of& each& constituent&element& by& fine9tuning& the& regulatory& elements& can& be& tested& for& sSIgA&production& in& seeds.& Recently,& our& group& reported& that& the& longer& arcelin&terminator&bearing&3’&regulatory&region&(length&4100&bp&vs&600&bp)&correlates&to&
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comparatively& higher& accumulation& (De& Wilde,& 2012).& Thus& by& adjusting& the&length& of& 3’& regulatory& sequence& the& rate& of& accumulation& of& each& of& the&polypeptides&chains&of&the&SIgA&can&be&fine9tuned&in&seeds.&Further,& the& stoichiometry& of& each& of& these& elements& might& also& influence& the&assembly& and& hence& their& detection& in& ELISA.& The& SC& is& a& highly& glycosylated&protein& when& expressed& in& mammals& both& natural& as& well& as& in& recombinant&systems& (Corthésy,& 2002).& The& seed& produced& porcine& SC& also& bear& glycans,&which& could& be& detected& by& glycan& specific& stain& (Figure& 5.11).& There& was&aberrant&glycosylation&of&the&SC&detected&in&many&of&the&plant&lines,&resulting&in&two&to&three&glycoprotein&bands&ranging&from&~65&kDa&to&~75&kDa&(Figure&5.9,&b).&We&did&not&evaluate&if&the&glycans&decorating&the&SC&or&the&VHH9IgA&had&any&influence&on&the&assembly&of&the&complex,&but&it&would&be&interesting&to&evaluate&this&in&future.&&Also&worth&evaluating&is&the&necessity&of& J&chain&for&the&assembly&of&tetravalent&simplified& sSIgA& within& the& 12& lines& expressing& only& the& SC& and& the& VHH9IgA&(Venn&diagram,&Figure&5.7).&However,& it& has&been& stated& in&previous& reports&of&SIgA&production& (heavy,& full& size& conventional&molecule)& that& the&presence&of& J&chain&is&necessary&for&the&formation&of&SIgA&in&mammals&(Brandtzaeg&and&Prydz,&1984),&also& in&recombinant&expression&systems&both& in!planta& (Ma! et!al.,&1995)&and& in& mammalian& cells& (Corthésy,& 2003;& Rindisbacher! et! al.,& 1995).& The&recombinant&SC&does&not&interact&with&monomeric&IgA&that&are&devoid&of&J&chain.&&Dimeric&IgA&&The& J& chain& ELISA& detected& 7& transformants& expressing& assembled& functional&dimeric&IgA&among&the&32&plant& lines&identified&as&dIgA&producing&lines&by&PCR&(Figure&5.7&and&5.10).&The&results&as&compare&to&controls&also&indicate&that&the&J&chain& specifically& interacts&with& the&VHH9IgA& and&does& not& bind& to& the& antigen&FaeG&in&the&absence&of&VHH9IgA&(data&not&shown&here).&&Among&these&7&functional&dIgA&producing&lines,&plant&dV4A2&did&not&bear&enough&seeds& for& further& analysis& and& propagation;& the& remaining& 6& lines& were&characterised& under& reducing& condition& via& immunoblot.& The& immunoblots&developed& with& anti9SC,& anti9porcine& IgA& and& anti9J& chain& antibody& confirmed&
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that&these&7&lines&did&not&express&any&SC,&and&the&detected&assembled&antibody&is&composite&entirely&of&VHH9IgA&chains&and&the&J&chain&(Figure&5.10).&The&VHH9IgA&accumulation& in& all& the& 6& lines& was& reasonably& similar& (Figure& 5.10,& b).& The&accumulation& of& the& functional& complex& (ELISA)& seemingly& correlated&with& the&expression&of&J&chain&in&5&out&of&the&6&lines&examines&(Figure&5.10,&a&and&c),&the&line&dV3A10&showed&the&highest&amount&of&J&chain&being&expresses&(immunoblot9&Figure&5.10,&c)&but& in&comparison&had&lower&signal& for& functional&dIgA&in&ELISA&(Figure&5.10).&The&pattern&of&abundance&of&the&49glycosylation&bands&in&the&VHH9IgA&of&the&dV3A10&lines&was&not&similar&to&the&other&5&lines;&the&proportion&of&the&high& molecular& weight& bands& was& comparatively& more& in& this& line.& Though&speculative,& this& dissimilarity& might& have& an& influence& on& the& comparatively&lower&assembly&of&the&functional&dIgA,&in&plant&dV3A10.&&
&
Figure!5.10:!Characterising!the!dIgA!producing!seeds!for!assembled!functional!antibodies.!The&two&parameters& firstly& the&relative&accumulation&of& functional&assembled&dIgA&detected&via&anti9J& chain& ELISA& (a)& and& secondly& the& corresponding& accumulation& of& each& of& the& two&constituent& elements& i.e.& VHH9IgA& (b)& (detected&with& polyclonal& anti9porcine& IgA& serum),& and& J&chain&(c)&(detected&with&anti9J&chain&monoclonal&antibody)&as&determined&by&immunoblot&under&reduced&conditions&correlates&for&all&but&dV3A10.&The&two&elements&were&detected&from&the&same&immunoblot,&by&successive&stripping&of&the&previous&detection&antibody.&Each&lane&contains&10&µl&of& seed& extract&made& by& suspending& every&milligram& of& crushed& seeds& in& 100& µl& of& extraction&buffer&(i.e.&each&lane&is&representative&of&100&µg&of&seed&weight).&The&bands&were&separated&on&a&12%&SDS9PAGE,&prior&to&immunoblotting.&&
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Glycosylation! and! proteolitic! degradation! of! VHHHIgA! as! factors! affecting!
assembly!of!IgA)The&VHH9IgA&expressed&in&the&Arabidopsis&seeds&showed&the&presence&of&4&bands&under&reduced&condition&on&immunoblots&developed&with&anti9pig&IgA&polyclonal&antibodies.&The&relative&abundance&of&each&of&the&4&bands&differed&from&plant&to&plant,&but&was&invariably&present&in&all&the&transformants&irrespective&of&the&co9expression&of&the&SC&and,&or&the&J&chain.&In&light&of&previous&knowledge&of&in&seed&expression&of&IgG&antibody&like&construct&(Loos!et!al.,&2011a;&Loos!et!al.,&2011b;&Van&Droogenbroeck!et!al.,&2007),&these&4&functional&(Supplementary&Figure&5.S5)&bands&could&either&be&the&result&of&differential&glycosylation&or&the&proteolytically&truncated&version&of&the&intact&protein.&Our&results&as&elaborated&below&suggest&that&both&of&these&reasons&might&contribute&to&the&observed&4&bands.&&The& IgA& heavy& chain& is& heavily& glycosylated& and& bears& both& N–linked& and& O9linked& glycans& in& natural& system,& as&well& as&when& recombinantly& expressed& in&mammalian&and&plant&systems&(Karnoup!et!al.,&2005).&The&N9linked&glycosylation&prediction&of&the&VHH9IgA&sequence&assigned&two&asparagine&residues&N147&and&N346&as&putative&N9linked&glycosylation&sites&(supplementary&Figure&5.S2)(Gupta!
et! al.,& 2004).& The& homologous& position& of& the& N346& residue& is& conserved& in&humans,&gorilla,&gibbon&and&orangutan;&this&residue&is&suggested&to&bear&N9linked&glycosylation& in& these& species& as&well& (UniProt& accession& no.& P01876& (human);&P20758&(gorilla);&H9HA31&(gibbon);&A2NVA6&(orangutan);&N.B.&position&of&N346&in& VHH9IgA& is& identical& to& N340& in& primate& sequence& analysed).& On& the& other&hand,& the& O9linked& glycosylation& prediction–& Net909glyc& software& indicated& a&threonine&residue&in&the&framework&region&4&of&the&VHH&to&be&a&putative&O9linked&glycosylation& site& (supplementary& Figure& 5.S2).& The& O9linked& glycosylation& in&plants& like&other&eukaryotes& takes&place& in& the&Golgi&apparatus.&Since& the&VHH9IgAs&were&KDEL& tagged& for&ER& retention,&no&O9linked&glycosylation&was& ideally&anticipated.& Thus& the& net& putative& sites& for& glycosylation& should& ideally& be& just&the& two&asparagine&residues&bearing&N9linked&glycosylation.&The&given&possible&permutation& of& glycosylation& at& these& sites,& would& explain& occurrence& of& three&aberrant&bands&but&not&4&bands&as9&one&with&no&glycosylation,&the&other&with&one&site& being& glycosylated& while& the& third& high& molecular& weight& band& bearing&glycans&at&both&asparagine&residues.&Glycoprotein&staining&of&these&4&bands&with&
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Periodic& acid9Schiff’s& reagent& (Kapitany& and& Zebrowski,& 1973),& indeed& showed&that& only& two& of& the& high&molecular& weight& VHH9IgA& bands& were& glycosylated&(Figure&5.11),&while&the& lower&two&bands&(counter&stained&with&Coomassie)&did&not&seem&to&bear&any&glycan.&&
&
Figure! 5.11:! Glycosylation! analysis! of! the! seed! made! IgAs.! Panel& ‘a’& shows& the& result& of!periodic& acid& Schiff& (PAS)& stained& gel& with& purified& sSIgA& and& dIgA& antibodies& from& the& sSIgA&expressing&T3&seeds&of& the& line&sV3A4091,&and&T3&seeds&of&dIgA&expressing& line&dV3A3891& (see&label& on& gel)& as& compare& to&wild& type& (WT)& seed& extract.& Of& the& 4& VHH9IgA& bands& (~50kDa& to&~37kDa),& the&upper& two&bands&were& stained&pink&with&PAS,& indicating& the&presence&of& glycans&(pink&arrows),&while&the&lower&two&bands&(counter&stained&with&Coomassie)&were&unglycosylated&(black& arrows).& The& bar& indicates& the& porcine& secretory& component& (~75&KDa)& in& purified&sV3A4091&seed&extract,&which&is&also&glycosylated&(a).&The&PAS&staining&results&(a)&were&affirmed&by&endoglycosidase&analysis&with&PNGase&F&and&Endo&H&of&the&same&purified&sIgA&antibodies&from&T3& seed& extract& of& sV3A4091& shown& in& panel& ‘b’,& where& the& 4& VHH9IgA& bands& (black& arrows&labeled& i,& ii,& iii,& iv)& on& cleaving& of& glycans& reduce& to& two& bands& (iii,& iv).& The& immunoblot& was&developed&with& anti9porcine& IgA& polyclonal& antibody& conjugated& to&HRP.& In& both& the& panels& ‘a’&and&‘b’&the&proteins&were&separated&by&a&12%&SDS9PAGE.&&On& endoglycosidase& digest& with& PNGase& F& and& Endo& H& (which& excises& the& N9linked&glycans&by&specifically&cleaving&of&at& the&beginning&of& the& first&GlcNAc&or&between& the& first& and& second& GlcNAc,& respectively)& the& high&molecular& weight&bands& were& reduced& to& the& molecular& weight& of& two& lower& bands;&consequentially& the& abundance& (signal& intensity)& of& the& lower& two& bands&increased& (Figure& 5.11& and& supplementary& Figure& 5.S3).& This& reconfirms& that&only&the&two&high&molecular&weight&proteins&are&glycosylated,&and&they&bear&N9
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linked& glycans.&However& this& only& partially& explains& the& 4& different& bands.& The&two& lower& molecular& weight& bands& with& excised& N9linked& glycans& could& have&different&molecular&weight&perhaps&due&to&truncation&of&the&terminal&peptide&by&proteases.&Or& the& third&band&(indicated&as&band& iii,& in&Figure&5.11)&still&harbors&glycans&with&antennary&structures&that&were&inaccessible&to&PNGase&F&or&Endo&H.&On&comparing&the&shift& in&signal&intensity&as&the&measure&of&relative&abundance&before& and& after& endoglycosidase& treatment& (Figure& 5.11& and& supplementary&Figure&5.S3),&it&seems&that&most&of&the&high&molecular&weight&sugar&bearing&VHH9IgA& is& converted& to& the& lowest&molecular& weight& (~37& kDa,& band& iv,& in& Figure&5.11),&while& the& accumulation& of& the& third& band& (band& iii,& in& Figure& 5.11)& only&marginally&increases.&Further&detailed&analysis&of&the&glycans&with&sensitive&tools&based& on& mass& spectrometry& will& help& in& unraveling& the& post9translational&modification&in&these&VHH9IgAs;&and&further&the&C9terminal&end&sequencing&will&help& in& exploring& the& truncation& hypothesis.& Our& preliminary& analysis& of& the&nature&of&the&glycans&shows&that&the&glycans&on&the&VHH9IgAs&are&predominantly&of& the& high& mannose& type& (relative& abundance=& Man7>& Man8>& Man5)&(supplementary&Figure&5.S4).&All&the&above&glycosylation&analysis&was&done&with&SSL7& (Staphylococcus! aureus& superantigen9like& protein& 7)& affinity& purified& IgAs&from&sV3A40&seeds,&in&which&the&4&bands&could&be&well&distinguished,&and&hence&easily&analyzed.&The&glycosidase&analysis&of&V2A&and&V3A&lines&seem&to&suggest&that&there&might&be&differences&in&glycosylation&correlated&with&the&different&VHH&fused& with& porcine& IgA,& however& this& would& also& need& to& be& analyzed& by&sophisticated&tools.&The&glycosylation&of&proteins&plays&an&important&part&in&its&in!
vivo&stability&and&maintenance&of&tertiary&structure&(Loos!et!al.,&2011a);&it&is&likely&that&the&variable&glycans&on&VHH9IgAs&might&influence&the&assembly&of&the&sSIgA.&Nevertheless,& the& glycosylation& of& IgA& is& necessary& for& its& efficacy& and& stability&against&proteases&in!vivo&(Corthésy&and&Spertini,&1999).&Unraveling&of&the&glycan&structures& will& help& in& further& optimizing& and& engineering& of& glycans,& which&might&lead&to&attaining&higher&amount&of&assembled&and&functional&sSIgA.&&Along&with& glycosylation,& the&proteolytic& cleavage& also&has& consequential& effect&on&the&accumulation,&assembly&and&functionality&of&the&antibody.&Seed&tissue&due&to& its& lower& protease& activity& is& often& suggested& as& a& suitable& tissue& choice& for&production&of&heterologous&proteins&in&plants&(Lau&and&Sun,&2009;&Muntz,&1998).&
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However,&specific&protease&activity&is&indeed&seen&in&seeds&and&is&also&suggested&to& bear& a& relation& with& the& glycosylation& along& with& the& amino& acid& sequence&(Loos! et!al.,&2011a;&Loos! et!al.,&2011b;&Van&Droogenbroeck! et!al.,&2007).&Within&the&VHH9IgA,&we&observed&substantial&amount&of&proteolytically&cleaved&VHH9IgA&fragments& (Figures& 5.8,& 5.9,& 5.10& and& 5.11)& and& the& total& amount& of& these&cleaved/degraded&protein&was&almost&equal&to&the&level&of&accumulation&of&the&4&VHH9IgA&bands& in& total& (supplementary&Figure&5.S3,& see&area&under& the&curve).&From& the& molecular& weight& of& the& fragments& determined& under& reducing&conditions&it&seems&that,&the&cleavage&results&in&removal&of&about&7915&kDa&mass&from&the&terminal&ends&(perhaps&N9&or&C9terminal)&of&the&intact&VHH9IgA.&&&
&
Figure! 5.12:! Visualisation! of! complexes! under! nonHreducing! condition.! The& sIgA& (sV4A7,&sV3A40& and& sV2A8)& and& dIgA& (dV2A42,& dV2A14& and& dV1cA27)& seed& extracts& were& separated&under&non9reducing& conditions&on& a&7%&SDS9PAGE&and& immunoblotted.&The& same& immunoblot&developed&with&polyclonal&anti9porcine&IgA&(top)&and&with&monoclonal&anti9porcine&SC&(bottom)&successively& after& stripping& the& previous& detection& antibodies& is& shown.& The& dimeric&mIgA& (80&kDa),&the&suggested&60&kDa&alternative&versions&of&mIgA,&the&probable&dIgA&and&sSIgA&bands&are&indicated&by& the&cartoon&next& to& the&arrow.&WT&stands& for&wild& type&control& seed&extract&while&defatted&swine&milk&was&used&as&comparative&reference.&&&&&
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Under& non9reduced& condition,& the& VHH9IgA& dimers& of&~80& kDa& and& another& of&~60&kDa&were&seen&(Figure&5.12).&The&60&kDa&dimer&could&be&the&result&of&union&of& such&proteolytically& cleaved& fragments& (as& illustrated& in& the& cartoon&besides&the& gel& picture& in& Figure& 5.12).& Cleaving& of& the& anterior& VHH& bearing& portion&would&ideally&render&the&60&kDa&dimer&incapable&of&binding&to&the&antigen,&on&the&contrary&excision&of&the&tail&end&of&porcine&IgA&Fc&i.e.&the&constant&α3&domain&will&not& inhibit& its& antigen& binding& capacity.& In& theory,& the& latter& ‘Fc& tail& nibbled’&molecule&would&bind&to& the&antigen&with&similar&strength&as& the&bivalent&mIgA,&since& its& bivalency& resulting& of& the& disulphide& bond&within& the& hinge&would& be&intact.& However& such& a& molecule& with& truncated& C9terminal& end& would& not& be&able&to&assemble&into&dIgA&or&subsequently&form&sSIgA.&We&did&not&evaluate&if&the&~60&kDa&dimer&binds&to&the&antigen;&evaluation&of&this&should&be&feasible&with&a&FaeG&based&immuno9precipitation&assay.&
In!vitro!inhibition!of!the!pathogenic!F4+ETEC!to!gut!villous!enterocytes)The& merit& of& multivalent& sSIgAs& is& its& potential& to& agglutinate& and& cross9link&bacterial& pathogens& and& thus& prevent& their& attachment& to& the& cellular& receptor&and&avoid&establishing&infection&(see&immune&exclusion&Figure&5.1,&a)&(Ma!et!al.,&1990).&The&ELISA&based&screening&assured&selection&of&plant&lines&that&produced&assembled& antigen9binding& IgA& antibody& formats.& Further& we& evaluated& the&potential& of& the& seed&made& three& IgA& variants& in& inhibiting& the& live& pathogenic&F4+ETEC&bacterial&attachment&to&its&receptor&on&porcine&gut&villous&enterocytes,&
in!vitro.&All&the&IgA&antibody&formats&bearing&the&4&different&antigen&binding&VHH&(4VHH& x& three& IgA& formats)& were& effective& in& inhibiting& bacterial& attachment&(Figure& 5.13& shows& results& of& sSIgA& producing& seed& extracts).& This& test& being&semi& quantitative,& does& not& allow& the& quantitative& comparison& of& efficacy&between&the&mIgA,&dIgA&and&sSIgA.&Comparison&of&mIgA,&polymeric&IgA&and&SIgA&in& previously& published& literature,& states& that& the& only& difference& between& the&mIgA&and&the&dIgA&format&is&the&enhanced&avidity&in&the&latter,&due&to&increased&antigen&binding&valence.&While&the&efficacy&of&the&SIgA&and&dIgA&bearing&similar&number&of&antigen&binding&paratopes,&is&usually&the&same.&The&SC&does&not&add&to&the&net&avidity&effect&of&the&dIgA,&but&attributes&to&the&stability&of&the&complex&and&increases& it& retention& time& at& the& mucosal& surfaces& (Corthésy,& 2003;& Strugnell&
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and&Wijburg,& 2010).& In& addition,& the& glycan& of& the& SC& can& act& as& a& barricade& to&pathogens&by&competing&either&with&the&pathogen&or&the&mucosal&epithelial&cells,&for& example& glycosylated& SC& can& prevent& human& group& A& erythrocytes& from&agglutination&by&ETEC,&while&glycosylated&human&SC&competes&with&Clostridium!
difficile&for&the&toxin&A&receptor&on&human&epithelial&cells&(Corthésy,&2002;&Dallas&and&Rolfe,&1998;&Giugliano!et!al.,&1995).& It&would&be& interesting&to& investigate& if&the&plant&made&porcine&SC&plays&a&role&in&sSIgA&interaction&with&ETEC.&&
&&
Figure! 5.13:! Inhibition! of! bacterial! attachment! to! the! porcine! gut! villous! enterocytes! in)
vitro.&In&the&semi9quantitative&in!vitro&villous&binding&inhibition&test,&100&µl&of&seed&extract&made&from&4&collective&pools& (sV1A9p,& sV2A9p,& sV3A9p,& sV4A9p)&of&T3&seeds&of& sV1A,& sV2A,& sV3A&and&sV4A&expressing&lines&(similar&expression&level)&prevent&attachment&of&F4+ETEC&bacterial&cells&to&microvilli.& Seed&extract& from&a&T2& transformant&expressing&secretory&component&alone& (Sc)&did&not& inhibit& the& F4+ETEC& attachment,& nor& did&wild& type& (WT)& seed& extract;& both& of&which& show&attachment&of&bacteria&similar&to&phosphate&buffer&saline&used&as&negative&control.& (N.B:&All& the&seed&extracts&were&made&by&suspending&8&mg&of&crushed&seeds&in&200&µl&of&extraction&buffer).&&&
!
Quantification!of!antigen!binding!VHHHIgA!chains!within!the!selected!high!
expressing!mIgA,!dIgA!and!sSIgA!lines!The& in! vitro& efficacy& results& obtained& with& the& anti9F4+ETEC& sSIgA& antibody&formats,& paves& the& way& for& its& future& prophylactic& application.& Prior& to& which&quantification& of& the& functional& seed& made& IgA& antibodies& it& was& necessary& to&formulate&a& therapeutic&prophylactic&dose.&However& the&background&presented&
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by& the& 4& aberrant&VHH9IgA&bands,& the& degradation,& existence& of& bi9species& and&the&suggested&functional&truncates&of&VHH9IgA&Fc—&make&it&difficult&to&precisely&measure&the&functional&units,&hence&we&used&a&combination&of&quantifying&tools&for&measuring&the&functional&seed&made&anti9F4+ETEC&IgA.&
&&
!
Figure! 5.14:! Quantification! of! accumulation!
of!functional!IgA!units!among!the!sSIgA,!dIgA!
and!mIgA! expressing! plant.& The& table& shows&the&expression&levels&of&seed&produced&VHH9IgA&in& mIgA,& dIgA& and& sSIgA& lines,& determined& by&the&sum&of& the&4&VHH9IgA&bands&(37&kDa&to&50&kDa)& from& the& respective& immunoblots.&immunoblot& ‘a’& and& ‘b’& –& shows& the& T2& and& T3&mIgA& lines,& while& ‘c’& and& ‘d’& show& T2& and& T3&sSIgA&and&dIgA& lines& respectively.&However&we&estimated& that& only& 50%& of& this& total&accumulation&is&functional&i.e.&on&an&average&1%&of&total&soluble&protein&or&0.2%&of&seed&weight.&Each&lane&contains&8&µg&of&total&soluble&protein,&and& the& VHH9IgA& bands& were& detected& with&polyclonal& anti9Pig& IgA& serum.& (n.d.& stands& for&not&determined).&&&
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As& discussed& earlier,& the& basic& functional& units& are& the& antigen& binding& VHH&domains& and&multiple9valence& adds& to& its& avidity.&With& this& understanding& we&firstly& aimed& at& visualising& the& FaeG& (antigen)& binding& units& by& an&immunoprecipitation&assay&followed&by&immunoblot.&The&results&suggested&that&all&4&VHH9IgA&bands&within&the&expected&molecular&weight&of&37&kDa&to&50&kDa&recognised&the&antigen&(Supplementary&figure&5.S5)&i.e.&these&4&aberrant&bands&in&principle& were& functional.& We& measured& the& sum& of& these& 4& VHH9IgA& bands&expressed& in& all& the& IgA& format& producing& lines& (sSIgA,& dIgA& and& mIgA)& by&immunoblot,& in& comparison& to& the& affinity& purified& seed& made& antibody& or&purified&porcine& IgA& from&swine&serum&as&reference&standards.&Thus&evaluated,&the&average&accumulation&of&mIgA&in&the&T2&seeds&was&observed&to&be&about&0.5&%& of& seed& weight& (Figure& 5.14)& roughly& corresponding& to& ~2.5%& of& the& total&soluble&seed&protein.&Furthermore&the&accumulation&in&the&homozygous&T3&seed&stocks&raised&from&these&single&locus&mIgA&lines&was&also&measure.&Homozygous&seed& stocks& not& only& facilitates& the& upscaling,& but& also& the& accumulation& of&heterologous& protein& expressed& in& Arabidopsis& seeds& has& been& reported& to&increases& in& the&T3&homozygous&seeds&perhaps&due&to&doubling&of&gene&dosage&(De& Jaeger! et! al.,& 2002;& Van& Droogenbroeck! et! al.,& 2007).& Such& increase& in& T3&homozygous& line& producing& VHH9IgA&was& seen& only& in& one& line& by& a&marginal&increase&of&0.12%&of&seed&weight,&where&as& the&overall&average& in& the&T3&stock&was& about& 0.6& ±& 0.1%&of& seed&weight& (N.B.& 20%&of& Arabidopsis& seed&weight& is&protein).& There& were& also& instances& where& the& accumulation& barely& increased&from&T2&to&T3&homozygous&seeds&(mV1cA38,&in&Figure&5.14).&&The& accumulation& of& the& VHH9IgA& in& the& sSIgA& and& the& dIgA& lines& was& also&comparatively& similar& to& the& expression&measured& in& the&monomeric& VHH9IgA&lines&with&an&average&of&0.5%&accumulation&in&T2&seeds&and&an&increase&in&some&T3&homozygous&seed&stock&to&an&average&of&0.7%&or&0.8%&of&seed&weight&(Figure&5.14).&Thus&seemingly,&the&co9expression&of&the&J&chain&or&the&SC&did&not&have&any&significant&enhancing&effect&on&accumulation&of&the&VHH9IgA&of&V1A,&V2A,&V3A,&or&V4A&as&reported&by&Ma&et!al.&in&tobacco&produced&SIgA&(Ma!et!al.,&1995).&ELISA9based& quantification& of& each& of& these& functional& units& is& theoretically&possible&but&requires&that&each&of&the&respective&IgA&format&be&purified,&to&serve&
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as&standard&reference;&as&the&affinity&of&each&of&these&formats&with&different&VHH&at&their&antigen9binding&domain&is&different.&With&a&few&purified&mIgA&standards&we& evaluated& via& ELISA& that& only& half& of& the&measured& sum& of& the& 4& VHH9IgA&bands&is&functional.&Form&our&calculations&based&on&ELISA&and&immunoblot&data&we& estimate& that& the& overall& functional& IgA& in& the& oligomeric& pool& (sSIgA,& dIgA&and&mIgA)& is& about& 1%&of& the& total& soluble& protein,&which& is& 0.2%&of& the& seed&weight.&
Conclusion!!In& conclusion,& this& study& shows& for& the& first& time& that& a& simplified& version& of&secretory& IgA& (sSIgA)& can& be& produced& effectively& in& plants,& which& is& a& viable&expression& platform& for& recombinant& secretory& IgA& production& (Paul& and& Ma,&2011).& In& comparison& to& the& previously& produced& and& now& commercialised&CaroRx®& antibody& in& stably& transformed& tobacco& lines& by& successive& filial&crossing& (Ma! et! al.,& 1995),& our& co9transformation&method& is& fast.& Further& both,&our& 2PM9PCR& and& ELISA9based& approach& enable& screening& of& vast& amounts& of&primary& transformants& for& identifying& the& best& expressing& lines.& The& cloning&approach& utilised,& incorporating& database& sequestration& provides& an& example&that&synthesis&of&customised&recombinant&sSIgAs&can&be&attempted&for&different&species,& in& which& the& sSIgA& is& yet& uncharacterised.& The& in& seed& production,&together&with&prospects&of&oral& in& feed&delivery&would&makes&sSIgAs&particular&worth& evaluating& for& oral& mucosal& passive& immunisation& against& enteric&veterinary&diseases&(we&evaluate&this&possibility& in&Chapter&6).&Swapping&of& the&VHH& against& other& porcine& enteric& pathogens& can& be& done& conveniently& in& the&current&anti9F49VHH9IgA&construct.&Once&high&expressing&primary&transformants&for&the&new&VHH9IgA&are&identified,&it&could&be&crossed&with&the&porcine&SC&and&J&chain& expressing& lines& (porcine& SC& +& J& chain& expressing& T2& plants,& Figure& 5.7)&from& our& co9transformation& library,& for& future& convenience& of& producing&porcinised9&sSIgA&or&dIgA.&&Along&with&these&merits&our&results&show&that&there&is&a&window&of&opportunity&to& further& develop& and& optimise& the& seed& production& platform& for& maximum&production&of& sSIgA.&Our&current&estimates& is& that&only&about&50%&of& the&VHH9IgAs& expressed& are& functional,& and& of& the& 50%& the& ones& that& form& sSIgAs& and&
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Fusion!of!the!VHH!to!Pig!Fc!!The& IgAb& was& chosen& as& the& fusion& partner& for& production& of& VHH9IgA& based&antibodies.& The& entry& clones& were& made& as& described& for& VHH9IgG& fusion& in&Chapter&4.&Briefly,& the&codon&usage&within& the&native&sequence&of& IgAb& (derived&from&UniProt&accession&no.&U12594)&was&compared&to& that&of&Arabidopsis&seed&storage&proteins&and&was&manual&optimised.&The&first&V1A&fusion&was&chemically&synthesised&within&the&attB19attB2&Gateway&recombination&sites&in&the&following&5’& to& 3’& direction—& ‘EcoRI& restriction& site,& Kozak& sequence& (CCACC),& 2S2& seed&storage& signal& peptide& sequence,& VHH& V1fused& with& the& codon& optimised&sequence&of& IgAb,& a&KDEL&endoplasmic& retention& signal,& stop& codon&and&BamHI&restriction&site’.& In&a&Gateway&BP&reaction,& this&stretch&of&DNA&was&recombined&with& the& Gateway& Donor& plasmid& pDon221& (bearing& kanamycin& resistance)&according& to&manufacturers& instruction,&which& results& in& an& entry& clone,&which&was&named&pEV1A.&&For&cloning&of&other&three&anti9F4+ETEC&VHHs–&V2,&V3&and&V4&in&fusion&with&IgA&Fc&the&DNA&sequence&for&restriction&site&for&EcoRI&+&Kozak&sequence&+&2S2&seed&storage& signal& peptide& +& each& of& the& three& VHHs& was& chemically& synthesised.&Then& Using& the& EcoRI& and& the& BstEII& (located& in& framework4& of& all& VHHs)&restriction& sites,& the& VHHs& V2,& V3& and& V4& with& the& 2S2& signal& peptide& were&swapped&with& the& V1& from& entry& clone& pEV1A.& Thus,& Entry& clones& (E)& pEV2A,&pEV3A&and&pEV4A&were&made.&&
Porcine!J!chain!and!secretory!component!!The& amino& acid& sequence& of& the& porcine& J& chain& is& not& defined,& however& from&homology& based& search& as& compare& to& the& human& J& chain& (accession& no:&NP_653247)& within& the& porcine& EST& database& we& could& identify& the& J& chain&homologous& gene& from& the& cDNA& library& made& from& alveoloar& macrophages&(accession&no.:&AK231006).&This&gene&was&then&defined&as&porcine&J&chain.&Using&the& signal& peptide& predictor& (SignalP& 3.0)& the& signal& peptide& of& J& chain& was&identified& (Bendtsen! et! al.,& 2004)& and& replaced&with& the& signal& peptide& of& 2S2&Arabidopsis&seed&storage&protein.&Thereafter,&using&parameters&as&define&earlier&
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(Chapter& 4)& the& codon& usage& was& optimised& for& Arabidopsis& seed.& The& coding&sequence& for& the&endoplasmic& reticulum&retention&signal& (KDEL)&was&added&on&the&3’&end&(C9terminal&end)& followed&by&a&stop&codon,& this&DNA&was&chemically&synthesised&within& the&attB1&and&attB2&Gateway&sites,& and& the&Kozak&sequence&(nucleotides9& CCACC)& was& added& upstream& of& the& signal& peptide& during& this&process.& Further& via& Gateway& BP& recombination& reaction& this& construct& was&recombined& into& the&pDONR221&(kanamycin&resistance)& (according& to&Gateway&manual)&to&result&into&an&entry&vector,&which&was&called&pEJ.&Secretary&component&(SC)&is&the&resultant&product&of&proteolytic&cleavage&of&the&polymeric& immunoglobulin& receptor& (pIgR),& which& results& in& either& free& SC& or&associated& with& the& dimeric& IgA.& The& sequence& of& the& porcine& SC& was& derived&from& the& published& sequence& of& porcine& pIgR& (Kumura! et! al.,& 2000)(accession&no.:&NM_214159,&UniProt&accession&no.&Q9N2H7).&The&endogenous&signal&peptide&of&pIgR&was&determined&using&prediction& tool& (Bendtsen! et! al.,& 2004)& and& then&replaced&by&the&signal&peptide&of&the&Arabidopsis&2S2&seed&storage&proteins.&After&the& signal& peptide& the& first& 579& aa& length& spanning& until& the& 5th& domain&(corresponds&to&the&585&aa&of&human&SC)&was&selected&and&defined&as&porcine&SC.&The& nucleotide& sequence& of& this& porcine& SC& bearing& Arabidopsis& 2S2& signal&peptide& was& also& codon& optimised& as& described& above,& and& chemically&synthesised& with& attB1& and& attB2& flanking& sequences.& This& construction& was&cloned&in&the&multiple&cloning&site&of&pUC57,&and&then&later&recombined&in&a&BP&reaction& with& the& pDONR221& to& get& the& entry& plasmid& pESC& with& kanamycin&resistance&(in&accordance&to&the&Gateway&manual).&&
Gateway! recombination! into! destination! vector! and! Agrobacterium!
mediated!transformation!All&the&entry&clones&except&the&pEJ&were&recombined&via&an&Gateway&LR&reaction&into& the& destination& vector& pPhasGW& (Morandini! et! al.,& 2011)& following& the&Gateway& instruction&manual& (as& described& in& Chapter& 4).& The& T9DNA& of& which&bears& the& nptII& gene,& which& confers& for& kanamycin& resistance& in& plants.& The& 4&expression&clones& (X)&bearing& the&VHH9IgA& fusion&were&named:&pXV1A,&pXV2A,&pXV3A,&pXV4A&and&the&expression&plasmids&bearing&SC&was&called&pXSC.&&&
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To& facilitate& the& identification& of& co9transformed& plants,& the& entry& plasmid& pEJ&was& recombined& into& a& multisite& gateway& cassette& pBm43GW,0& the& T9DNA& of&which& bears& the& bar& gene& that& confers& for& phosphinothricin& (PPT)& selection&(Karimi! et! al.,& 2005).& According& to& Multisite& Gateway& instructions,& 3& entry&plasmids9&pEJ& (bearing& J& chain,&attL19L2),&pEPhas& (bearing&Phaseolin&promoter,&flanked&by&attL49attR1&(De&Wilde,&2012))&and&pEArc600&(3’&regulatory&sequences&bearing& arcelin& terminator,& flanked& by& attR29attL3& (De& Wilde,& 2012))& were&recombined&to&result&in&the&expression&plasmid&which&was&called&pMXJ.&&The&expression&plasmids&were&checked&by&restriction&digestion&sequencing&of&the&gene& of& interest& and& flanking& regions.& On& confirmation,& the& plasmids& were&transformed& into& Agrobacterium& strain& C58C1RifR& and& used& for& floral& dip&transformation& as& described& previously& in& Chapter& 4.& With& the& slight&modification,&To&produce&plants&expressing&a&complete&sSIgA&complex&(with&the&VHH9IgA& fusion,& the& J& chain& and& the& SC& chain)& three& Agrobacterium! strains&carrying&the&plasmids!pMXJ,&pXSC&and&one&of&the&plasmids&pXV1A,&pXV2A,&pXV3A&or& pXV4A;& each&were& inoculated& in& 20ml& YEB&medium&without& any& antibiotics&overnight& and& when& the& OD600& reached& about& 1.7;& 3.3& ml& of& each& of& the& three&cultures&were&mixed&together.&This&mixture&was&made&up&to&50&ml&with&dipping&solution& (10%& sucrose& and& 0.05%& Silwet& solution& in& water)& and& used& for& the&floral& dip& transformation.& For& each& of& the& 4& different& VHH9IgA& fusions& (the& 4&mixes:&V1A+SC+J;&V2A+SC+J;&V3A+SC+J;&V4A+SC+J)&ten&Arabidopsis!thaliana&(Col&0)& plants& were& transformed& to& produce& different& formats& of& IgA& antibodies&bearing&the&4&different&antigen&binding&domain.&&From&each&transformed&plant&1000&seeds&were&sown&on&kanamycin&bearing&MS&medium&and& the&primary& transformant&were& selected.& (for& detailed&protocol& of&sowing,& selection& of& primary& transformants& and& plant& growth& conditions& see&Chapter&4).&
Callus!Induction!for!selection!of!J!chain!positive!T1!transformants!from!coH
transformed!sSIgA!lines!The& callus& induction& test& was& used& to& determine& the& presence& of& the& J& chain&bearing& T9DNA& within& the& transformants& screened& positive& on& kanamycin&selection& plates& (SC& and/or& VHH9IgA& present).& The& plantlets& on& the& selection&
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plate&were&numbered&and&one& leaf&per&plant&was& taken& for& the&callus& induction&test.& The& plates&were& opened& in& a& laminar& flow& and& a& representative& leaf& from&each& numbered& plant,& was& cut& transversely& through& the& midrib& with& a& sterile&sharp&blade,& this& leaf&piece&per&plant&was& transferred& to&a&Petri&plate&with&grid&markings,& containing& callus& induction&medium&(4.308&g/l&Murashige&and&Skoog&salts,&0.5&g/l&MES,&30&g/l&sucrose,&pH&5.7,&with&0.7%&agar)&with&100&mg/ml&PPT,&MS&Vitamins,&0.1&mg/l&NAA&(19Naphthaleneacetic&acid)&(auxin)&and&1&mg/l&BAP&(69Benzylaminopurine)& (cytokine).&One& leaf&piece&was&placed&per& square& in& the&pre&marked&grid&of&the&Petri&plates&with&its&abaxial&surface&touching&the&medium.&Each& leaf&was&numbered&similar& to& its&parent&plant.&The& lids&of& the&Petri&dishes&were&sealed&with&porous&adhesive&tapes&(Milipore)&and&incubated&in&the&growth&chambers& at& 21°C& with& 16& hours& light& and& 8& hour& dark& photoperiod& (light&intensity&80&μE/m2/s).&At& the&end&of& three&weeks,&growth&of&healthy&callus&was&indicative&positive&for&bearing&J&chain&T9DNA.&Thus&perspective&dimeric&(4xVHH9IgA& +& J& chain)& and& sIgA& (4xVHH9IgA& +& J&chain& +& SC)& producing& lines& could& be&segregated&from&pool&of&kanamycin&resistant&T1&transformants&(VHH9IgA&and/or&SC).&
PCR! based! screening! of! the! SC,! J! chain! and! VHHHIgA! genes! in! coH
transformed!plants!!Cetyltrimethylammoniumbromid&(CTAB)&based&high&through&put&DNA&extraction&The& DNA& was& extracted& from& green& siliques& using& cetyltrimethylammonium&bromide& (CTAB)& method& modified& for& high9throughput& extraction& in& 969tube&micro9rack& format.& Each& tubes& was& filled& with& 2& steel& balls& of& 3&mm& diameter&each,& into& which& two& siliques& were& harvested.& Once& filled& the& entire& rack& was&snap&chilled& in& liquid&nitrogen&and& the& frozen&siliques&were&crushed& to&powder&using& the&mixer&mill& (MM4009Retsch)& at& 30& Hz& frequency& of& oscillation& for& 30&seconds.&The&rack&was&given&a&brief&spin&(eppendorf&centrifuge&95810&R&equipped&with&adapters&for&96&tube&multi&racks)&and&then&400&μl&of&extraction&buffer&(2&x&CTAB&buffer:&2%&w/v&CTAB,&100&mM&Tis9HCl&pH&8.0,&20&mM&EDTA,&1.4&M&NaCl&and&1%&w/v&polyvinylpyrrolidone)&was&added&and&vortexed&to&homogenise&the&crushed& material.& This& mixture& was& incubated& at& 37°C& for& 45& minutes,& cooled&down& to& room& temperature,& 400& μl& of& chloroform& was& added& mixed& by& brief&
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Screening! for! transformants! expressing! high! amount! of! functional!
antibodies:!The&protein&was&extracted&from&the&seeds&using&the&high&throughput&extraction&procedure,& the& protein& concentration& was&measured,& and& the& concentration& of&TSP& was& adjusted& to& 1& mg/ml& as& described& in& Chapter& 4.& Based& on& the& FaeG&immobilised& ELISA& set& up& the& seed& extracts& were& analysed& for& seeds& stocks&expressing&highest&amount&of&functional&antibody&as&described&in&Chapter&4,&with&the&exception&that,&for&detection&of&VHH9IgA&antibodies,&100&μl&of&the&polyclonal&anti9porcine& IgA& antibody& raised& in& goat& conjugated& to& HRP& (AbD& serotech&AA140P)&diluted&1/10,000&in&2%&skimmed&milk&was&used.&In&order&to&determine&the&presence&of&functional&dimeric&IgA&[4&x&(VHH9IgA)&+&J&chain]&and&sSIgA&antibodies&via&ELISA,&all&the&steps&until&seed&extract&addition&to&FaeG& immobilised&ELISA&wells&was& followed&(Chapter&4).&To&detect&dimeric& IgA&antibody,& the&anti9J& chain&monoclonal& antibody& (Thermo&scientific&MA1980527)&was& used,& diluted& 1/1000& in& 2%& skimmed&milk& in& PBS.&Whereas,& to& detect& the&secretory& sSIgA& antibody& [4&x& (VHH9IgA)& +& J& chain& +& secretory& component]& the&monoclonal& anti9pig& secretory& component& antibody& (Thermo& Scientific& MA1980544)&was&used.&The&primary&antibody&was&incubated&for&90&minutes&followed&by& 5& washes& (0.1%& Tween20& in& PBS).& The& secondary& antibody,& anti9mouse&polyclonal&made& in& sheep& conjugated& to&HRP& (Amersham&Bioscience,& NA931V)&was&used,&diluted&1/5000&in&2%&skimmed&milk&in&PBS,&the&plate&was&incubated&at&room&temperature&for&1&hour.&Thereafter,&the&plate&was&washed&and&100&μl&of&the&substrate&TMB&was&added& into& each&well.&After& incubation& for&30&minutes&blue&colour& developed,& which& was& read& at& 640& nm,& using& the& VERSAmax& tunable&microplate&reader&(Molecular&Devices,&USA).&From&the&optical&density&measured&
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at&640&nm&the&plants&were&ranked&according&to&the&expression&level&for&dimeric&or&secretory& IgA.&These&plant&extracts&were& then&analysed&using&SDS&PAGE&and&immunoblot&techniques&as&described&in&Chapter&4&and&(De&Buck!et!al.,&2011).&&Polyclonal& anti9porcine& IgA& antibody& raised& in& goat& (AbD& serotech& AA140P)&diluted& 1/4000& in& 2%& skimmed&milk&were& for& detection& of& VHH9IgA& chains.& In&case&of&J&chain&detection,&the&primary&antibody,&anti9J&chain&monoclonal&antibody&(Thermo&scientific&MA1980527)&diluted&1/4000&was&used;&while&for&SC&detection&monoclonal& anti9pig& secretory& component& antibody& (Thermo& scientific& MA1980544)&was&used&diluted&1/2000.&The&secondary&anti9mouse&polyclonal&made&in&sheep& conjugated& to& HRP& (Amersham& Bioscience,& NA931V)& was& always& used&diluted&1/4000&in&2%&skimmed&milk.&&The& commassie& stained& gels& and& immunoblots& were& documented& using& the&ChemidocTM& system& (Biorad);& and& using& the& Image& Lab& software& the& protein&bands& were& quantified& using& affinity& purified& V2A& antibody& (from& V2A17& T2&seeds)&or&purified&IgA&from&swine&milk&as&reference.&&




Affinity!purification!of!seed!produced!antibodies!For& purification& of& VHH9IgA& and& all& IgA& antibody& formats& the& Staphylococcus!
aureus&superantigen9like&protein&7&(SSL7)/Agarose&resin&(InvivoGen)&was&used,&either&5&cm&long&columns&were&hand9packed&then&plugged&into&AKTA&system&or&the& proteins& were& purified& via& batch& system,& depending& upon& the& quantity& of&purified& antibodies& desired.& In& principle& the& resin& was& washed& and& then&equilibrated& with& the& binding& buffer& pH& 8& and& then& the& protein& extract& was&applied& to& it,& the& unbound& proteins& were& washed& away& with& PBS.& The& bound&antibodies& were& eluted& by& changing& the& pH& with& 0.1& M& glycine& buffer& pH& 3.&Immediately&after,&the&column&and&the&eluted&fraction&was&neutralised&with&1&M&Tris&pH&7.2.&The&resin&was&stored&in&20%&ethanol&in&PBS.&
Piglet!villi!binding!inhibition!test!The&villi&binding& inhibition&test&was&performed& in&accordance&to&Coddens!et!al.,&2009&(also&see&Chapter&4).&&





Supplementary! figure! 5.S1:! Amino! acid! sequence! of! the! porcine! polymeric!
immunoglobulin! receptor.! The& sequence& of& the& porcine& SC,& spanning& the& 5& extracellular&domains&is&underlined,&the&native&signal&peptide&is&bold&face,&the&predicted&N9Link&glycosylation&sites&within& the&extracellular&domain&are&bold& faces& in&red&and&the&amino&acid&count&per& line& is&indicated&in&square&brackets&at&the&end&of&the&line.&&&&&
&&Supplementary!figure!5.S2:!Amino!acid!sequence!of!the!V2A!as!representative!of!the!antiH





sV3A40-1 + PNGase F 
sV3A40-1 + EndoH &&&
Supplementary!Figure!5.S3:!Alternative! representation!of! the!mobility! shift! assay,&where&the&intensity&of&the&signal&of&each&band&is&plotted&on&the&graph&above&it,&and&shows&the&shift&in&the&intensity&of&the&signal&from&first&and&second&glycosylated&band&(i&and&ii)&predominantly&to&the&4th&band&(iv).&The&total&amount&of&degradation&is&roughly&equivalent&to&the&total&accumulation&of&the&4&bands&of&VHH9IgA&(area&under&the&curve).&&&&
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Supplementary!figure!5.S5:!FaeG!binding!VHHHIgA!fragments.!The& antigen& FaeGac& covalently& linked& to& agarose& beads& was& used& to& determine& the& antibody&fragments&that&bind&the&antigen,&it&was&seen&for&several&lines&that&all&of&the&4&VHH&bands&between&the&molecule&weights& of& 37& and& 50& kDa& detected& by& anti9pig& IgA& antibody& bind& to& the& antigen&FaeG.&Representative& results& from& two&plant& lines& have& been& shown& (labelled& FaeG9binding)& in&comparison&to&the&VHH9IgA&expressing&seed&extract&(labelled&seed&extract).&&&&&&&&&&
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Abstract:!F4& fimbriae& bearing& enterotoxigenic& Escherichia! coli! (F4+ETEC)! caused& post9weaning&diarrhoea&is&one&of&the&most&important&causes&of&heavy&economic&losses&to&the&global&porcine&rearing& industry.&With&the&ban&on&traditional&prophylactic&use&of&antibiotics& in&several&countries,& there& is&a&desperate&need& for&alternative&prophylaxis& against& F4+ETEC& infection.&Of& the& several& alternatives,& oral& passive&immunisation&with&anti9F4+ETEC&antibodies&has&been&by&far&the&most&promising.&So& far& the& anti9F4+ETEC& antibodies& were& sourced& either& from& animal& plasma&proteins& or& from& immunised& hen& eggs.& The& issues& of& safety& and& consistency& of&anti9F4+ETEC& from&pig&blood&and& the&high&cost&of&producing&antibodies& in&eggs&has&limited&their&widespread&use.&&&As&a&solution,&we&previously&developed&anti9F4+ETEC&antibodies& in&the&seeds&of&the&model&plant&Arabidopsis! thaliana& to&evaluate&a& cost&effective&alternative& for&specific& anti9F4+ETEC& oral& prophylaxis.& These& seed& produced& anti9F4+ETEC&antibodies& were& functional& in& preventing& F4+ETEC& bacteria& attachment& to& gut&villous&enterocytes,&in!vitro.&In&this&study&we&evaluate&the&in!vivo&efficacy&of&these&seed&produced&antibodies& to&protect& against&F4+ETEC&challenge&on&oral& in9feed&antibody&administration.&These&seed&produced&antibodies&were&custom&designed& for& in9feed&oral&passive&immunisation.& This& customisation& was& achieved& by& using& the& antigen& binding&‘variable& domains& of& heavy& chain& only& antibodies’& (VHH)& from& lama,&which& are&known& to& be& robust&molecules.& VHHs& selected& against& the& F4+ETEC& from& lama&immune&library&were&grafted&on&to&porcine&Fc&and&expressed&in&seeds.&By&fusion&to&porcine&IgG3&Fc&and&IgAb&Fc,&two&basic&formats&i.e.&VHH9IgG&and&VHH9IgA&were&produced.&Further&by&co9expression&of&porcine&J&chain&and&secretory&component&dimeric&and&secretory&IgA&like&antibodies&were&made&from&the&VHH9IgA.&Overall&4& plant& lines& expressing& different& VHH9IgG& and& 12& lines& expressing& different&formats& of& VHH9IgA& antibody& were& scaled& up,& and& the& respective& seeds& were&pooled&to&form&two&oligomeric&cocktails&of&each–&VHH9IgG&and&VHH9IgA.&&From& the& two& oligomeric& pools,& three& prophylactic& feeds& were& formulated&namely:& VHH9IgA920,& VHH9IgG920,& VHH9IgG980& such& that& a& daily& intake& of& 300&
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grams&of&feed&per&pig&would&administer&20&mg&of&oligomeric&cocktail&of&VHH9IgA&or&20&mg&of&VHH9IgG&or&80&mg&of&VHH9IgG&antibodies,&respectively.&The&efficacy&of& these& 3& feeds&was& evaluated& together&with& negative& control& feed& containing&wild&type&Arabidopsis&seeds,&on&challenge&with&pathogenic&F4+ETEC.&&Shedding&of&bacteria&was&seen& in&piglets&of&all& the&4&groups,&however& in&case&of&VHH9IgA920&group&the&shedding&declined&progressively&every&day&and&reduced&to&below& detection& levels& by& day& 4.& VHH9IgG920& group& also& had& swift& decline& in&bacterial&shedding,&however&it&was&detected&post9mortem&that&2&of&the&3&piglets&in&this&group&were&insensitive&to&F4+ETEC&since&they&had&low&F4&receptors&(F4R)&hence& the& protection& of& VHH9IgG920& feed& would& have& to& be& re9evaluated& in& a&prospective& study.& While& within& the& piglets& of& the& VHH9IgG980& feed& group&shedding& of& challenge& bacteria& until& the& end& of& the& experiment& till& day& 11&was&observed,& and& thus& VHH9IgG980& failed& to& protect.& The& seroconversion& also&corroborated&the&shedding&profile;&piglets&of&the&VHH9IgA920&had&a&lower&rate&of&seroconversion&than&the&negative&control&or&the&VHH9IgG980&group.&&The&effect&of&VHH9IgG920,&and&the&reason&for&ineffective&VHH9IgG980&needs&to&be&further& investigated.&While& the&VHH9IgA920& seems& as& a& promising& prophylactic&solution& to& the& F4+ETEC& caused& PWD.& In& future,& it& would& be& interesting& to&produce&VHH9IgA&antibodies&in&crop&seeds,&that&can&be&conveniently&scaled&up&to&evaluate&prophylaxis&in&a&piglet&field&trial.&&





et! al.,& 1992).&Opportunity& of& oral& delivery& in& feed& is& particularly& interesting& for&large9scale& porcine& rearing& industry.&We& envisage& that& oral& delivery& of& in9feed&produced&passive&immunity&during&the&critical&stress&window&period&for&about&a&week&or&2&post9weaning&may&prevent&F4+ETEC&infections.&A& few& years& ago& Harmsen& et! al.& (2005)& isolated& novel& VHH& against& F4+ETEC&bacteria& for& oral& passive& immunization& with& the& understanding& that& VHHs& are&robust&antibody&fragments.&In&spite&of&the&group’s&promising& in!vitro&results&the&VHH&passive&immunotherapy&failed&to&offer&any&protection&in!vivo.&They&reasoned&that& failure& to& protect& in! vivo& could& be& due& to& proteolysis& of& VHH& in& the&gastrointestinal&tract&among&other&reasons&(Harmsen!et!al.,&2005).&Evidently,&oral&passive& immunization&though&is&an&apt&route&for&attaining&passive&protection&at&the&mucosal&surface,& it& is&only&guaranteed&by&antibodies& that&can&withstand&the&transit& through& the& harsh& gastric& environment& and& be& functional& at& the& site& of&infection&which&for&F4+ETEC&is&the&small&intestine&(Reilly!et!al.,&1997).&&Oral& in& feed&delivery&of& in&seed&produced&antibodies,&which&are&retained&within&the&endomembrane&system,&in&theory&enable&protective&bio9encapsulation&(Khan!
et!al.,&2012).&However&their&release&from&the&feed&matrix,&in&the&elementary&canal&and& functionality& there& after& needs& to& be& experimentally& evaluated.& With& this&rationale,& we& expressed& anti9F4+ETEC& VHH9IgG& Fc& and& VHH9IgA& Fc& fusion&antibodies&in&seeds&of&the&model&plant–&Arabidopsis!thaliana.&Aiming&to&produce&robust& antibodies&with& capacity& to&withstand&gastric&denaturation&we&designed&novel& chimeric& ‘porcinised9lama’& antibodies.& From& an& immunised& lama& library,&four&F4&fimbriae&binding&variable&domains&of&heavy&chain&only&antibodies&(VHH)&were& carefully& selected& and& grafted& on& to& porcine& Fc& region& (fragment&crystallisable&region)&of&IgG3&or&IgAb&chains.&In&seed&expression&of&the&VHH9IgG&Fc&fusion& led& to& production& of& 4& divalent& antibodies,& namely:& V1G,& V2G,& V3G& and&V4G.&Building&further&on&the&similar&strategy,&by&VHH9IgA&fusion&we&produced&4&divalent&IgA&like&antibodies&(mV1A,&mV2A,&mV3A&and&mV4A).&Further&along&with&the& VHH9IgA& construct,& co9expression& of& Joining& chain& (J& chain)& and& porcine&secretory&component&(SC)&in&seeds,&tetravalent&dimeric&(dV1A,&dV2A,&dV3A&and&dV4A)&antibodies&with&VHH9IgA&+&J&chain;&and&secretory&IgA&(sV1A,&sV2A,&sV3A&
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and&sV4A)&antibodies&with&VHH9IgA&+&J&chain&+&SC&were&made.&&All& the& seed9produced& fusion& antibodies& prevented& bacterial& binding& to& gut&villous& enterocytes& in! vitro& (Chapter& 4& and& 5).& While& in! vitro& results& are& an&important&primary&step&towards&therapeutic&development,&in&the&long&course&of&drug&development,&they&need&to&be&evaluated&for&in!vivo&functionality.&Hence&we&evaluated& in& an& in! vivo& feed9challenge& experiment& the& potential& of& Arabidopsis&seed9produced&fusion&antibodies&in&preventing&F4+ETEC&bacteria&from&colonizing&the&small&intestine.&
Results!and!Discussion!
Optimisation!of!the!feedHchallenge!experiment!The&experimental&disease&model&as&described&by&Cox&et!al.&for&evaluation&of&anti9F4+ETEC& immunotherapeutic& upon& challenge& requires& fasting& period& and&deprival& of&water& before& inoculation& of& the& bacteria& via& intragastric& intubation&(Cox!et!al.,&1991).&This&model&ensures&experimental&infection&of&each&animal,&and&has&been&used&in&several&mucosal&vaccination&experiments&(Van&den&Broeck!et!al.,&1999a;&Van&den&Broeck!et!al.,&1999b;&Verdonck!et!al.,&2004b)&including&evaluation&of&in!planta&produced&FaeG9based&vaccine&to&prevent&F4+ETEC&infection&(Joensuu!





pig&intestine&after&experimental&F4+ETEC&infection.&Lactose& in& varying& concentration& can& be& found& in& almost& all& commercially&available&starter9feed,&and&is&highly&preferred&since&it&increases&the&palatability&of&starter9feed& during& transition& from&milk& to& solid& feed& and& benefits&weight& gain&(O'Doherty! et! al.,& 2004;& Pierce! et! al.,& 2004).& Since& pure& lactose& is& expensive,&commercially& whey9premixes& are& available& as& cheap& source& of& lactose.& Such&whey9premix&contains&up&to&6%&whey&powder&and&other&essential&vitamins.&Our&
in! vitro& analysis& of& such& a& commercial& whey9premix& showed& that& increasing&concentration&of& this&premix&higher& than&2.5%&has&an& inhibitory&effect&on&F4ac&fimbriae&binding& in&ELISA&with& immobilised&mucus& receptors,&while& 1%&whey9premix& solution& completely& inhibits& any& bacterial& binding& to& its& villous&enterocyte& receptor& in& an& in! vitro& villous& adhesion& test& (Figure& 6.1,& a& and& b).&Comparatively,& the& basic& feed,& devoid& of& any& whey9premix& does& not& present&similar& inhibitory& effect& and& only& marginally& influences& the& anti9F4& antibody&interaction& with& F4& fimbriae& at& 10%& feed& solution,& which& is& the& highest&concentration&tested&(Figure&6.1,&a).&&
&&
Figure!6.1:! In)vitro! inhibition!of!whey!containing!premix! in!comparison! to!basic! feed.!As&compared&to&soluble&extracts&made&from&basic&feed&without&lactose&source,!soluble&extracts&made&from&whey&(as&lactose&source)&containing&premix&inhibits&the&F4&fimbriae&interaction&with&anti9F4&antibody& in& a& competitive& ELISA& (a).& The& extracts& from&whey& containing& premix& even& prevent&F4+ETEC&attachment&to&villous&enterocytes&(b).!!
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!In&the&villous&binding&test&as&well,&the&basic&feed&without&lactose&was&about&75%&less& effective& in& preventing& bacterial& attachment& (Figure& 6.1,& b).& Though& field&experiences& differ;& as& addition& of& lactose& or& whey& does& not& inhibit& bacterial&infection&and&onset&of&diarrhoea&(Fairbrother!et!al.,&2005),&our&in!vitro&evidence&of& molecular& interference& of& whey9premix& cannot& be& discounted& while&establishing& a& feed9challenge& experimental& model.& Thus& with& an& aim& to& have&controlled& and& standardised& infection& (relatively& similar,& reduced& variation)&without& deprival& of& food& and& water& prior& to& challenge,& the& following&modifications&were&tested.&&
The!in)vivo!effect!of!two!different!basic!feed!formulations–!!
Feed! with! and! without! lactose! were! evaluated! in! combination! with! two!




commercial& feed& was& used& as& basic& feed& in& which& antibody& producing&Arabidopsis&seeds&were&added&to&formulate&the&prophylactic&treatment&feed.&&
&
Figure! 6.2:! Optimisation! of! feed! and! challenge! regimen! by& comparison& of& the& F4+ETEC&shedding& profile.! The& error& bars& represent& standard& deviation& within& the& experimental&population.&&
Palatability!of!Arabidopsis!seeds!in!piglet!diet!Feed& ingredients& influence& the& taste,& smell,& digestibility& and& thus& the& general&acceptance& and& palatability& of& a& particular& feed& formulation.& Addition& of&flavouring& agents& is& suggested& to& influence& the& feed& intake& and& a& preferred&pleasant& flavour& also& eases& the& transition& from&milk& to& solid& feed16.&Along&with&the& flavour,& the& basic& feed& composition,& primarily& the& protein& (followed& by&minerals)& concentration,& influences& the& feed& to& weight& gain& conversion& ratio&(FCR)&(feed&conversion&ratio&=&mass&of& feed&consumed&/&body&mass&gain& in& the&given& period& of& time)& which& is& an& important& parameter& for& judging& the& feed&influence&on&economic&profit&margin&(Heo!et!al.,&2012;&Kim!et!al.,&2012;&Sola9Oriol!
et!al.,&2011).&Moreover&in&case&of&in9feed&administration&of&a&therapeutic&protein,&an& increase& or& decrease& in& the& palatability& and& acceptance& of& the& feed& can&influence&the&final&dose&of&the&therapeutic&protein&administered.&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&16&Vande&Ginste&J.&“Palatability&improves&young&piglets’&feed&intake”&(http://alturl.com/rx6g6)&&&&
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To&the&best&of&our&knowledge&the&palatability&of&Arabidopsis&seeds&in&piglet&feed&has& never& been& assessed,& possibly& since& apart& from& being& a& model& plant& for&studying& plant& biology& Arabidopsis& is& regarded& as& a& weed.& Arabidopsis& seeds&have&about&40%&crude&fat,&20%&crude&protein;&and&to&human&olfactory&senses&the&seeds& have& no& strong& odour& but&milled& Arabidopsis& seed& flour& bears& a& peanut&butter9like&scent.&We&noticed&that&addition&of&10920%&of&Arabidopsis&seed&flour&(premixes)&to&piglet&basic&feed&also&changes&the&colouration&of&the&piglet&feed&to&a&darker&shade&of&brown&however&these&effects&diluted&out&at&higher&dilution&(~2%&inclusion&rate).&&
Table!6.1:!Arabidopsis!seed!(wild!type!seeds)!flour!at!2%!inclusion!rate!in!
piglet!feed!was!observed!to!be!palatable!
  Daily average feed intake (in grams) 
Total weight gain 
in 6 days (in kg) 
Feed to weight 
conversion ratio (FCR) 
  Day 1 Day 2 Day 3 Day 4 Day 5 Day 6   
Starter feed without wild type 
Arabidospsis seeds  380 ± 40 405 ± 40 475 ± 70  530 ± 80  640 ± 100  0.700 ± 40  2.850 ± 0.29 1.10 ± 0.04 
Starter feed with wild type 




accepted& the&Arabidopsis& containing& feed.&The&FCR&was&within&1.3,&which& is& an&average&standard&FCR&reported&for&different&feeds&for&piglets&at&this&age17.&These&two& factors& encouraged& the& use& and& further& evaluation& of& transgenic& antibody&producing&Arabidopsis& seeds& in&piglet& feed,&without& the& requirement& of& special&feed&flavouring&or&nutritive&ingredients&to&maintain&its&palatability.&&
FeedHchallenge!experiment:!evaluation!of!protection!conferred!by! in!seed!
made!antiHF4+ETEC!fusion!antibodies!on!experimental!challenge!From&the&previous&results&we&demonstrated&that&all&formats&of&in&seed&produced&anti9F4+ETEC& antibodies& i.e.& VHH9IgG& in& its& monomeric& and& VHH9IgA& in& its&monomeric,& dimeric9tetravalent& and& in& sSIgA& formats& are& functional& in! vitro!(Chapter&4&and&5).&These&antibodies&were&designed&and&produced&in&plants&with&an&aim&to&protect&upon&oral&passive&immunisation&against&F4+ETEC&related&PWD.&We& evaluate& this& fitness& and& functionality& of& the& seed& produced& antibodies& on&oral& administration& in& the& in! vivo& optimised& feed9challenge& experiment.& We&evaluated&both&the&antibody&formats&VHH9IgG&and&VHH9IgA&in&their&own&merit&by&using&an&oligomeric&cocktail&of&each.&&To& select& the& treatment&dose& for& therapeutic& feed& formulation,& our& calculations&were& drawn& from& the& previous& results& of& De& Geus& et! al.& (1998)& where& in& a&neonatal& challenge& model& they& demonstrated& the& protection& conferred& by&monoclonal& anti9F4+ETEC& antibodies& (murine& IgG1)& at& a& concentration& of& 8&mg/100&ml&of&milk.&Based&on&the&consumption&of&milk&by&neonatal&piglets&until&weaning&(4&weeks&of&age)&and&the&weight&gain&to&feed&consumption&ratio&during&the& first& and& second&week&after&weaning,&we& estimated& that& if& not&weaned,& 495&weeks&old&piglets&would&consume&a&minimum&of&one&litre&milk&per&day.&Thereby&to& attain& equivalent& protection& ~80! mg! of! antibody! would! be! needed! per!
piglet!per!day.!!The&VHH9IgG&oligomeric&cocktail&contained&approximately&equal&parts&by&weight&of&the&4&VHH9IgG&antibody&producing&Arabidopsis&seed&stocks,&i.e.&V1G&seed&stock&expressing& antibody& up& to& 2%& of& seed& weight,& V2G& seeds& stock& expressing&antibody&up&to&3%&of&seed&weight,&V3G&and&V4G&seeds&each&expressing&antibody&up&to&0.4%&of&seed&weight&(Chapter&4).&Thus&the&antibody&content&in&the&pool&of&oligomeric& VHH9IgG& cocktail&was& about& 1.4%& of& seed&weight& (average& of& the& 4&
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accumulation,& also& experimentally& verified& in& a& sample& protein& extract& made&from& the& oligomeric& pool& of& VHH9IgG& seeds).& Similarly& the& VHH9IgA& oligomeric&cocktail& contained& approximately& equal& parts& by& weight& of& the& 12& antibodies&producing& Arabidopsis& seed& stock,& i.e.& the& 4& monomeric& IgAs& (mV1A,& mV2A,&mV3A&and&mV4A),&the&4&tetravalent9dimeric&IgAs&(dV1A,&dV2A,&dV3A&and&dV4A)&and&the&4&sSIgAs&(sV1A,&sV2A,&sV3A&and&sV4A).&Since&the&concentration&of&each&of&these&12&IgA&producing&line&was&similar&about&0.2%&of&seed&weight&(Chapter&5),&the&concentration&of&functional&antibody&(all&3&formats)&in&the&pooled&IgA&seeds&remains& about& 0.2%& of& the& seed& weight.& Thus& every& gram! of! VHHHIgG!
oligomeric! cocktail! of! Arabidopsis! seeds! contained! 14! mg! of! VHHHIgG!
antibody;!while!a!gram!of!IgA!oligomeric!cocktail!of!Arabidopsis!contained!



















VHH>IgG>80' '80'mg/300'gram'feed)' 7'pigs' 21.36' 1.9%'(0.40'Kg)' 1.4%'(0.3'Kg)'
Nega8ve'control'' 7'pigs' 21.36' 1.9%'(0.40'Kg)' 1.4%'(0.29'kg)'
VHH>IgA>20' (20mg/300'gram'feed)' 4'pigs' 15.3' 3.3%'(0.50'Kg)' n.a.'
VHH>IgG>20' (20mg/300'gram'feed)' 3'pigs' 10.5' 0.48%'(0.05'kg)' 2.82%'(0.3'kg)' &The& average& daily& feed& consumption& of& piglet& at& 3& –& 4&weeks& of& age& is& about& 300& grams.& (n.a.&stands&for&not&applicable)&&&The& concentration& of& VHH9IgG& antibody&was& 14&mg& in& every& grams& of& crushed&VHH9IgG&Arabidopsis&seed&flour.&Therefore,&to&formulate&a&dose&80&mg&antibody&per&pig&per&day&in&VHH9IgG980&feed,&5.71&grams&of&Arabidopsis&flour&was&mixed&in&every&300&grams&of&basic&piglet&feed&i.e.&at&inclusion&rate&of&1.9%.&Further,&to&dose&20&mg&of&VHH9IgG&per&pig,&same&VHH9IgG&Arabidopsis&seed&flour&was&added&to&basic&feed&at&4&times&less&inclusion&rate&of&0.48%.&Similarly&since&the&VHH9IgA&antibody&concentration&was&2&mg/gram&of&crushed&Arabidopsis&VHH9IgA&flour,&to&dose&20&mg&per&pig&per&day,&10&grams&of&VHH9IgA&Arabidopsis&flour&was&mixed&in&every&300&grams&of&basic& feed,& i.e.&at&an& inclusion&rate&of&3.3%&(Table&6.2).&The&negative& control& group& piglets& received& feed& with& 1.9%&wild& type& Arabidopsis&seed& flour& (equivalent& to& VHH9IgG980& feed).& Each& of& these& 4& experimental& feed&formulations& thus& had& varying& concentration& of& Arabidopsis& seeds;& this& could&have& had& an& effect& on& the& nutrition& of& each& feed.& So& as& to& maintain& nutritive&homogeneity,& flax&seed&meal&was&added.&The& flax&seed&composition& is&relatively&similar&to&Arabidopsis&about&41%&fat,&20%&crude&protein,&28%&crude&fiber,&7.7%&moisture&and&3.4%&crude&ash&(Morris,&2007)18.&Further&the&milled&flax&seeds&do&not&have&any&strong&odour&and&can&be&commercially&procured.&The&feed&VHH9IgA9&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&18&From&flaxcouncil.ca&&
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20& contained& the&highest& amount& of&Arabidopsis& seeds& i.e.& 3.3%& inclusion& rate;&hence& to& equalize& the& nutritive& content& flax& seed&meal&was& added& to& the& other&three& experimental& treatment& feeds& (Table& 6.2).& Additionally& to& enable& similar&nutritional& balance& throughout& the& experiment,& the& piglets& were& fed&with& feed&containing& 3.3%& crushed& flax& seeds& (flax9feed)& both& before& and& after& the&challenge&regimen&(see&scheme,&Figure&6.3).&
&&




schematically& represented& in& Figure& 6.3,& where& the& first& day& of& challenge& is&regarded& as& day& 0.& One& day& before& challenge& the& flax& feed& in& each& pen& was&replaced&with& their&respective&experimental& feed;&300&g&of&respective& feeds&per&pig& (plus&about&50&grams& to&account& for&spillage)&was&provided& in& the&common&feeding&vats&per&pen,&until&day&4.&&&The& daily& rectal9faeces& samples& collected& per& piglet&were& plated& on& blood& agar&plates& with& 1& mg/ml& streptomycin& and& 20& µg/ml& tetracycline& to& evaluate& the&daily&shedding&of& the&F4+ETEC&challenge&strain–&Gis26Rstrep19.&These&colonies&of&Gis26Rstrep& isolated& from& faeces& upon& challenge,& produced&marked& haemolysis,&the&specific&count&of&which&could&be&dually&confirmed&with&an&immunoblot&assay&with& anti9F4& monoclonal& antibodies.& An& overview& of& the& individual& shedding&patterns&is&given&in&Supplementary&Table&6.ST1.&All&the&piglets&shed&high&titers&of&the& challenged& F4+ETEC& strain& immediately& after& first& day& of& challenge.& The&negative&control&group&on&an&average&shed&bacteria&higher&than&6&log10&per&gram&of&faeces&until&day&4,&after&which&the&bacterial&shedding&gradually&declined&until&day&8&(Figure&6.4).&
&Figure& 6.4:& In& feed& provided& VHH9IgA& rapidly& decreases& bacterial& shedding& post& experimental&infection& as& compare& to& other& groups.& In& the& group& fed& with& feed& supplemented& with& seeds&containing& VHH9IgA& (VHH9IgA920,& n=4),& the& bacterial& shedding& rapidly& decreased& post&experimental&infection&as&compared&to&other&groups&fed&with&feed&supplemented&with&wild&type&seeds&(Negative&control,&n=&7)&or&supplemented&with&seeds&containing&VHH9IgG&(group&VHH9IgG920,n=3& and&VHH9IgG980,& n=& 7).& The& error& bars& represent& standard& deviation&within& the& group.&The&evolution&of&bacterial&shedding&in&the&course&of&time&within&the&group&VHH9IgG980,&VHH9IgA920& and& the& Negative& control& group& was& significant& (p& =& 0.019).& The& experimental& feed& was&provided&till&day&4.&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&19& N.B.& Gis26& is& a& field& isolate,& serotype&O149:K91:& F4ac,& producing& the& heat9labile& enterotoxin& (LT+)& and&heat9stable& enterotoxin& types& a& and& b& (STa+,& STb+)& which& was& progressively& scaled& up& on& higher&concentration&of&streptomycin,&to&produce&strain&resistant&to&1&mg/ml&streptomycin&called&Gis26Rstrep&
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showed&maintenance& of& high& infection& pressure,& and& clearly& indicates& that& the&VHH9IgG& at& 80&mg& dose& per& day& failed& to& protect& the& piglets& (Figure& 6.4).& The&prolonged&higher&rate&of&shedding&as&compared&to&negative&control&suggests&that&the&VHH9IgG&treatment&at&the&dose&of&80&mg&per&day&was&rather&detrimental&and&synergistic&for&F4+ETEC&infection&than&protective.&&These& results& at& the& first& instance& suggested& that& equivalent& dose& of& 20&mg& of&VHH9IgG&antibody&per&day&per&pig,& to&be&equally&effective& in&bacterial&clearance&as&20&mg&of&VHH9IgA&antibody&cocktail&per&day&per&pig&(Figure&6.4).&However&the&quantitative& determination& of& the& F4R& status& performed& post9mortem& by& villi&binding&test,&revealed&that&out&of&three&piglets&in&this&group,&two&had&very&few&F4&receptors& (Supplementary& Table& 6.ST1).& In& this& test& the& average& number& of&F4+ETEC& bound& per& 250& µm& of& the& villous& enterocytes& surface& gives& a& relative&account&of&F4R&receptors&expressed&(Coddens!et!al.,&2009).&Less&than&5&bacteria&per& 250& µm& of& villous& surface& is& regarded& as& F4& receptor& negative& piglet,& 5930&bacteria/250& µm& villous& surface& is& regarded& as& moderate& distribution& of& F4&receptor& while& more& than& 30& is& regarded& as& high& expression& of& F4& receptors.&Within&the&group&VHH9IgG920,&an&average&of&7.5&and&5.75&bacteria&per&250&µm&of&villous& length& was& observed& in& piglet& no.& 15& and& 17& respectively,& leaving& just&piglet&no.&16&with&an&average&of&36.25&bacteria&per&250&µm&of&villous&surface&as&the&only&susceptible&piglet&in&this&group.&Piglets&with&no&or&relative&absence&of&F4&receptors& are& known& to& be& naturally& insensitive& to& F4+ETEC& infection,& such&piglets&shed&very&low&bacteria&and&are&protected&even&on&experimental&challenge&(Geenen!et!al.,&2004;&Geenen!et!al.,&2007).&This&situation&within&the&VHH9IgG920&group&would&lead&to&an&overall&diminished&infection&pressure&in&the&pen&since&2&of&3&piglets&were&relatively&insensitive&to&F4+ETEC&infection.&With&this&knowledge&it’s& difficult& to& attribute& the& protective& effect& of& VHH9IgG920& feed& bearing&antibody& for& the& reduction& of& ETEC& bacterial& shedding& in& piglet& 16& by& day& 3.&Hence,&we&decided&to&exclude&this&group&from&any&of&our&comparative&statistical&group& analysis.& But& at& the& same& time& one& cannot& discount& the& putative& role& of&VHH9IgG920& feed& against& F4+ETEC& infection& in& susceptible& piglets.& Hence& we&report&the&finding&of&this&group&as&preliminary&results.&Piglets&in&the&other&group&on&an&average&had&moderate&expression&of&F4R.&In&the&
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Arguably,&this&synergistic&effect&of&VHH9IgG980&could&be&due&to&an&overdose&effect&and&a& lower&dose&might&be&protective,&or&there&might&be&another&mechanism&at&play.& Nevertheless,& further& insight& into& this& hypothesis&would& be& interesting& in&not&just&evaluating&the&reason&of&this&observed&effect&on&shedding&of&bacteria&but&more& importantly& it& will& also& pave& way& for& immunisation& strategies& to& elicit&gastric& mucosal& immune& response& together& with& systemic& immunity,& by&exploiting&the&role&of&FcRn&mediated&transport&across&gut&epithelium&(Stirling!et!
al.,&2005).&&
Seroprofile!corroborates!shedding!profile!!The& overall& shedding& profile& of& each& of& the& treatment& groups& correlated& to& the&observed&rise&of&anti9F4&fimbriae&antibodies&observed&in&the&blood&samples&taken&on& day& 93,& day& 4& and& day& 11& for& each& respective& group;& providing& dual&confirmation& of& the& efficacy& of& each& treatment& and& casting& more& light& on& its&mechanism&(Figure&6.5).&The&rise&in&serum&IgM&levels&as&early&as&the&4th&day&post&challenge&is&indicative&of&this&challenge&being&the&primary&infection&and&immune&response& to& F4+ETEC& bacteria& (Figure& 6.6).& In& various& previous& challenge&experiments& rise& in& anti9F4& fimbriae& IgG& in& serum& has& been& detected& in& the&control&group&on&an&average&by&the&7th&day&post&challenge&(Snoeck!et!al.,&2003).&In&agreement&with& the&previous& studies,& high& titers& of& serum&anti9F4& fimbriae& IgG&were&detected& in&serum&collected& from&the&negative&control&group,&and&also& for&both& the&VHH9IgG& treatment& groups& later& in& the& experiment& on&day&11& (Figure&6.6).& In& comparison&with& these& three& groups,& the& evolution& of& immunoglobulin&seroconversion& rate& observed& for& the& 4& piglets& in& the& VHH9IgA920& group& over&time&was&much&lower&at&each&time&point&(at&day&93&p=0.018,!at&day&4&p=0.059,!at&day& 11& p=0.033)& (Figure& 6.5).& This& suggests& that& the& in& seed& made& VHH9IgA&antibodies& at& its& 20& mg& dose& per& day& provided& passive& protection& at& the& gut&mucosal& surface& by& preventing& the& interaction& of& the& pathogenic& bacteria&with&host&cells&and&avoiding&priming&of&the&immune&system.&&Contrary&to&the&VHH9IgA&the&feed&formulations&VHH9IgG980&failed&to&achieve&such&passive& protection,& as& evidently& the& respective& seroconversion& rate& over& time&was& comparatively& high.& The& single& susceptible& piglet& from& the& VHH9IgG920&group&also&seroconverted&at&a&faster&rate,&however&the&average&(as&plotted&in&the&
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graph)&was&approximately&similar&to&the&negative&control.&Whereas,&for&the&VHH9IgG980& group& a&higher& average& titer& on&day&11& and& early& rise& in& antibody& titer,&was&noticed&on&the&day&4.&The&overall&higher&titer&of&VHH9IgG980&group&could&be&due& to& the& higher& bacterial& infection,& which& corroborates& by& higher& bacterial&shedding&in&the&group.&&&
&
Figure! 6.5:! Rate! of! seroconversion! (all! antibody! classes)! post! challenge! in! the! 4!





Figure! 6.6:! Comparison! of! serum! immunoglobulin! isotype! response! post! F4+ETEC!




Effect!of!the!in!feed!prophylaxis!on!the!weight!gain!of!piglets!The& pattern& of& bacterial& shedding& and& the& seroconversion& rate& are& important&parameters&for&assessing&the&protection&conferred&by&the&in9feed&produced&anti9F4+ETEC&antibody& treatment.&However,& for& the&porcine& industry&additionally& to&the& efficacy& of& treatment,& the& piglet& weight& gain& parameter& is& of& utmost&importance&since&it&bears&a&direct&relation&to&economic&benefits.&Piglets&suffering&from& post9weaning& diarrhoea& usually& have& a& worse& feed& to& weight& conversion&ratio,&in&comparison&to&healthy&piglets.&&In& our& study,& we& found& that& the& average& weight& gain& for& the& negative& control&piglets&(from&day&93&to&day&11)&was& low.&On&the&contrary,& the&weight&gain& in&all&three&experimental&feed&treatment&groups&was&higher&than&the&negative&control&(Supplementary&Table&6.ST2).&The&average&weight&gain&was&highest&for&the&VHH9IgG920&group&and&like&the&rapid&bacterial&clearance&seen&in&this&group;&the&weight&gain& could& also& be& the& effect& of& F4R& related& insensitivity& to& F4+ETEC& infection.&Hence,& except& this& group& the& daily&weight& gain& of& the& remaining& piglets& in& the&three& groups&was& calculated& from& the&weight&measured&during& the& experiment&(see&scheme,&Figure&6.3).&&








Bulk! production! of! antiHF4+ETEC! antibody! expressing! seeds! and!




challenge& experiment,& varying& concentrations& of& transgenic& Arabidopsis& seeds&determined& by& the& dose& of& antibody&were&milled& and& fed& to& the& piglets& (Table&6.2).&The&maximum&concentration&of&transgenic&Arabidopsis&seeds&was&3.3%&for&the&IgA&category.&In&all&the&other&formulations&where&the&transgenic&Arabidopsis&seeds&were&less&than&3.3&%&of&the&feed,&milled&flax&seeds&were&added&to&the&feed&to& make& up& the& equivalent& 3.3%& proportion& and& thus& maintain& nutritive&homogeneity&in&all&the&feed&formulations.&Before&and&after&the&treatment&regimen&(Figure&6.3)& all& the&piglets&were&provided&Flax& feed,&which& contained&3.3%& flax&seed&mill&and&no&Arabidopsis&seeds.&&
Evaluating!the!palatability!of!Arabidopsis!seeds!in!piglet!diet!Before& the& in! vivo& feed& trial,& it& was& necessary& to& assess& the& palatability& of&Arabidopsis&seeds&in&the&feed&of&young&piglets.&Hence&8&piglets&were&weaned,&and&housed&in&individual&feeding&cages&for&2&weeks.&Each&piglet&received&1&kilogram&of&feed&every&morning&which&they&could&eat&ad!libitum!over&the&whole&day.&Any&leftover&feed&from&the&previous&day&was&collected&and&weighed&to&determine&the&daily&feed&consumption.&For&the&first&week&all&the&8&piglets&were&given&identical&creep& feed& to& acclimatise& all& the& piglets& to& solid& feed,& once& acclimatised& in& the&second&week&the&feed&for&4&piglets&was&replaced&with&piglet&starter&feed&(ILVO)&as&control&group&and&other&4&pigs&received&the&same&starter&feed&supplemented&with&2%&milled&Arabidopsis&wild&type&Col&0&seeds.&The&consumption&pattern&of&all&the&piglets&was&compared&at& the&end&of& two&weeks&and& the& influence&of&adding&2%&Arabidopsis&seeds&on&the&consumption&of&feed&was&evaluated.&
In) vivo! evaluation! of! protection! on! feeding! seed! produced! antiHF4+ETEC!
antibodies!and!subsequent!experimental!F4+ETEC!infection!Selection&of&piglets&Farms& with& relative& absence& of& the& F4+ETEC& infection& were& identified.& The&suckling&piglets&per&sow&were&screened&for&anti9F4+ETEC&seronegative&status&by&F49specific& ELISA& and& such& seronegative& pigs& were& further& evaluated& for& their&susceptibility&by&genotyping&mucin4&receptor&by&RFLP&(Rasschaert!et!al.,&2007),&as&follows.&&&
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Genotyping&of&sero9negative&piglets&expressing&F4+ETEC&receptor&Piglets&seronegative&for&anti9F4+ETEC&antibodies&were&screened&for&presence&of&F4ac& receptor& (F4R)& via& the& non9invasive& mucin4& polymorphism& based& PCR9RFLP& assay& as& described& by& Rasschaert& et! al.& based& on& the& patent&WO2004/0486069A2.& The& genomic& DNA&was& extracted& from& the& blood& cells& in&the&uncoagulated&blood&fraction&with&10%&EDTA&as&anti9coagulant.&The&nucleated&blood& cells& were& pelleted& by& centrifugation& for& 1& minute& at& 3800& g,& the&supernatant& was& discarded& and& the& cells& were& washed& 2& times& with& PBS& each&time&maintaining&the&same&centrifugation&parameters.&To&the&washed&cells,&200&µl& of& proteinase& K& buffer& (50& mM& KCl,& 20& mM& Tris9HCl,& 2.5& mM& MgCl2,& 0.5%&Tween20,&pH&8.3)&with&2&µl&of&proteinase&K&(Gibco)&was&added,&and&incubated&at&370C&for&1&hour,& the&enzyme&was&then&deactivated&by& incubation&at&95°C&for&10&minutes.&Five&μl&of&this&crude&mixture&containing&the&genomic&DNA&was&used&in&a&20&µl& volume&PCR;& containing&1x&Taq&buffer,& 1& units& of& Taq&polymerase,& 2&mM&MgCl2,& 200& µm& of& each& dNTPs& and& 1& µM& of& each& of& the& forward& and& reverse&primers& (5’& 9GTGCCTTGGGTGAGAGGTTA93’/5’9CACTCTGCCGTTCTCTTTCC93’).&The& thermocycling&was& conducted& for&35& cycles&with&annealing& temperature&of&65°C.&The& amplicons& were& digested& with& XbaI& enzyme& as& per& manufacturer’s&instructions& and& the& digested& pattern& was& observed& after& separation& on& 4%&agarose&gel&electrophoresis.&The&presence&of&the&XbaI&polymorphism&within&the&intron&7& of& the&mucin4& gene& corresponds& to& the&presence& of& F4ac/ab& receptor.&Thus&a&single&band&of&367&bp&is&indicative&of&homozygous&(RR)&resistant&piglets,&3&bands& of& 367& bp,& 216& bp& and& 151& bp& represent& heterozygous& (RS)& susceptible&piglets,& while& two& bands& of& 216& bp& and& 151& bp& represents& homozygous& (SS)&susceptible&piglets.&Such& twenty9one& seronegative,& and& heterozygous& (RS)& susceptible& piglets&were&selected&for&further&in!vivo&experiment.&&Challenge&strain&and&bacterial&inoculum&The&pathogenic&isolate,&E.!coli&strain&GIS&26&(O149:K91:F4ac,&LT+,&STa+,&STb+)(Cox&and& Houvenaghel,& 1993)& was& used& in& this& experiment.& For& convenience& of&
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screening&the&pathogen&post&infection,&streptomycin&resistance&of&the&strain&was&raised& in&step&wise&manner&unto&1&mg/ml&of&medium&by&progressive&screening&for&bacterial&colonies&that&grew&on&higher&dose&of&streptomycin.&Prior&to&infection&presence& of& all& the& toxins& in& this& streptomycin& (1&mg/ml)& resistant& strain&was&confirmed&by&PCR.&The& expression&of& F4& fimbriae& and& its&potential& to& attach& to&F4R& was& confirmed& by& an& in! vitro& adhesion& test,& and& this& strain& was& named&GIS26Rstrep.& One& day& before& challenge,& the& inoculum& was& prepared& with&GIS26Rstrep& as& described& previously& (Snoeck! et! al.,& 2003),& briefly& single& colony&was& inoculated& in& Tryptone& Soya& Broth& (Oxoid,& Basingstoke,& UK)& and& cultured&overnight&at&37°C&and&85&rpm,&bacteria&were&collected&by&centrifugation&(2000g,&35&minutes&at&4°C)&and&resuspended&in&PBS&(pH&7.4)&to&an&optical&density&of&1&at&wavelength&of&660&nm,&where&OD&of&1&corresponds&to&109&bacteria/ml&(Snoeck!et!




per&pig&in&the&common&feeding&units&installed&in&each&pen.&The&negative&control&group&(NC)&included&7&piglets&(piglet&number&19&7)&and&received&feed&with&milled&wild&type&Arabidopsis&seed.&Next&7&piglets,&no.&8&to&14&constituted&the&‘VHH9IgG980’& group& receiving& the& VHH9IgG980& feed,& average& daily& consumption& of&which&would&lead&to&a&dose&of&~80&mg&of&VHH9IgG&per&pig&per&day.&Piglets&15,&16&and&17&comprised& the&VHH9IgG920&group&and& received& low&dose& IgG& treatment& in& feed&VHH9IgG920,&daily&dietary&allowance&of&this&feed&formulation&would&provide&~20&mg&of&VHH9IgG&per&pig&per&day.&The&remaining&4&piglets&(no.&18&to&21)&received&VHH9IgA920& feed& bearing& an& cocktail& of& VHH9IgA& antibodies& (mIgA,& dIgA& and&sSIgA),&also&at&a&concentration&to&enable&~20&mg&dose&per&pig&per&day.&However&after&moving& the& piglets,& some& distress& and& loose& faeces& was& noticed& in& a& few&piglets,& most& likely& due& to& moving& stress.& Hence& as& precaution& colistin& was&administered& orally& on& day& 93& and& on& day& 92& flax& feed& was& given.& On& day& 91,&piglets& showed& normal& signs& of& healthy& behaviour& and& the& experimental& feed&regime&was&started& fresh&again.&The&experimental& feed&with&milled&Arabidopsis&seeds&was&fed&from&the&day&91&until&day&4&of&the&experiment.&After&day&4&the&feed&in&each&pen&was&switched&to&flax9feed,&which&was&then&provided&ad&libitum&until&day& 11& when& the& piglets& were& euthanized,& secundum& artem,& by& injecting& an&overdose&of&Nembutal&(60&mg/kg&body&weight).&&Challenge:& To& reduce& the& bacterial& gut& flora,& on& day& 96& and& 95& the& piglets&were&orally&given&a&broad&spectrum&antibiotic&mix&of&1&ml&florfenicol&(Nuflor®)&and&2.5&mg/kg&body&weight&of&Baytril&(enrofloxacin)&in&5&ml&of&PBS,&and&further&150,000&U/kg&of&colistin&was&administered&orally&on&day&93.&After&the&antibiotics&cleared&from&the&piglet& system,&on& the&day&0&and&day&1& the&piglets&were&challenged&via&intra9gastric&inoculation&of&1010&bacterial&particles&in&accordance&to&the&protocol&described&previously&(Cox!et!al.,&1991)&with&the&exception&that&the&piglets&were&not&fasted&or&deprived&of&water&both&before&and&after&the&challenge.&Briefly,&the&piglets&were&sedated&with&2&ml&azaperone&(Stressnill®& Janssen&Animal&Health),&the& gastric& pH& was& neutralised& with& 60& ml& of& NaHCO3& (1.4%& w/v& in& distilled&water)& administered& via& orogastric& intubation,& 15930&minutes& later& via& similar&intubation&10&ml&of&challenge&bacterial&suspension&in&PBS&(109&bacteria/ml)&was&inoculated.&During& the&course&of& the&experiment& the&weight&gain&was&evaluated&by&measuring&the&body&weight&on&day&96,&93,&1,&3,&5,&7&and&11.&Blood&samples&were&
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taken&from&the&jugular&vein&on&the&day&93,&4,&and&day&11;&while&faecal&sample&was&taken& from&the&anus&(or& through&rectum)&on&the&day&93,&day&1&to&8&and&day&11.&After&euthanizing,&the&piglets&were&dissected;&the&content&from&ileum&and&caecum&was&taken&and&processed&similarly&as&faeces&sample.&Also&~20&cm&long&segment&of& the& jejunum& was& excised& washed& with& sufficient& PBS& followed& by& Krebs9Henseliet&buffer&and&fixed&by&incubation&for&60&minutes&in&Krebs9Henseliet&buffer&with& formaldehyde& (1%& v/v).& The& villus& enterocytes& were& scrapped& from& this&segment&and&used&to&reconfirm&the&phenotypic&expression&of&the&F4R&receptors&via&adhesion&assay.&&Determination&of&F4+ETEC&shedding&in&faeces&The&faeces&collected&were&kept&on& ice,&and&processed& immediately;&a&cold&chain&was&maintained&until&platting&of& the& faecal&dilution.&Firstly,& a&10%&(w/v)& faecal&suspension&was&made&in&PBS,&and&serially&diluted&from&10%&stock&to&1x1095,&100&











piglet no. F4+ETEC shedding post challenge  (log10 bacteria per gram of faeces) F4R status  (average  F4+ETEC/  
250µm of villous surface) 











4.76 4.11 x x 3.30 x x x x 25.25 
2 4.34 3.60 2.00 x x x x x x 40.00 
3 4.04 3.60 3.48 2.78 3.30 x x x x 7.00 
4 6.84 6.56 4.76 4.08 3.79 3.60 2.48 x x 40.25 
5 6.72 6.54 6.99 7.77 5.08 5.09 2.90 x x 16.25 
6 5.40 5.58 3.30 2.93 3.30 2.00 2.70 2.30 x 24.75 










4.36 n.d. 5.99 3.71 x x x x x 22.00 
9 5.39 4.81 3.00 3.22 4.30 4.63 3.48 3.41 x 34.00 
10 7.49 6.40 4.69 4.13 5.78 4.15 2.70 x x 37.25 
11 n.d. 6.76 5.08 3.71 3.60 3.60 2.30 2.00 x 22.50 
12 8.97 7.50 5.05 5.10 5.10 5.52 3.00 3.08 x 23.75 
13 5.90 3.95 3.00 x x x x x x 31.00 








15 7.58 5.62 x x x x x x x 7.50 
16 6.22 6.13 4.51 x x x x x x 36.25 









0 6.48 5.70 3.00 x x x x x x 23.00 
19 4.31 3.85 x x x x x x x 30.00 
20 6.83 4.27 3.00 x x x x x x 29.75 

























7,1 7,8 7,4 8,2 9,3 10,0 10,5 1,5 1,2 
2 7,8 8,3 7,9 9,1 9,5 10,4 11,1 1,2 1,6 
3 7,9 8,7 7,8 8,1 9,9 11,1 11,5 1,2 1,6 
4 6,4 6,6 5,6 6,8 7,8 9,1 9,0 1,2 1,2 
5 9,9 8,4 8,3 9,8 10,1 11,5 12,3 1,7 2,2 
6 7,8 10,1 9,6 11,1 12,9 13,6 14,2 2,8 1,3 









6,9 5,4 5,6 6,5 7,2 7,4 9,0 1,8 1,8 
9 6,5 6,9 7,5 7,0 7,4 7,8 9,0 0,5 1,6 
10 6,7 6,9 8,7 9,0 9,3 9,8 12,5 2,4 3,2 
11 6,4 6,6 6,9 7,3 8,0 8,1 10,0 1,4 2 
12 7,7 8,6 8,7 9,6 10,2 10,1 12,1 1,6 1,9 
13 7,9 8,1 10,5 10,8 11,4 12,0 14,3 3,3 2,9 








15 6,4 6,7 7,7 8,0 8,7 10,1 11,9 2 3,2 
16 5,0 5,1 5,7 6,2 6,9 7,8 9,7 1,8 2,8 








0 6,1 6,5 7,4 8,1 8,2 9,1 11,0 1,7 2,8 
19 6,5 6,8 6,4 7,7 8,1 8,9 10,1 1,3 2 
20 8,9 9,1 10,1 10,6 11,3 12,6 15,5 2,2 4,2 









General conclusions, discussion 
and perspectives
In seed production of antibodies for oral passive immunisation— 







In!a!nut!shell!Passive&immunisation&strategies&have&an&unrealised&potential&for&prevention&and&treatment&of&several&human&and&animal& infections.&The&present&high&cost&of& the&recombinant& antibody& production& limits& the& wide& spectrum& use& of& passive&immunisation.&Several&non9conventional&expression&systems&are&being&utilised&to&attain&high&production& level.& Since&production& levels&are& inversely&proportional&to& the& cost& of& final& therapeutic& product& it& is& hoped& that& in& the& future& passive&immunisation& would& be& affordable& to& include& in& the& basic& human& health& care&system& and& also& used& for& animal& health.& Amongst& these& non9conventional&methods& plants& are& emerging& as& a& promising& platform& to& achieve& the& low& cost&antibody&production.&In&particular&expression&in&seeds&is&an&exciting&opportunity&for&oral&in&feed&administration&of&antibodies&to&farm&animals.&In&this&Ph.D.&thesis&we& deliver& the& proof& of& concept& of& such& prophylaxis,& in& preventing& F4+ETEC&infection&in&piglets,&by&production&of&novel&antibodies&in&the&seeds&of&Arabidopsis!
thaliana.&&Broadly,& the& seed& made& antibodies& were& robust& and& remained& active& en! route!gastric&transit.&The&VHH9IgA920&feed&containing&the&cocktail&of&VHH9IgA&antibody&formats&at&a&concentration& that&would&enable&antibody&dose&of&20&mg/pig/day,&inhibited& the& colonization& of& the& challenge& strain& leading& to& speedy& bacterial&clearance& from& the& piglet& system.& This& group& also& had& the& highest&weight& gain&towards& the& end& of& the& experiment,& compared& to& the& control& and& the& VHH9IgG&antibody& receiving& groups.& The& VHH9IgG& antibody& bearing& experimental& feeds&evaluated&in&this&study&failed&to&demonstrate&similar&protection.&In&fact&the&VHH9IgG980& treatment& group& (dose& of& ~80& mg& VHH9IgG& antibody& per& pig& per& day)&showed&prolonged&shedding&of&bacteria&compared&to&the&negative&control&group,&which& received&wild& type&Arabidopsis& seeds.& Also& as& compared& to& the& negative&control&a&higher&and& faster& seroconversion&was&seen& in& the&piglets&of& the&VHH9IgG980& group.& The& porcine& IgG3& Fc& of& the& VHH9IgG& perhaps& interacts& with& the&porcine& neonatal& Fc& receptor& present& on& gut& epithelial& cells& enabling& prompt&trans9epithelial&transport&of&the&antigen&resulting&in&earlier&triggering&of&immune&system&and&higher&seroconversion.& Interaction&of&F4+ETEC&bacteria& to&VHH9IgG&bound& to& the& epithelial& FcRn& receptor& might& have& also& influenced& the&
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colonisation;& it& would& be& interesting& to& evaluate& this& hypothesis& in& the& future.&And&if&this&turns&out&to&be&correct&then&as&an&alternative&other&IgG&isotopes,&which&have&lower&affinity&for&FcRn&can&be&experimented&as&fusion&partners&for&VHH.&The& ability& to& protect& against& F4+ETEC& challenge& and& furthermore& curtailing&bacterial& shedding,& present& the& VHH9IgA& prophylaxis& with& higher& merits& as&candidate& antibody& format& for& evaluation& in& a& field& trial.& Transformation&of& the&VHH9IgA&constructs&in&seed&crops&like&soybean&would&enable&bulk&production&of&VHH9IgA&bearing&feed&for&a&prospective&large9scale&field&trial.&&&




harmonised&(Boothe!et!al.,&2010;&De&Wilde,&2012).&Alternatively&other&regulatory&elements& at& the& 5’& and& 3’& end& could& be& fine& tuned,& as& shown& in& case& of& the&transient& expression& vector& pEAQ,& where& the& modified& 5’UTR& leads& high&expression& of& more& than& 10& to& 20%& of& TSP& for& most& heterologous& protein&(Sainsbury& and& Lomonossoff,& 2008;& Sainsbury! et! al.,& 2009;& Thuenemann& and&Lomonossoff,&2010).&Another&strategy&would&be&to&cross&the&plant&lines&expressing&high&levels&of&VHH9IgA& with& a& transformant& that& express& lower& levels& of& J& chain& and& SC.& Such&candidate&J&chain&+&SC&expressing&plant&lines&could&be&identified&from&our&pool&of&transformants.& On& the& same& principles& the& ratio& of& J& chain& to& VHH9IgA& can& be&adjusted&for&higher&dIgA&production.&In& chapter& 4,& we& described& the& production& of& VHH9IgG& divalent& anti9F4+ETEC&antibodies,&which&were&functional&in!vitro,&but&did&not&prevent&the&bacteria&from&establishing&the&infection&at&a&dose&of&80&mg/piglet&per&day.&While,&the&protective&effect& in& case& of& lower& dose& of& VHH9IgG& at& 20&mg/piglet& per& day& could& not& be&evaluated& since& the& piglets& did& not& bear& sufficient& receptor& necessary& for&susceptibility& to&F4+ETEC&bacteria.&Hence& it& is&difficult& to&conclude& if& the&20&mg&dose&would&have&been&protective;&if&so,&it&would&also&suggest&that&a&higher&dose&of&antibody& is& detrimental& and& ineffective.& Without& evidence,& this& statement&remains& speculative& in& nature,& and& would& need& further& evaluation.& Once& the&effect& of& VHH9IgG& at& 20& mg& daily& dose& per& piglet& is& evaluated& it& can& then& be&compared&with&the&20&mg&dose&of&VHH9IgA&oligomeric&cocktail&in&treatment&feed&per&piglet&per&day.&For&re9evaluation&of&these&questions&and&to&take&this&concept&close&to&valorisation,& it& is& ideal&to&transfer&these&constructs&in&crop&seeds.&Along&with&production& in& crop& seed,&high&accumulation&will& be&necessary& to& reap&any&benefits.&&
Attaining!high!accumulation!!With&the&aim&to&achieve&highest&accumulation&of&the&anti9F4+ETEC&antibodies&we&chose& the& β9phaseolin& promoter& and& the& 3’& arceline& terminator& bearing&regulatory&sequence,&the&combination&of&these&gene&regulatory&elements&have&led&to&a&very&high&accumulation&of&antibodies&in&Arabidopsis&in&the&past.&In&chapter&4,&
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ER9associated&degradation&pathway& (Clerc! et! al.,& 2009).& Further& analysis&of& the&isoform&of&the&high&Man7&residue&will&shed&more&light&on&these&questions.&&
Classical!breeding!techniques!in!increasing!accumulation!!Classical&breeding&techniques&have&been&used&since&ages&to&increase&the&yield&of&crops&or& to&obtain&better&vigour.&Such&breeding& techniques&have&also&proved&to&increase&the&accumulation&of&recombinant&antibodies&made&in&plants&(Hood!et!al.,&2002).& A& transgenic& maize& line& producing& a& recombinant& industrial& enzyme&resulted& in& 709fold& increase& in& accumulation& on& crossing& it& with& an& elite&germplasm,&and&in&case&of&avidin&producing&maize&lines&this&method&resulted&in&increase&of&up&to&1509fold&in&accumulation&(Hood!et!al.,&2002).&Recently&the&seed&yield&parameters&for&Arabidopsis&mutant&and&transgenic&lines&has&been&analysed&in& detail& (Van&Daele! et! al.,& 2012).& Candidate& plants& from& this& collection& can& be&crossed&with&antibody&producing&lines&to&evaluate&if&this&crossing&leads&to&higher&antibody& accumulation& in& F1&progeny.& This& technique&would&be& very&beneficial&for&attaining&higher&accumulation&in&crop&seeds.&The&high&yielding&varieties&and&know9how&for&classical&breeding& techniques&already&exist& for&most&of& the&crops&like&soybean,&pea,&bean&etc.&
V2G!X!V3G!–!production!of!oligomer!cocktail!in!one!line!Apart&from&the&proposed&strategies&to&swap&the&CDRs&of&V3G&with&V2G,&one&could&also&try&crossing&the&high&expressing&line&(e.g.&V2G)&with&low&expressing&line&(e.g.&V3G),& it& will& be& interesting& to& evaluate& what& happens& to& overall& accumulation&then.& In&conjunction,& this&method&will&enable&production&of&oligomer&cocktail& in&one& line.& In& principle& a& V2G& x& V3G& line& would& produced& bispecific& VHH9IgG&antibody&with&V2&and&V3&VHH&domains&(V2,V39G)&along&with&homodimers&with&two&V2&or&V3&domains&(V2G&and&V3G).&&Such&strategy&of&filial&crossing&can&be&incorporated&for&bringing&in&more&antibody&elements&in&one&plant&line;&these&antibodies&could&be&against&different&epitopes&of&the&same&pathogen,&or&different&pathogens.&For&instance&along&with&anti9F4+ETEC&antibodies,&similar&antibodies&against&other&diarrhoea&causing&bacteria&with&F18&fimbriae& bearing& ETEC& could& be& isolated,& produced& in& plants& and& crossed&together.& Thus& aiming& to& make& a& disease& specific& seed& based& therapeutic.&
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Weather&a&bispecific&antibody&produced&in&seeds&would&have&added&benefits&than&merely&mixing&two&antibodies&producing&feed,& in&terms&of&efficiency&against&the&antigen&would&need&to&be&investigated.&&These& tips& discussed& above& could& be& effectively& utilised& in& attaining& high&expression&in&crop&seeds.&However,&the&later&discussed&crossing&technique&might&be&more&suitable&for&crops,&since&transformation&of&crops&like&pea&and&soybean&is&a&lengthy&and&difficult&process.&&
From!Arabidopsis!to!crop!seeds!




expressing&V2G,&low&expressing&V3G&and&the&VHH9IgA,&V2A.&These&three&antibody&constructs&were&transformed&in&pea&by&Agrobacterium9mediated&transformation&of& embryo& explants& (Figure& 7.1)& in& accordance& to& the& protocol& described&(Polowick!et!al.,&2000).&& &
Figure! 7.1:! Transformation! of! V3G! in! pea,& the& image&shows& the& co9cultivation& step& in& the& pea& transformation&protocol.& Thin& slices& of& embryo& explants& dissected& from&imbibed& seeds& were& co9cultivated& with& Agrobacterium&strain& bearing& V3G& within& the& pPhasGW& expression&cassette.&Transformation&of&pea&was&performed&in&the&lab&of&Prof.&Inge&Broer&at&the&University&of&Rostock.&&The&soybean&was&transformed&by&Agrobacterium9mediated&transformation&using&half& seed& (cotyledon& node)& as& explant& (Paz! et! al.,& 2006)& (by& the& plant&transformation&service&of&the&Iowa&State&University).&The&seeds&from&the&primary&transformants& of& both& these& plant& species& are& expected& in& August& 2012,& after&which&the&expression&and&efficacy&of&pea&and&soybean&produced&antibody&would&be&evaluated.&&Piglet& feed& is& either& available& as& milled& flour& or& in& the& form& of& pellets,& the&preference& differs& in& accordance& to& the& available& animal& husbandry&infrastructure.&To&make&a&product&for&a&broader&market&the&antibody&producing&pea&and&soybean&will&be&tested&for&antibody&survival&and&stability&on&extrusion&to&make&feed&pellets.&These&stability&experiments&are&planned&first&quarter&of&2013.&
Why!pea!and!soybean?!Both& pea& and& soybean& are& routinely& used& in& piglet& feed& as& source& of& protein.&Recently&the&“Feasibility&of&pea&as&an&expression&system&for&pharmaceuticals”&has&been& excellently& reviewed& (Mikschofsky& and& Broer,& 2011).& Pea& contains& about&40%& protein,& thus& VHH9Fc& antibody& expression& of& up& to& 2%& of& TSP& would&correspond& to& about& 8& mg& VHH9Fc& per& gram& fresh& weight.& This& proportion& is&higher&than&in&Arabidopsis&seeds,&meaning&that&if&the&pPhas&expression&cassette&leads&to&equally&high&accumulation&of&antibody&as&seen&in&Arabidopsis&seed,&then&the& final& inclusion& rate& of& pea& in& piglet& feed& would& be& less.& This& would& be&advantageous&for&two&reasons9&nutrition&and&regulation.&Some&legumes&like&pea&
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experiment&performed&with&Arabidopsis&seed&(Chapter&4).&&&Alternatively,& soybean& can& also& be& grown& in& greenhouses.& In& fact& it& has& been&reported&that&exploitation&of&the&photoperiod&in&green&house&can&lead&to&10&times&increase&in&seed&yield&(Vianna!et!al.,&2011).&Can&this&be&a&solution&to&looming&GM&risk& related& issues?& Well,& a& detail& evaluation& might& help& to& investigate& this&possibility&for&molecular&farming.&
Prediction!for!the!future!The&possibility&to&prevent&ETEC&related&PDW&and&related&piglet&mortality&would&prevent&annual&losses&and&provide&a&huge&economic&boost&to&the&porcine&rearing&industry.& In& a& developed& country& like& Belgium,& 2%& of& the& weaning& piglets& die,&which&accounts&for&~300,000&deaths&per&year.&At&the&rate&of&30&euro&per&piglet,&the& economic& loss& is& EUR& 9& million& per& annum.& Economic& loss& due& to& piglet&mortality& in& developing& countries& can& bear& direct& detrimental& consequence& on&the& basic& livelihood& of& the& farmer.& Even& the& surviving& piglets& have& reduced&weight& gain,& which& adds& to& the& economic& burden;& overall& every& year& Belgian&porcine&industry&faces&a&loss&of&EUR&15&million.&This&economic&loss&is&mainly&due&to& the& ETEC& induced& PWD.& There& is& a& huge& market& demand& for& an& effective&product;& especially& since& the& products& currently& available& in& market& fail& to&effectively&prevent&ETEC&related&PWD.&The& in& seed& made& antibody& strategy& not& only& ensures& a& specific& anti9ETEC&product&to&meet&this&demand,&but&it&aims&at&achieving&this&at&a&cost&effective&rate.&The& production& cost& of& soybean& containing& F49specific& antibodies& will& be&influenced& by& various&market& parameters,& and&will& be& a& subject& of& a& follow9up&study.&Deregulation&and&obtaining&the&precise&certification&is&one&of&the&foreseen&expenses& in& the& road& to& valorization.& Usually,& apart& from& production& cost& the&expenses&incurred&during&valorization&and&marketing&phase,&largely&influence&the&final& cost& price& of& therapeutics.& We& estimate& the& production& cost& of& adding&antibody9producing& soybean& at& a& ratio& of& 2%& to& the& starters& feed& would& be&approximately&less&than&EUR&20&per&ton&of&feed.&A&ton&of&basic&starter&feed&cost&about&EUR&400&in&the&market,&and&feed&with&4%&plasma&protein,&which&is&sold&as&ETEC& prophylactic& feed,&whose& efficacy& is& questionable,& cost& EUR& 560& per& ton.&Comparing&which,&in&terms&of&cost,&soybean9containing&feed&would&have&a&margin&
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Summary!!Post9weaning& diarrhoea& caused& by& F4& fimbriae& bearing& enterotoxigenic&
Escherichia!coli& (F4+ETEC)& is&a&common&disease& in&piglet&rearing& industry.&Such&F4+ETEC&infections&routinely&cause&morbidity&leading&to&reduced&weight&gain&and&in& acute& cases& (~2%)& lead& to& mortality22& (Fairbrother! et! al.,& 2005).& This&consequentially&results&in&heavy&economic&losses&to&the&global&porcine&industry,&seriously& affecting& the& profit& margin& of& the& large& scale& porcine& farms& in& the&western& hemisphere& while& in& developing& countries& it& can& affect& the& daily&livelihood& of& a& subsistence& farmer& (Amezcua! et! al.,& 2002;& Hong! et! al.,& 2006).&Prophylactic&use&of& antibiotics&has&been&hugely& successful& in& the&past,&however&the& risk& of& introducing& resistance& strains& has& led& to& the& prohibition& of&prophylactic&antibiotic&application.&This&crisis&has&led&to&an&urgent&demand&for&a&successful&treatment&(Adjiri9Awere&and&Van&Lunen,&2005).&&Passive& immunisation&has&been& suggested&as& an& alternative& to& antibiotic&use& in&animals& and&human&bacterial& infections& (Berghman! et! al.,& 2005;&Oleksiewicz! et!
al.,& 2012).& In& different& piglet9challenge& experiments,& the& prophylactic&administration&of&either&anti9F4+ETEC&monoclonal&antibodies,&or&immunised&egg&protein,& or& animal& plasma& as& source& of& antibodies& has& been& successful& in&preventing& F4+ETEC& infection& (Marquardt! et! al.,& 1999;& Niewold! et! al.,& 2007;&Yokoyama! et! al.,& 1992).& However& it& has& been& difficult& to& implement& these&techniques& outside& the& laboratory,& since& immunised& hen& egg& antibodies& are&expensive&and&there&are&concerns&about&the&safety&and&efficacy&of&animal&blood&derived& plasma,& owing& to& which& use& of& animal& plasma& in& feed& is& strongly&discouraged.&In& this& research& project,& we& envisaged& production& anti9F4+ETEC& antibodies& in&plant&seeds&that&can&be&incorporated&into&the&feed&of&weaning&piglets.&To&this&end,&as&a&proof&of&concept,&we&designed&a&novel&robust&antibody&by&fusing&the&antigen&binding& domains& of& camelid& antibodies& (VHH)&with& the& fragment& crystallisable&(Fc)&of&porcine&immunoglobulin&IgG3&(proteolytically&stable).&Four&anti9F4+ETEC&VHHs&were&selected&via&panning&from&a&lymphocytic&cDNA&library&derived&from&a&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&22& From& the& archives& of& Dierengezondheidszorg& Vlaandern& (Animal& health& care,& Flanders)&http://www.dgz.be/&
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lama& immunized&with&purified&major& adhesion&molecule9& FaeGac,&which&makes&the& F4& fimbrial& shaft.& The& VHH9IgG& fusion& DNA& coding& sequences& were&introduced& into& a& seed& specific& expression& cassette& and& transformed& in&Arabidopsis.& Transformants& with& each& of& these& VHH9IgG& antibodies& were&screened& for& the& highest& antibody& producing& seed& stocks.& Of& these& VHH9IgG&antibody,& the& one& named& V2G& accumulated& to& very& high& levels& of& about& 3%& of&seed&weight&(i.e.&~30&gram&antibody&per&kg&of&seeds);&while&another&named&V1G&accumulated& to&~2%&of& seed&weight,&while& the& remaining& two&named&V3G&and&V4G& each& accumulated& to& about& 0.4%& of& seed& weight.& All& the& 4& VHH9IgG&antibodies&were&functional&in&an&ELISA&assay&and&agglutinated&the&bacteria.&Thus&proving& that& functional! VHHHIgG! antibodies! can! be! produced! in! high!
amounts!in!seeds&of&transgenic&plants&(Chapter&4).&&Further& based& on& the& same& VHH9Fc& fusion& strategy& we& developed! a! novel!
format! of! secretory! IgA! (SIgA)& antibodies.& Secretory& IgA& antibodies& are& the&predominant&class&of&antibodies&at&the&mucosal&surface&and&they&are&involved&in&establishing&a&first&line&of&defense&(Corthésy,&2003).&Role&of&mucosal&immunity&is&likewise& also& suggested& to& be& essential& in& preventing& the& pathogenesis& of&F4+ETEC&in&piglets&(Verdonck!et!al.,&2004b).&By&grafting&the&4&isolated&VHHs&onto&the& Fc& fragment& of& porcine& IgA& and& co9expressing& these& fusions& with& porcine&joining& chain& (J& chain)& and& porcine& secretory& component& (SC)& in& seeds& of&Arabidopsis&plants,&we&demonstrated&that&three&different&and&unique&functional&formats& of& IgA& can& be& produced–& monomeric,& dimeric& and& secretory& IgA& like&molecules&designated&as&simplified!secretory!IgA!(sSIgA).&The&accumulation&of&the& assembled&molecules& depended& on& the& expression& of& each& element,&mainly&the&J&chain&and&SC;&while&the&expression&of&the&4&VHH9IgA&antibodies&was&roughly&equivalent& in& all& seed& stocks& analyzed.& The& overall& production& levels& of& these&functional&assembled&sSIgA&molecules&was&estimated&to&amount&to&about&0.2%&of&seed&weight&(Chapter&5).&All& the&antibody&producing& seed&extracts& (each&of& the&4&VHH9IgG&and& the& three&formats&of& the&VHH9IgA& i.e.&monomeric,& dimeric& and& sSIgA,& bearing& the& same&4&VHH&antigen&binding&domains)&specifically&agglutinated!the!F4+ETEC!bacteria!
and! inhibited! the! interaction!with!gut!villous!enterocytes! in)vitro.& Further&
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the&protective&efficacy&of&these&antibodies&was&evaluated&in&an&animal&challenge&experiment.&Milled&Arabidopsis&seeds&with&and&without&antibodies&were&added&to&the&feed&of&weaned&piglets&prior&to&challenge&with&high&dose&of&F4+ETEC&bacteria.&Throughout& the& experiment,& the& daily& shedding& of& F4+ETEC& bacteria& was&determined,& the&seroconversion&of&F4&specific&serum&immunoglobulin&(IgM,& IgG&and&IgA)&were&analyzed&and&the&piglet&weight&were&recorded.&Analysis&of&which&showed&that&a&prophylactic&feed&formulation&with&an&oligomeric&cocktail&of&all&the&IgA& based& antibody& formats& at& a& daily& dose& of& 20& mg/pig& (VHH9IgA920)& was&protective,&while& the& IgG&antibody& format&was&not.&The&piglets& receiving& (VHH9IgA920& feed)& showed& a& swift& decline& in& bacterial& titer& as& compared& to& negative&control& piglets& that& received& wild& type& Arabidopsis& seeds& in& their& feed.& The&results& for& the& piglets& receiving& VHH9IgG& cocktail& in& their& feed&were& not& clear;&neither&at& a&dose&of&20&mg/pig/day& (VHH9IgG920&group)&nor&at&80&mg/pig/day&(VHH9IgG980&group).&Two&of&the&3&piglets&receiving&the&20&mg&dose&of&VHH9IgG&feed&turned&out&to&be&relatively&insensitive&to&the&F4+ETEC&pathogenesis,&as&they&had&very&low&phenotypic&expression&of&the&F4+ETEC&receptor&(F4R).&In&the&VHH9IgG980& group,& all& 7& piglets& had& moderate& phenotypic& expression& of& F4R,& and&showed&prolonged&shedding&of&bacteria,&indicating&that&the&VHH9IgG&treatment&at&this&dose&was&not&protective.& In&conclusion,& the&oligomeric&cocktail&of&VHHHIgA!
administered!in!feed!is!a!promising!antiHF4+ETEC!therapeutic!for&preventing&F4+ETEC& infections& post& weaning.& For& further& valorization& of& VHH9IgA& based&prophylactic& therapy,& the& technique& and& the& antibody& used& has& been& patented&(Application& no.& EP& 12182774.5).& Also& the& expression& of& VHH9IgA& will& be&evaluated&in&the&seeds&of&pea&and&soybean&as&these&crops&can&be&bulk&produced&and&are&routinely&used&within&the&standard&piglet&feed.&Thus&this&Ph.D.&research&project&has&brought&the&antibody&based&anti9ETEC&prophylaxis&one&step&closer&to&its& translation& towards&a& commercial& feed&based&prophylaxis.&We&envisage& that&similar& approach& could& also& be& used& for& many& other& diseases& in& humans& and&animals&(Chapter&6).&&&&&&&
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Abstract!The& present& invention& relates& to& an& antibody& that& can& protect& against& ETEC&infection&in&a&passive&immunization&set&up.&More&specifically&it&relates&to&a&VHH&grafted&on&an&IgA&scaffold,&and&produced&in&plant&seeds.&When&the&seeds&are&given&in&food&or&feed,&the&subject&is&protected&against&ETEC&infection.&
Claims!1. A&fusion&protein&comprising&an&anti&ETEC&VHH&fused&to&an&IgA&Fc&domain.&2. The& fusion& protein& according& to& claim&1&wherein& said& anti& ETEC&VHH& is&selected& from&the&group&consisting&of&an&anti&F4+&ETEC&VHH&and&an&anti&F18+&ETEC&VHH.&3. The& fusion& protein& according& to& claim&2&wherein& said& anti& ETEC&VHH& is&specific&for&the&FaeG&domain&of&the&E.!coli!F4&fimbriae.&4. The& fusion& protein& according& to& claim&2&wherein& said& anti& ETEC&VHH& is&specific&for&the&FedF&domain&of&the&E.!coli!F18&fimbriae.&5. The&fusion&protein&according&to&any&of&the&previous&claims,&wherein&said&IgA&is&a&porcine&IgA.&6. The&fusion&protein&according&to&claim&5,&wherein&said&porcine&IgA&is&IgAb.&7. A& protein& complex,& comprising& a& fusion& protein& according& to& any& of& the&claims&196,&and&a&J&chain&and/or&a&secretory&component&chain.&8. A&nucleic&acid,&encoding&a&fusion&protein&according&to&any&of&the&previous&claims.&9. The&nucleic&acid&according&to&claim&7,&wherein&said&nucleic&acid&comprises&SEQ&ID&N°&1,&SEQ&ID&N°2,&SEQ&ID&N°&3&or&SEQ&ID&N°&4.&10. A& transgenic& plant,& expressing& a& fusion& protein& according& to& any& of& the&
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‘Episode!2H!LayHman!in!the!big!town’&&Before& I& could& get& my& feet& wet& into& the& subject& I& found& myself& drenched& in& Brussels&(literally).& If&Ann&was&the&steering&wheel&of&my&PhD,& then&Henri& (Henri&De&Greve)&was&the&ignition.&Henri,&got&me&kick&started&into&the&topic&with&panning&of&nanobodies&from&lama& immune& library.&He& introduced&me& to&my&mentor&Els! (Els&Pardon),& thanks& to& the&able& and& very& structured& guidance& of& whose;& I& had& the& ideal& Nanobodies& in& no& time.&Thank&you&Els.&&I&remember&one&of&those&first&days,&Henri!not& just&showed&me&around&his& lab,&but&also&pleasantly& surprised& me& when& he& actually& took& the& pipet& and& showed& me& the&agglutination& protocol.& Henri,& you& haven’t& ceased& to& pleasantly& surprise&me& since& that&day&on.&You&have&always&been&a&phone&call&away,&you&promptly&replied&to&my&mails&even&in& the&wee&hours.& You&were& always& enthusiastic& and& as&we& say& in& India& ‘ready& on& one&foot’& to&come&down&to&Ghent& for&any&meeting&or&guidance&that&I&needed.&Your&constant&support&and&backing&was&always&motivating.&I&am&particularly&thankful&for&your&coaxing&during&the&final&leg&of&my&thesis&writing,&which&helped&in&achieving&what&seemed&like&a&herculean&task&of&writing&thesis&in&a&month&and&a&half.&&&
‘Episode!3H!A!greenhouse!with!200!gardeners’&&It&was&in&a&talk&that&I&once&heard,&“One’s&postdoctoral&career&is&his&own&responsibility&but&the& credit& of& your& PhD& goes& to& your& department”.& Those&words& though& percolated,& its&true& wisdom& only& dawned& on&me& later.& I& am& so& thankful& to& the& entire& department& of&Plants& Systems& Biology& for& presenting& this& unique& environment& to& excel.& Thank& you,&
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